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Abstract
A dynamic contrast-enhanced (DCE) near-infrared (NIR) method to measure
cerebral blood flow (CBF) in the neurocritical care unit (NCU) is described. A
primary concern in managing patients with acquired brain injury (ABI) is
onset of delayed ischemic injury (DII) caused by complications during the
days to weeks following the initial insult, resulting in reduced CBF and
impaired oxygen delivery.
The development of a safe, portable, and quantitative DCE-NIR
method for measuring CBF in NCU patients is addressed by focusing on four
main areas: designing a clinically compatible instrument, developing an
appropriate analytical framework, creating a relevant ABI animal model, and
validating the method against CT perfusion. In Chapter 2, depth-resolved
continuous-wave NIR recovered values of CBF in a juvenile pig show strong
correlation with CT perfusion CBF during mild ischemia and hyperemia
(r=0.84, p<0.001). In particular, subject-specific light propagation modeling
reduces the variability caused by extracerebral layer contamination. In
Chapter 3, time-resolved (TR) NIR improves the signal sensitivity to brain
tissue, and a relative CBF index is be both sensitive and specific to flow
changes in the brain. In particular, when compared with the change in CBF
measured with CT perfusion during hypocapnia, the deconvolution-based
index has an error of 0.8%, compared to 21.8% with the time-to-peak method.
To enable measurement of absolute CBF, a method for characterizing the AIF
is described in Chapter 4, and the theoretical basis for an advanced analytical
framework—the kinetic deconvolution optical reconstruction (KDOR)—is
provided in Chapter 5. Finally, a multichannel TR-NIR system is combined
with KDOR to quantify CBF in an adult pig model of ischemia (Chapter 6). In
this final study, measurements of CBF obtained with the DCE-NIR technique
show strong agreement with CT perfusion measurements of CBF in mild and
moderate ischemia (r=0.86, p<0.001).
ii

The principle conclusion of this thesis is that the DCE-NIR method,
combining multidistance TR instrumentation with the KDOR analytical
framework, can recover CBF values that are in strong agreement with CT
perfusion values of CBF. Ultimately, bedside CBF measurements could
improve clinical management of ABI by detecting delayed ischemia before
permanent brain damage occurs.

Keywords
Near-infrared spectroscopy, cerebral blood flow, time-resolved, dynamic
contrast-enhanced, delayed ischemic injury, acquired brain injury
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Chapter 1
INTRODUCTION
The objective of this introductory chapter is to provide the reader with an
appreciation of why the topic of this doctoral thesis—the development and
validation of near-infrared (NIR) methods to quantify cerebral blood flow
(CBF) in the neurocritical care unit (NCU)—was studied. First, the rationale
for this work will be provided within the context of the clinical problem:
acquired brain injury (ABI). This will involve a description of the pathological
mechanisms underlying some of the most common conditions treated in the
NCU—traumatic

brain injury

(TBI) and nontraumatic

subarachnoid

hemorrhage (SAH). The importance of quantifying CBF for the management
of these patients will be highlighted, and current methods for measuring CBF
will be described. After establishing the motivation for this work, the
theoretical basis of dynamic contrast-enhanced (DCE) NIR techniques, which
encompasses the methods developed in this work, will be provided. In
particular, the specific challenges of applying DCE-NIR methods to an adult
head to measure CBF will be highlighted. This final point represents the
main knowledge gap that this thesis will address.

1.1. Rationale
The neurocritical care unit (NCU) has emerged as a specialized intensive care
unit responsible for the treatment of life-threatening neurological illnesses.
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Often, patients admitted to the NCU are comatose or paralyzed and present
with injuries to other parts of the body, making their management difficult.
In a collaborative effort, neurointensivists, neurosurgeons, diagnosticians and
nurses are responsible for the clinical management of NCU patients to
ensure the best chance for survival (Diringer et al 2001). Acquired brain
injuries—including TBI, diffuse acquired brain injury, stroke, and SAH from
traumatic or aneurysmal origin—comprise the majority of cases for which
patients are admitted to the NCU. For the purpose of this thesis, discussion
will be limited entirely to ABI and principally those injuries caused by TBI
and its sequelae, as well as SAH.

Figure 1.1: Prognosis of traumatic brain injury.
The approximate outcomes of 1.7 million TBIs that occurred annually in the United States
during years 2002-2006. Of the 275,000 hospitalizations, 52% of individuals died or suffered
permanent disability. (Figure adapted from Langois 2010 and Baron and Jallo 2007).

From an epidemiological standpoint, TBI is the single most common
cause of death and disability among children and young adults (Langlois
2000). At least 1.7 million people sustain a TBI each year in the United
States (figures from 2002-2006, when the US population was approximately
300 million); 275,000 of those individuals are subsequently hospitalized and
about 52,000 of those injuries are ultimately fatal (CDC 2010). The term
“traumatic brain injury” reflects an etiology (i.e., a brain injury sustained in

3
trauma) rather than a specific pathology, which can be complex and
multifaceted. Therefore, TBI is further stratified according to mechanism
(blunt or closed injury versus penetrating or open injury), spatial pattern of
disease (focal or diffuse), and severity of primary brain damage (Glasgow
coma scale). Proper classification of TBI can help establish a prognosis, and
provide insight into possible complications that are likely to follow. For
example, a focal pattern of TBI is likely to result in cerebral contusions,
hemorrhages, and hematomas (Baron and Jallo 2007).
In addition to TBI, the NCU supports patients with non-traumatic ABI
such as ischemic stroke and subarachnoid hemorrhage. In particular, SAH
accounts for about 5% of strokes, but remains among the most lifethreatening neurological diseases and affects primarily adults under the age
of 60. In fact, because SAH affects preferentially young individuals—with a
mean age of 50 years (Nieuwkamp et al 2005)—the number of years of
potential life lost by SAH accounts for about 25% of all stroke-related
diseases (Johnson et al 1998; Hop et al 1997). Therefore, SAH has a societal
impact comparable with ischemic stroke. Nontraumatic SAH—for which 85%
of cases are secondary to the rupture of an aneurysm (Sehba et al 2012)—
occurs when blood extravasates into the CSF-filled space between the
arachnoid membrane and pia mater known as the subarachnoid space. The
mortality rate of SAH is 40%, and includes approximately 10-20% of patients
who die before receiving advanced medical care (Sehba et al 2012).
Furthermore, SAH patients are susceptible to serious complications following
the initial injury, which will be further discussed in the subsequent section
(van Gijn J 2001).
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1.2. Complications in acquired brain injury
1.2.1. Clinical presentation
Following the primary brain injury caused by either TBI or SAH, the
principal concern of the NCU is to minimize complications during the acute
recovery stage that compromise the outcome of the patient. Complications
that develop secondary to the initial injury represent the single greatest
threat to the outcome of the patient, as a significant portion of neurological
damage develops during the days to weeks following hospitalization, rather
than during the primary insult. Most often, these complications result from
impaired blood flow which prevents adequate oxygen delivery to the brain
tissue, resulting in permanent "secondary brain injury" or “delayed ischemic
injury” (DII) (Wartenberg 2011; Coles 2004). Although DII is the
manifestation of a pathological cascade beginning within hours of brain
injury, it is a target for intervention since it tends to progress gradually while
the patient is in the NCU. Therefore, a primary concern of the NCU is to
detect and minimize these complications, which include intracranial
hypertension, edema, vasospasm, and other bleeding disorders (Rincon and
Mayer 2007), before permanent brain injury results.
Intracranial hypertension, in which intracranial pressure (ICP)
becomes elevated, is among the most important complications that occur in
brain injury patients. An increase in ICP usually results from a mass effect—
either edematous or hemorrhagic in nature (Steiner and Andrews 2006).
Since the skull acts as a closed container, ICP becomes elevated when the
overall volume of three elements—brain parenchyma volume, blood volume,
and cerebrospinal fluid (CSF)—increases. To some degree, slight variations in
one element can be compensated by the other two according to the MonroKellie doctrine (Mokri 2001). Figure 1.2 shows a schematic of this
compensatory mechanism.

5

Figure 1.2: Compensatory mechanism
In a normal state, the intracranial pressure (ICP) is tightly regulated. When a mass effect
occurs due to some underlying pathology, a small increase in volume can be accommodated
by reductions in blood volume and cerebral spinal fluid (CSF). Larger increases overwhelm
the compensatory mechanisms and brain tissue expansion causes elevated ICP leading to
herniation and distortion.

Compensation occurs as either blood volume, or more often CSF, is reduced to
accommodate the expanding lesion. In the latter case, CSF is reabsorbed and
the production of new CSF is reduced in the presence of slightly elevated ICP
(Cutler et al 1968). Continued expansion of the mass will result in
progression

through

compensation,

partial

four

stages

of

compensation,

intracranial

hypertension:

decompensation,

and

total

vasomotor

paralysis (Barlow and Stewart 2007).
A principle cause of intracranial hypertension is brain edema, which
increases the brain parenchymal volume. Defined as the swelling of brain
tissue, brain edema can be vasogenic or cytotoxic in origin (Ropper 1984). In
vasogenic edema, the blood-brain barrier is disrupted by the primary or
secondary injury, allowing the extravasation of fluid and proteins across the
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otherwise tightly regulated endothelium and into the interstitial space of the
brain parenchyma. As a result, an osmotic gradient is created, drawing water
into the interstitum. In cytotoxic edema, the primary insult causes a
disruption in brain energy metabolism, resulting in a depletion of energy
stores needed to maintain ion homeostasis (Liang et al 2007). The resulting
increase in interstitial osmolality draws water across the blood-brain barrier
and causes a subsequent increase in intracranial pressure. Edema of the
brain can result in secondary brain injury if the increase in parenchyma
volume overwhelms the compensatory mechanisms described in the previous
paragraph.
An additional cause of intracranial hypertension is the development of
a hematoma, a localized collection of blood outside of the vessels, which can
pool between the dura mater and the skull (i.e., epidural hematoma) or
between the dura mater and the arachnoid mater (i.e., subdural hematoma).
Epidural and subdural hematomas are examples of extra-axial hemorrhage
(Wilberger et al 1991)―bleeding that occurs outside of the brain tissue but
within the skull. In addition to extra-axial hemorrhage, intra-axial or
cerebral hemorrhage can also occur. When cerebral hemorrhage occurs
secondary to brain injury, it is usually due to penetrating head trauma or
acceleration-deceleration trauma (Udstuen and Claar 2001). In all of these
examples, elevated ICP is a principle concern. In some circumstances, this
can be mitigated by early evacuation of the hematoma (Wilberger et al 1991).
Delayed ischemic injury is also a primary concern in SAH, and
develops in approximately one third of patients within the first two weeks.
The main cause of DII in SAH patients is the development of vasospasms—
spontaneous spasms in cerebral blood vessels leading to vasoconstriction—
which have a high rate of mortality and must be treated aggressively
(Crowley et al 2011). The risk of developing vasospasm following aneurysmal
SAH appears to be related to blood clot burden, and is likely triggered by an
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inflammatory response within the blood-vessel wall that manifests sometime
between days 4 and 12 post-SAH. The fact that the amount of blood seen on
the initial CT scan is the best predictor of the occurrence of vasospasm in
aneurysmal SAH (Hijdra et al 1988) also suggests that vasospasm induction
is blood-mediated. Cerebral vasospasm can also occur in TBI, and while the
importance of vasospasm in aneurysmal SAH has been well-studied,
considerable controversy surrounds the exact relationship between TBI and
vasospasm (Werner and Engelhard 2007). Unlike in SAH, where vasospasm
seems to be directly related to factors released by the blood clot, TBI-related
vasospasms are frequently detected in patents without CT evidence of
bleeding (Taneda et al 1996). This calls into question whether all vasospasms
share the same pathophysiology, and underlines the challenge in managing
patients for whom vasospasm-related complications may not be easily
predicted based on CT imaging.

1.2.2. Clinical management
There is a growing body of evidence that suggests that the NCU has
improved both survival and outcome in patients with ABI (English et al 2012;
Varelas et al 2006). For example, a reduced mortality rate following
intracerebral hemorrhage was observed in patients admitted to NCUs
compared to general intensive care units (Diringer and Edwards 2001).
Improvements in patient recovery has been principally due to the NCU’s
ability to manage the complications associated with secondary brain injury,
which combine standard clinical practice of intensive care medicine with
interventions that target specific complications such as elevated ICP, reduced
CBF, and hemorrhage.
Osmotherapy is considered the first-line method for managing raised
ICP and involves the rapid infusion of mannitol or hypertonic saline.
Mannitol, a crystalline sugar alcohol, creates an osmolar gradient in the
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brain, drawing water across the blood-brain barrier (Muizelaar et al 1984). A
similar ICP-lowering effect is achieved by the infusion of hypertonic saline.
When administered repeatedly, osmotherapy can be an effective means to
manage raised ICP, notwithstanding the additional risks that require careful
monitoring of electrolyte status and serum osmolarity. In addition to
osmotherapy, decompressive craniectomy can be used to reduce ICP.
Decompressive craniectomy involves removing part of the skull to allow the
expansion of the brain parenchyma in the presence of uncontrollable elevated
ICP. Despite being used for more than a century to manage brain swelling
and ICP, its current use is controversial. Several previous studies (Hofmeijer

et al 2009; Vahedi et al 2007; Jüttler et al 2007) reported neutral findings,
and while a meta-analysis of these studies suggests a benefit to craniectomy
in certain patient subgroups, further research is needed before routine
decompression craniectomy can be recommended (Mitchell et al 2009).
While there is no general consensus on the treatment or prevention of
DII following SAH, current treatment recommendations include prophylactic
nimodipine (Barker et al 1996), along with the so-called "triple H" therapy
(hypervolemia, hypertension, and hemodilution) (Weyer et al 2006). The
motivation behind these treatments is to prevent contraction of cerebral
arterial smooth muscle cells and/or to counter the effects of increased
vascular resistance by increasing cerebral perfusion pressure and reducing
blood viscosity. For instance, nimodipine, a dihydropyridine-type calcium
channel blocker, inhibits the influx of extracellular calcium which acts on
smooth muscle cells to effect vasoconstriction. As a standard-of-care, the only
proven therapy for vasospasm is nimodipine (Weyer et al 2006); however,
"triple-H" therapy may be indicated for individual patients on a case-by-case
basis.
In addition to the management of DII, best evidence-based practices
generally indicated for intensive care patients remain important for
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neurotrauma patients. These include ensuring optimal oxygenation through
proper ventilation, maintaining appropriate levels of glucose and nutrition,
and monitoring temperature homeostasis. In particular, the injured brain is
thought to have low tolerance to hypoglycemia, and is a concern unique to
neurocritical care (Vespa et al 2006).

1.3. Assessing delayed ischemic injury
1.3.1. Current clinical methods
While many of the management options discussed in the previous section are
effective in alleviating some of the deleterious complications that develop
during recovery, a principle challenge is detecting the onset of DII in NCU
patients. First, it is often difficult to differentiate between clinical features
resulting from the primary injury and those symptoms that develop
subsequently. Early signs of DII present as general neurological defects or
reduced consciousness, which can also be attributed to other causes (e.g.,
effect of sedatives, hypotension, heart failure). In addition, many NCU
patients are comatose or heavily sedated, and clinical features are unreliable
for these individuals (Vergouwen et al 2010).
Electroencephalography (EEG) is used to monitor cerebral electrical
activity (i.e., voltage fluctuations that result from neuronal activation in the
cortex). Several studies have investigated the use of EEG to detect DII in
SAH patients (Vespa et al 1997; Claassen et al 2004a) and TBI (Claasen et al
2004b), in part by identifying clinical features associated with energy failure.
In particular, epileptic activity, which can be accurately detected using EEG,
could exacerbate brain energy impairments and increase glutamate-mediated
excitotoxicity (Vespa et al 1998). As well, a relationship between increased
seizure activity and cerebral hyperglycolysis has been documented in several
studies (Engel et al 1983; Evans et al 1984; Theodore et al 1983).
Hyperglycolysis, which occurs acutely after severe TBI, is indicative of
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impaired oxygen metabolism and can also occur during a major reduction in
CBF (Bergsneider et al 1997). In general, SAH and TBI produce a wide
variety of EEG abnormalities, some of which may be predictive of DII
(Rivierez et al 1991; Claassen et al 2004). However, in all cases, large sets of
EEG data must be interpreted by an expert, which is time consuming and
subjective, making general clinical thresholds for directing patient therapy
unlikely.
Intracranial pressure monitoring has become a mainstay of the NCU
as a standard surrogate of CBF. Because these methods are invasive, their
use is generally limited to poor-grade SAH (Wartenberg 2011) and severe TBI
(Brain Trauma Foundation 2008). Being a surrogate of CBF, there is
considerable controversy surrounding its use in directing patient therapy,
since large variations in optimal thresholds are likely to exist due to
differences in cerebral autoregulation (Jaeger et al 2007). Four randomized
clinical trials reported no significant relationship between ICP monitoring
and survival in TBI patients (Mauritz et al 2007; Mauritz et al 2008;
Thompson et al 2008; Griesdale et al 2010), and two additional studies
demonstrated conflicting results (Lane et al 2000; Shafi et al 2008). A
sytematic review of these studies found that the benefit of routine ICP
monitoring in severe TBI is not established and further research is needed
(Mendelson et al 2012).
The gold standard in the diagnosis of vasospasm is cerebral
angiography, despite having a specificity of only 50% (Uterberg et al 2001). In
addition to angiography, vasospasm is monitored using transcranial Doppler
(TCD), which can detect elevated blood flow velocities that occur with vessel
narrowing (Sloan et al 1989). However, like in the case of ICP monitoring,
vessel narrowing is only a surrogate of CBF, and not all patients with
vasospasm develop DII (Vergouwen 2011). Furthermore, DII can occur in
regions where large-vessel narrowing was not observed, but regional
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hypoperfusion and oligemia were nevertheless present (Dhar et al 2012).
Taken together, these studies suggest that vessel narrowing detected by
angiography, or the resulting elevated blood flow velocity detected with TCD,
are not reliable markers of DII, especially when neurological assessment is
unavailable (Vajkoczy et al 2003).
Recently, thermal diffusion flowmetry (TDF) has been described as a
potential method to measure absolute CBF and has been validated against
XeCT in adult sheep. (Vajkoczy et al 2000). While the ability of TDF to
measure CBF in absolute units is a positive step, the TDF technique is
invasive, requiring microprobes to be inserted directly into the cortical
parenchyma. The degree to which this might result in complications, such as
intracerebral hemorrhage or infection, is not yet known. Another limitation of
this technique is that it is only able to provide local CBF measurements from
a very small region of tissue. As such, a single microprobe placed in the
region of brain most susceptible to SAH-related vasospasm could miss up to
20% of cases (Vajkoczy et al 2003), likely requiring the placement of multiple
microprobes with additional patient risk.
Finally, xenon-enhanced computed tomography (XeCT) has emerged as
a promising method of measuring CBF in NCU patients (Yonas et al 1996), in
part due to the advent of portable CT units that can be used at the patient
bedside (Kim et al 2009). Like other CT perfusion methods, XeCT provides
only a single snapshot of CBF and the use of ionizing radiation, as well as the
expensive nature of inhaled xenon gas, precludes its use for frequent serial
measurements.
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1.3.2. Clinical value of measuring cerebral blood flow
In a normal, healthy adult, CBF is maintained by autoregulation at
approximately 50 ml min-1 100g-1. However, in pathological conditions,
autoregulation is disrupted or overwhelmed and CBF can decrease to critical
levels. When this occurs, depletion of high-energy phosphates—the brain’s
energy stores—occurs rapidly. If CBF falls below about 17 ml min-1 100g-1,
electrocortical activity is lost, as evinced by EEG, and increased anaerobic
metabolism occurs (Sharbrough et al 1973). Further reduction of blood flow
below 10 ml min-1 100g-1 results in the loss of ion homeostasis (due to failed
membrane integrity) and leads to an efflux of potassium from neurons.
Cytotoxic edema and subsequent cell death follow quickly (Astrup et al 1981).
In addition, the progression of tissue state from ischemia to infarction
depends on the duration of the insult. For example, extremely low CBF (less
than 5 ml min 100g) can result in an infarction within minutes. On the other
hand, when CBF is held at around 18 ml min-1 100g-1, permanent damage
occurs only after several hours (Astrup et al 1981). This dependency of
infarction on insult duration has been well established in the treatment of
acute stroke, where tissue is salvaged by prompt recanalization.
As highlighted in the previous section, complications that occur
following

ABI―including

elevated

ICP

from

edema,

hemorrhage

or

hematoma, and SAH-induced vasospasm―can severely reduce CBF and
result in DII and poor patient outcome (Rincon and Mayer 2007). Current
clinical methods to detect DII are limited, and involve monitoring surrogates
of CBF (e.g., ICP, CPP, blood velocity, etc.). A cursory review of literature
supports two principle conclusions. First, each of these methods may be
indicated for certain patients on a case-by-case basis; however, the systematic
use of any of these techniques is not supported by current evidence. Second,
emerging evidence supports the use of guideline-driven management of
severe TBI patents (who present with heterogeneous features that are
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unreliable for steering intervention) which has been shown to improve
patient outcome (Griesdale et al 2012). Presumably, measurements of CBF,
for which well-defined thresholds exist, have the potential of informing these
clinical guidelines.
In an early study by Yonas and colleagues, CBF measurements by
XeCT were acquired in fourteen SAH patients exhibiting symptoms of
vasospasm (Yonas et al 1989). Regions of CBF above 18 ml min-1 100g-1 did
not progress to infarction, whereas areas with CBF lower than 12 ml min-1
100g-1 resulted in conversion to infarction. For regions between 12 - 18 ml
min-1 100g-1, infarct conversion was variable. Although the sample size of the
study was too small to accurately determine optimal thresholds for CBF
predictive of infarct conversion, the determination of such a threshold could
enable more individualized treatment to the patients with the most to gain
(i.e., with CBF values close to the threshold for which infarct conversion is
variable).
Thermal-diffusion flowmetry was used to evaluate regional CBF in
fourteen patients with high-grade SAH. In each patient, two TDF
microprobes were inserted into the white matter of regions of the brain
supplied by the artery that was affected by the aneurysm (which included the
internal carotid artery, the anterior communicating artery, and the middle
cerebral artery). Thermal-diffusion flowmetry values of CBF predicted
symptomatic vasospasm in these patients with 85% sensitivity and 97%
specificity when a threshold of 10 ml min-1 100 g-1 was used. While the
threshold used in this study was lower than loss of neuron function
thresholds (i.e., 18 ml min-1 100g-1)―likely due to the lower blood flow in
white matter where the probes were implanted―the reliability of TDF
measurements was greater than TCD.
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Most recently, CT perfusion was acquired in 85 SAH patients to
determine a diagnostic threshold value with optimal sensitivity and
specificity to DII (Dankbaar et al 2010). Values of CBF and mean transit time
(MTT) were able to distinguish DII with greater than 70% accuracy.
However, since imaging was only performed at a single time-point, more
transient instances of vasospasm may have gone undetected.
The handful of studies investigating the ability of CBF measurements
to predict subsequent development of DII in high-risk SAH patients suggests
a CBF diagnostic threshold exists, and that a direct assessment of CBF can
confirm vasospasm and enable aggressive treatment (Powers et al 1985;
Soucy et al 1990). For this reason, the ability to directly measure CBF in
patients with SAH has been highly sought by clinicians (Vajkoczy et al 2003).
While the role of CBF measurements in TBI is less clear, it is well
established that CBF less than 18 ml min-1 100g-1 is present in about one
third of TBI cases, and is correlated with poor outcome and early mortality
(Bouma and Muizelaar 1995). Given the importance of proper stratification of
patients in the randomized clinical trials of future therapies for ABI, CBF
thresholds are likely to have an important role. The limitations of current
methods highlight the need for a non-invasive bedside technique to measure
CBF in NCU patients. Dynamic contrast-enhanced NIR techniques are well
suited to this goal, and the remainder of this chapter will provide the
necessary background on DCE methods in general, and in particular, on the
DCE-NIR method that was developed for NCU applications.

1.4. Dynamic contrast-enhanced measurement of
cerebral blood flow
1.4.1. History in humans
The pioneering work in the field of quantitative CBF measurement was
accomplished largely by Kety and Schmidt, who in 1945 described a method
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of measuring CBF based on the Fick principle (Kety and Schmidt 1945). This
method utilized the highly diffusible gas nitrous oxide as a blood flow tracer.
Cerebral blood flow was calculated by measuring the time-varying
concentration of nitrous oxide in arterial blood and venous blood samples
from the jugular bulb. A significant advancement in CBF measurements was
achieved using radiolabeled

85Kr

instead of nitrous oxide, as this provided a

means of assessing regional CBF by placing scintillation counting devices at
various locations on the scalp (Lassen and Munck 1955). This approach was
further improved by the use of radioactive

133Xe,

and through the work of

Obrist who modified the Kety-Schmidt equation to account for three tissue
compartments: extracerebral tissue, gray matter (which has a higher blood
flow (BF)), and white matter (which has a lower BF) (Obrist et al 1967).
Furthermore, the arterial input function (AIF) could be determined noninvasively from end-tidal

133Xe

measurements instead of requiring carotid

artery catheterization, making the technique more desirable clinically.
Diffusible tracer methods proved very popular in subsequent imaging
approaches, including the first truly tomographic method of quantifying
cerebral blood flow achieved using positron emission tomography (PET) and
H215O (Frackowiak et al 1980).
Around the same time, Axel published the theoretical groundwork for
DCE CT that implemented a sequence of scans following an intravenous
bolus injection of contrast to determine CBF (Axel 1980). Unfortunately, the
method required ultrafast acquisition times with little inter-scan delay
times―something the CT scanners at the time were unable to accomplish. As
well, the proposed method for analyzing the dynamic CT data relied on a
number of assumptions and was prone to subject-dependent effects (such as
the tissue hematocrit level) (Gobbel et al 1990). Nevertheless, the
groundwork by Axel laid the foundation for CT perfusion, which would

16
receive considerable attention as CT technology and analytical methods
improved over the next decade.

1.4.2. Current techniques
During the 1990s, CT scanners were developed with the capability of
performing repeat scans with acquisition times of about 100 milliseconds and
interscan

delays

of

about

1-2

seconds,

so

that

quantitative

CBF

measurements with dynamic CT imaging became feasible (Brix et al 1999).
As a result, CT perfusion has emerged as a robust, reliable, and accurate tool
to quantify CBF and is capable of providing parametric maps of CBF as well
as cerebral blood volume (Cenic et al 2000), mean transit time (Eastwood et

al 2002), and bolus arrival time (Eastwood et al 2002; Mayer et al 2000).
Current CT perfusion techniques can be considered variations on the
methodology outlined by Axel: CT slices are acquired at a high temporal
resolution during the injection of a bolus injection of contrast agent. The
analysis consists of reconstructing the time-series of images, defining the AIF
and voxel or region-of-interest (ROI) specific tissue concentration curves, and
performing kinetic analysis on these curves to recover kinetic parameter
maps. Most techniques differ by the manner in which they perform the final
step of kinetic analysis: mainly, whether they use a compartment-based
approach (Miles 1991; Mullani and Gould 1983) or deconvolution approach
(Cenic et al 2000; Eastwood et al 2002). The latter approach will be discussed
in following section. In addition to CT perfusion, CBF measurements can be
made using XeCT, DCE magnetic resonance imaging (MRI) (typically in
conjunction with a gadolinium-based tracer) or with the MRI arterial spin
labeling (ASL) technique (Wintermark et al 2005). In recent years, there has
been a rekindled interest in XeCT due to the development of portable and
intraoperative CT devices (Kim et al 2010). However, limitations of the device
include the high costs of xenon gas and the use of ionizing radiation (120
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mGy CTDIw), which makes it unsuitable for bedside measurements of CBF on
a continual basis.

1.4.3. Tracer kinetic modeling
The DCE NIR techniques presented in this thesis, in addition to CT
perfusion, rely on a bolus injection of a contrast agent to provide
hemodynamic information about a tissue region-of-interest (ROI). In this
context, the contrast agent acts as a blood flow tracer, which by definition is a
substance that behaves in the same manner as blood as it travels through the
tissue of interest (Lassen and Perl 1979). The transport of the tracer through
the microvasculature of the tissue can be described by constructing a kinetic
model and applying it to time-dependent measurements of the tracer
concentration. For example, the blood flow (F) to an organ can be determined
using the Fick principle if the time-dependent concentration of tracer in the
organ, Q(t), in the arterial blood, Ca(t), and the venous blood draining the
organ, Cv(t), are measured. In this case, the following expression describes
the dynamic behaviour of the tracer:

d Q(t )
 FCa (t )  FCv (t ).
dt

(1.1)

The most common type of model used in kinetic analysis is the Kety model,
which describes the behaviour of a highly diffusible tracer in a single tissue
compartment. Compartment models form the basis of the radioactive and
stable Xenon CT techniques and the radioactive H2O PET methods described
in the previous section.
There is a fundamental problem with applying compartmental models
to non-diffusible, intravascular tracers (e.g., iodine-based CT contrast agents,
and optical tracers such as indocyanine green (ICG) that bind to vascular
proteins) because the intravascular space (IVS) dynamics are much faster
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than the minimal extravascular space (EVS) component. Therefore, the tissue
cannot be treated as a single, well-mixed compartment. Instead, it is more
appropriate to consider the tissue vascular bed as a mesh of microvessels
supplied by a single input and draining to a single output (Fig. 1.3), where
each possible path from the artery to the vein has a specific transit time. In
this case, the concentration of tracer in the tissue at a given time point is a
function of its collective path through the capillary bed, as well as the AIF.

Figure 1.3: Blood flow through a capillary bed.
The convolution theory of kinetics treats the capillary bed as a black box, with an arterial
input, a venous output, and a transfer function based on the distribution of transit times
required by possible paths through the mesh.

The path that a particular tracer molecule takes is nondeterministic,
but a distribution of transit times, h(t), can be described for a bulk set of
tracer molecules (Meier 1954). This distribution describes the effect of a timeinvariant linear system on the input, Ca(t), such that the venous output can
be modeled as:
t



C v (t )  C a (u )h(t  u )du,

(1.2)

0

where u is a dummy variable in the convolution. Equation 1.2 provides a
definition for Cv(t) that is not dependent on any modeling assumptions, such
as instantaneous equilibrium, and by substitution, Eq. 1.1 becomes:
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dQ(t )
 FC a (t )  FC a (t )  h(t ).
dt

(1.3)

where * represents the convolution operator. To simplify Eq. 1.3, a more
convenient and closely related function, R(t), called the impulse residue
function is used to describe the dynamics of the system. R(t) is defined as the
fraction of dye remaining in the system at time, t, following the injection of
an idealized bolus (i.e., a Dirac delta function), and is given by:
t

R(t )  1   h(u)du,

(1.4)

0

Substituting R(t) for h(t), Eq. 1.3 becomes

Q(t )  C a (t )  FR (t ).

(1.5)

A deconvolution method (also called nonparametric analysis) is used to solve
Eq. 1.5, and does not require any explicit assumptions regarding the
underlying behaviour of the tracer beyond that required by the definition of a
linear time-invariant system. In other words, knowledge of the number
compartments and their distribution volumes are not necessary. However,
deconvolution is a mathematically difficult problem from the perspective of
real data analysis. In particular, even small amounts of noise in the
measured functions Ca(t) and Q(t) are amplified during linear inversion due
to the ill-conditioned nature of the inverse problem. Consider the matrix form
of Eq. 1.5 following discretization:

Q  FCA R

(1.7)

where the arterial input function, Ca(t), is now represented by the Toeplitz
matrix:
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The function FR(t) can be solved in a least squares sense by optimizing:



arg min CA  FR  Q
FR

2



(1.9)

where . is the Euclidean norm. Because of the redundancy of information in
CA, the problem is ill-conditioned, and minimization of Eq. 1.9 is highly
susceptible to experimental noise. A complete discussion of rank-deficient and
ill-posed problems is outside the scope of this thesis, but the reader is invited
to refer to (Hansen 1987) for more information. To stabilize the minimization
of Eq. 1.9, a number of options exist including truncated singular value
decomposition, Tikhonov regularization, and mathematical constraints based
on a priori knowledge (Dehghani et al 2007). All three methods have benefits
and limitations depending on the information that is desired. Since this
thesis is mainly concerned with the measurement of blood flow, it is assumed
that the principle parameter of interest is F. As previously mentioned, the
nonparametric method is useful when an explicit mathematical model of R(t)
is unavailable. However, there are some basic assumptions about the shape
of R(t) that can be inferred from an understanding of the basic physiology of
microcirculation that are unlikely to be violated even under pathological
conditions, and these form the basis for mathematical constraints that help
stabilize the deconvolution (Lee 2005). These assumptions are:
(i)

Tracer injected into a periphery vein will require a minimum
amount of time to travel to the heart and be pumped to the
tissue region-of-interrogation.
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(ii)

R(t) represents the residue function of a Dirac delta function; in
this unique case, the entire bolus of dye would reach the tissue
at a single instant in time.

(iii) In addition to (ii), there would be a finite amount of time before
the first molecule of dye left the region of interrogation.
(iv)

The dye must enter the tissue via an artery and exit via a vein
(i.e., no retrograde flow will occur).

These assumptions, which are all derived from a basic understanding of
physiology, will be satisfied under almost any clinically relevant condition;
however, from a mathematical point-of-view, they can be used to construct
rigid and powerful constraints that provide stability to the deconvolution.
Assumption (i) defines a finite delay between the injection and appearance of
dye, called the lag time, L, during which Q = 0. Assumptions (ii) and (iii)
defines a plateau equal to unity that begins after L time, and lasts for a finite
period of time called the minimum transit time, M. These provide the
equality constraints for R(t), mainly

R(t )  0

0t  L

R(t )  1

L t  LM

(1.10)

Assumption (iv) essentially implies that R(t) must be monotonically
decreasing, that is

dR(t )
0
dt

t LM

(1.11)

Finally, since there is no physical representation of negative tracer amount,

R(t) must be non-negative for all t. This final constraint enables the use of
the non-negative least-squares (NNLS) numerical method (Lawson and
Hanson 1974). The nonparametric method described above has been
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validated in CT perfusion using microspheres (Cenic et al 1999). For the
studies in this thesis, MATLAB was used to minimize Eq. 1.9 subject to the
inequality and equality constraints outlined above.
To a large degree, the use of DCE methods to measure CBF—and
tracer kinetics in general—have been confined to more established medical
imaging modalities such as CT, PET and MRI. However, in recent years,
kinetic modeling has been increasingly used in optics in combination with
light absorbing dyes. A major benefit of most optical techniques is that data
can be collected at high temporal resolution and with a high signal-to-noise
ratio (SNR). As a result, DCE methods are well suited to applications in
optics, and recent studies have established biomedical optics as fertile ground
for the advancement of new tracer kinetic methods and applications. In
particular, the deconvolution method has been used to measure CBF in
piglets (Brown et al 2002, Tichauer et al 2006, Diop et al 2010) and
premature newborns (Arora et al 2013) and it provides a foundation for the
analytical approaches used in Chapters 2-6 of this thesis.

1.5. Theoretical basis of near-infrared methods
1.5.1. Near-infrared scatter
Light scatter, (i.e. the deviation of light from a straight trajectory), is the
dominant interaction with tissue in the near-infrared range between 700 1000 nm. The main causes of scatter in this range are Mie scatter and
Fresnel reflection. A third type, Rayleigh scatter, represents interaction
between light and very small particles, and is increasingly important at
shorter wavelengths of light; therefore, it is outside the scope of this thesis.
As light propagates through tissue, it interacts with cell membranes, tissue
boundaries, and organelles; at each interface, light is reflected and refracted
by these objects, and therefore experiences a deviation in trajectory. The
majority of scattering in mammalian cells is thought to arise from structures
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within the cell, i.e. organelles (Mourant et al 1998). Mie scatter characterizes
the interaction of light with spherical particles of size similar to its
wavelength, and is described by the Mie solution to Maxwell's equations (Mie
1908). Most organelles such as nuclei (3-10 μm) and mitochondria (1 μm) can
be approximated as spheres or ellipsoids, and can therefore be described by
Mie scatter.
A significant portion of scatter in brain tissue occurs by cell
membranes, which are comprised of lipoproteins (Cope 1991). Since cells are
significantly larger than the wavelength of NIR light, it is best to consider
them as a set of randomly oriented flat, dielectric reflecting films (Cope
1991). The reflection and transmission of an incident plane wave of light as it
moves between two media of differing refractive indices is described by the
Fresnel equations. For a single, well defined interface, the amplitude and
phase of the transmitted and reflected light can be readily determined if the
angle of incidence and indices of refraction of the two media are known.
However, it would be impossible to produce an analytical solution for the
interaction of light between the roughly 1 x 108 cellular interfaces and
organelles that typically exist within 1 mm3 of tissue (estimated from
Norazmi et al 1990 and Loud 1968). Instead, the scattering of light is
described statistically using probability functions and empirically derived
approximations.
The scatter of light in tissue is typically discussed in terms of the angle
of scatter and the distance between scattering events. The scattering angle is
most commonly described by the Heyney-Greenstein phase function, which
was originally developed to describe the angular dependence of light
scattering by small particles in interstellar dust clouds (Heyney and
Greenstein 1941). The function describes the probability of a particular
scattering elevation angle, θ, given the tissue’s anisotropy factor, g:
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p( ) 

1 g2
1
.
4 (1  g 2  2 g cos  ) 3 / 2

(1.12)

The anisotropy factor, g, is the mean cosine of the scattering angle, and in
biological tissue, typically varies from 0 to 1. Such probability functions can
be used to sample the bulk behaviour of light, and form the basis of modeling
approaches collectively called Monte Carlo methods, which will be further
discussed in subsection 1.5.4.
The average distance between scattering events is described in terms
of the mean scattering length, ls, of a medium, usually in units of mm. More
commonly, the scattering property of tissue is defined by the scattering
coefficient, μs, which is equal to 1 / ls. For a medium with high scatter, such
as tissue, after a sufficient number of scattering events, a photon has lost any
knowledge of its incidence angle and can be considered effectively isotropic.
In this case, the scatter of light can be approximated by a single parameter,
the reduced scattering coefficient, μs′, which is defined as:

s  (1  g)s

(1.13)

In addition, the wavelength dependence of μs′ is well approximated by the socalled power law:

 s ( )  Ab

(1.14)

where A and b are constants either empirically determined or predicted by
Mie theory, depending on the application (Wang 2000). A good understanding
of the principles of light scatter is essential to any quantitative biomedical
optical techniques. In particular, the probability function in Eq. 1.12 and the
description of absorption in the next section form the basis for Monte Carlo
methods.
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1.5.2. Near-infrared absorption
As light propagates through a medium, energy from the incident field is
transferred to particles in the medium, which are in turn excited to a higher
energy state. While this excited state is short-lived, the resulting collisions
that occur between these particles and neighbouring ones results in a
transfers of energy—for example, by increasing the vibrational mode of the
particle and therefore the kinetic energy of the system, or by re-emitting the
light in a different color. This process is known as absorption, and causes a
reduction in the intensity of a light beam as it travels through the medium.
The first mathematical description of this process was given by Pierre
Bouguer in 1729, and later extended by August Beer to include the
dependency of light absorption not only on the pathlength through the
medium, but also on the concentration of light absorbing molecules, or
chromophores, in the medium. The resulting Beer-Lambert-Bouguer Law is a
given by:

A  ln

I0
   C  L,
I

(1.15)

where I0 is the incident intensity, I is the transmitted intensity, (the log ratio
of which is A, is the attenuation of light), C is the chromophore concentration,

L is the pathlength of light through the medium, and ε is the specific
extinction coefficient.
Within the NIR range of 700-1000 nm, there are three main
endogenous absorbers of light: water, hemoglobin, and deoxyhemoglobin.
Water is arguably the most important, since it is prevalent in biological
tissue. Although the absorption of NIR light by water is relatively weak
(about 50 times less than hemoglobin), because of its abundance in human
tissue it has a significant effect. In particular, the specific absorption of water
rapidly increases with wavelength after about 920 nm, effectively forming the
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upper-limit on what is termed the "optical window" of NIR. The concentration
of water in the adult brain is tightly regulated to a value of 80% by mass
(Woodard and White 1986).
Since the pioneering work of Jobsis in the 1970s, hemoglobin and
deoxyhemoglobin quantification has been a principle focus of many NIR
techniques. This can be attributed to the unique spectral features of both of
these chromophores in the NIR, and the clinical importance of hemoglobin in
being the molecule responsible for the transport of oxygen from the lungs to
the various tissues in the body. Structurally, hemoglobin is comprised of four
subunits which are each able to bind a single O2 molecule. Binding of oxygen
occurs at the heme group—an iron ion held in a porphyrin ring (Caughey et

al 1975) and induces a conformational change in its tertiary structure,
resulting in a dramatic change in absorption characteristics. The effect of this
change can be observed in the difference in specific absorption of deoxy- and
oxy-hemoglobin depicted in Figure 1.4. In addition to marked differences in
features at 760 nm and 900 nm, oxy- and deoxy-hemoglobin share an
isobsetic point at 800 nm (i.e., their specific extinction is equal at this
wavelength). The difference in absorption spectra between the two
hemoglobins forms the basis for the ability to determine oxygen saturation,
for example, in pulse oximetry (Aoyagi 2003).

27

Figure 1.4: Specific absorption spectra of H20, Hb, HbO2 and ICG in the NIR range.
Values for H2O and ICG are adjusted by a factor of 101 and 10-2, respectively, for illustrative
purposes. Spectra were obtained from (Oregon Medical Laser Clinic 2013).

1.5.3. Light propagation in tissue
Light transport, like any propagation of electromagnetic radiation, is
governed by Maxwell’s equations. In this paradigm, a beam of light interacts
with an object resulting in elastic scattering (i.e., the spreading of energy in
all directions at the frequency of the incident beam), as well as absorption
(i.e., the conversion of incident energy to other forms such as heat). The
resulting scattered field can undergo subsequent interactions with other
objects. In a highly complex, multiple scattering regime, analytical solutions
to Maxwell’s equations become intractable (Wilson and Jacques 1990).
Furthermore, to determine the superposition of multiple scattered fields, it is
necessary to know the exact location of each scatterer. In tissue, due to
Brownian motion, the scatterers exist in randomized positions. Therefore, it
is more appropriate to consider light as comprised of individual photons that
are absorbed or scattered by discrete random particles. This description of
light is governed by the radiative transfer equation (RTE), which is given by:
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1 
Lr, t , sˆ   sˆLr, t , sˆ    a   s Lr, t , sˆ    s
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 Lr, t, sˆPsˆ, sˆd  S r, t, sˆ

4

(1.16)
and describes the propagation of radiance Lr, t , sˆ  in the medium as a
function of the position r, moving in direction ŝ , at time t. Other parameters
include υ, the velocity of light in the medium, μa and μs, (the absorption and
scattering coefficients, respectively), Psˆ, sˆ , the scattering phase function,

S r, t , sˆ , the source term, and d, the solid angle around ŝ .
To obtain analytical solutions specific to a particular problem,
boundary conditions are applied to the RTE. The most common solution in
the field of tissue optics is the diffusion approximation (DA). In the DA, it is
assumed that the source of light is an isotropic point source, and that
scattering within the medium is isotropic. This greatly simplifies Eq. 1.16, by
eliminating the dependency on ŝ , and by reducing the phase function to a
constant (1/4π). However, for short source-detector distances, and for complex
arbitrary media, the diffusion approximation can be inaccurate. A statistical
approach, rather than an analytical solution, can provide a powerful means of
sampling the RTE while incorporating effects of anisotropy. These solutions
are known as Monte Carlo methods.

1.5.4. Monte Carlo modeling
Monte Carlo simulations are a ubiquitous statistical approach used in a
variety of applications―e.g. nuclear physics (Anderson 1986), computational
biology (Huelsenbeck and Ronquist 2001), pricing financial derivatives
(Glasserman 2003)―when a closed-form expression is unavailable or
prohibitively difficult to formulate. Monte Carlo methods to model lighttissue interactions were introduced in 1983 by Wilson and Adam, and
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modifications were made by various groups, before the publication of the
Monte Carlo modeling of photon transport in multi-layered tissues (MCML)
which forms the foundation of almost all modern Monte Carlo light
propagation models (Wang et al 1995). Monte Carlo methods define
probability functions that describe the expected values of parameters—i.e.,
length between scattering events, direction of scatter and absorption—that
describe the interaction of light with tissue. For a simulated photon of light,
these probability functions are repeatedly sampled until the photon is either
detected by a hypothetical photodetector, or absorbed by the medium. Then,
the process is repeated for a large number of photons, typically 10 8, to
describe the fluence and flux of light in terms of spatially and/or temporally
dependent

functions.

To

increase

computational

efficiency,

some

simplifications are made that are not believed to affect the overall outcome of
the simulation. For example, photons are considered as "packets" which loose
a portion of their energy with each scatter event, and following each scatter
event, a photon continues, or is "killed"—with an increased likelihood of
being killed as its energy diminishes. Another implicit assumption is that
photons are independent of each other, and therefore, do not interact.
The MCML algorithm is divided into a series of decisions representing
physical interactions. For example, a photon packet is launched from a source
at a position and direction specified by the user. The first calculation
determines the photons step size (i.e., the distance from source to the first
scattering event). To understand how this is done, recall the definition of the
scattering coefficient from the previous section, which describes the expected
number of scattering events per unit length. Since each unit length is
expected to interact with a constant fraction of photons, a series of successive
unit lengths will result in an exponentially decaying number of photons that
have not been deviated from their trajectory. The probability of a photon
having a step-size, s, is given by

30

p( s )   s e   s s

(1.17)

This non-uniform probability function can be sampled with a computergenerated pseudorandom number using the following relationship (Wang and
Wu 2007):
x

 p( x)dx   ,

(1.18)

0

where ξ is a pseudorandom number in the interval 0 to 1. Substituting the
probability function from Eq. 1.17 into Eq. 1.18, integrating, and replacing (1ξ) with ξ on the basis that ξ is symmetrical about 0.5, yields

s

ln( )

s

.

(1.19)

This provides a sampling function for the step-size of a photon packet moving
through a semi-infinite turbid medium (Wang et al 1995). In addition to the
photon step size, the direction of scatter must be determined by sampling the
azimuth angle,  [0,2 ], and the elevation angle  [0,  ] . The manner in
which Monte Carlo treats the directionality of scatter differentiates it from
the DA and produces more accurate solutions in cases where the DA
assumptions are invalid. The azimuth angle is sampled uniformly over the
defined interval, but the elevation angle is determined by sampling the
Henyey-Greenstein function that was introduced in subsection 1.5.1.
Applying Eq. 1.18 to the phase function in Eq. 1.12,
2
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(1.20)
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Each successive scattering event causes a reduction in the weight, W, or
energy of the photon packet, represented by a fraction of its initial weight.
The reduction in weight, ΔW, is calculated by

W 

a
W
a  s

(1.21)

By sampling these three functions, Monte Carlo methods allow the user to
provide the optical properties (μa, μs, and g) of the tissue, and calculate the
fluence distribution (spatially or temporally) in the medium. In addition, the
pathlength of light can be summed for each photon packet and the mean
partial pathlength (MPP)—i.e., the average pathlength of light in each
region, or tissue type—can be recorded.
Small differences exist in between Monte Carlo methods in terms of
how they handle reflection at boundaries (Fresnel reflection), layers or
arbitrary geometries, detection of photons by a virtual photodetector, and
parallelization or scalability. In Chapter 2, the Monte Carlo method used in
the reported study was based upon the MCML code, and was written in
house using the C++ programming language, so that it could be run on a high
performance computing architecture called SHARCNet. In subsequent
chapters, the Monte Carlo eXtreme (MCX) method by Fang is used. This
algorithm is based on the earlier tMCimg algorithm by Boas and colleagues,
which advanced the MCML algorithm to allow modeling of photon
propagation in 3D segmented image volumes. The MCX method is essentially

tMCimg written in such a way that enables the use of graphics processing
units (GPUs) to run multiple instances of Monte Carlo in parallel. Because
each simulated photon packet is treated as an independent event, the Monte
Carlo problem is highly parallelizable; the first report of MCX demonstrated
an acceleration of about 300 times on a GPU capable of 500 GFLOPS. The
performance of GPUs has increased at a rate much greater than that of
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central processing units, and at the time of the writing of this thesis,
commercially available GPUs for personal computing use are capable of 20004000 GFLOPS. For a typical MCX simulation on an MRI human head atlas
(Fang and Boas 2009), 108 photon packets could be simulated in 47.5 − 95
seconds.

1.6. Near-infrared measurements in adults
1.6.1. Extracerebral contamination
Near-infrared methods of measuring CBF have been successful, especially in
neonatal applications (Arora et al 2013; Brown et al 2008; Edwards et al
1988; Tichauer et al 2009), where the scalp and skull is negligible and the
head can be thought of as a homogenous region comprised mostly of brain
tissue. However, when applied to adult subjects, these same methods
measure signal that is comprised of multiple tissue layers including brain
and scalp (Fig. 1.5). In some cases, the signal arising from the extra-cerebral
layers (ECL) can account for more than half the overall signal.

Figure 1.5: Interrogation of adult head with NIR light
Illustration of the underlying structure of the human head and the typical region of
interrogation by a NIR optode pair spaced about 30 mm apart. Note the large contribution to
light absorption by the extracerebral layer.

Both the scalp and skull are metabolically inactive and therefore poorly
perfused tissues. For example, the blood flow in the scalp is about 1/10th that
of the brain (approximately 5 ml min-1 100g-1). As a result, single-probe NIR
measurements acquired on the surface head, without accounting for
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contamination from the ECL, produce CBF values that are significantly
underestimated (Gora et al 2002). Figure 1.6 demonstrates the relationship
between extracerebral thickness and brain signal percentage, determined
using Monte Carlo simulations. To minimize the errors caused by ECL
contamination, it is necessary to increase cerebral signal sensitivity and
remove ECL signal contributions through some type of reconstruction
method.

Figure 1.6: Effect of extracerebral layer thickness on brain sensitivity.
The effect of increasing ECL thickness on the percent contribution of brain tissue to the total
differential pathlength for a 30 mm source-detector distance, as determined by two-layer
Monte Carlo simulation. The ECL was assumed to comprise 60% scalp, 30% skull, and 10%
CSF, and optical properties were taken from Strangman et al 2003.

1.6.2. Increasing cerebral sensitivity
Increasing the sensitivity to changes occurring in cerebral tissue reduces the
amount of ECL contamination, thereby helping to differentiate signals from
the ECL and the brain. This can be achieved through a combination of
instrumentation improvements and more sophisticated analytical methods,
which will both be discussed in this section. These advancements form the
crux of this thesis, as detailed in the research objectives presented in Section
1.7.
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Instrument-based solutions
The penetration depth of light increases as a function of source-detector
distance; therefore, the easiest method of increasing sensitivity to the brain is
by moving the detector optode further from the source. However, the flux of
photons across the surface of the head rapidly decreases with source-detector
distance representing an important trade-off that must be considered (Fig.
1.7)

Figure 1.7: Effect of source-detector distance on brain sensitivity and photon count.
The effect of increasing source-detector distance on the percent contribution of brain tissue to
the total differential pathlength assuming an ECL thickness of 10 mm. The flux of photons
exiting the surface decreases almost 5 orders of magnitude over the range of source-detector
distances.

Practically, a source-detector upper-limit of 40 mm is imposed by
signal-to-noise considerations for most current systems that use emission and
detection optodes comprised of fiber bundles with an active area on the order
of 400 um in diameter. However, a recent study avoided the substantial loss
of signal that occurs during fiber transmission by placing a photodetector
directly on the surface of the head (Liebert et al 2011). In addition to
minimizing fiber loss, this had the effect of increasing the active area
diameter of the optode from 400 um to 8 mm, the diameter of the
photocathode.
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A logical extension to the single channel approaches that have been
discussed is to deploy multiple optodes and collect data from these channels,
simultaneously.

This

multi-distance,

multichannel

or

depth-resolved

approach allows the separation of information into superficial and deep
components on the basis that light penetration increases with source-detector
distance. It is important to note, however, that due to the diffuse nature of
light, large source-detector distances only increase the proportion of signal
from the brain and don't eliminate the ECL contribution all together.
Nevertheless, by collecting information at multiple distances simultaneously,
it is possible to separate out information in terms of tissue layers, using an
optical reconstruction approach.
The development of time-resolved methods have greatly improved the
amount of information that can be acquired with a small number of optodes
and have opened up new avenues of exploration in terms of data analysis
(Diop et al 2010; Diop and St. Lawrence 2012). Time-resolved NIR methods
are photon counting techniques that use a laser light source to emit pulses of
monochromatic light and fast detectors to measure the time-of-flight of each
detected photon (i.e., the time required for a photon to travel from the laser to
the photomultiplier tube). This process is repeated, typically at a frequency of
around 80 MHz until about 107 photons are measured, and a histogram
called the distribution of times-of-flight (DTOF) is generated. Figure 1.8
shows a representative example of a DTOF collected on the surface of an
adult pig head. A series of DTOFs, resolved to typically 1024 time-bins, can
be collected continuously during the injection of a contrast agent at a rate of
about 2.4 Hz across multiple detectors simultaneously, representing a
staggering amount of information. Furthermore, because photons with longer
times-of-flight are more likely to have visited deeper tissue than those with
very short times-of-flight, selecting later time-bins has the effect of increasing
brain sensitivity. Combining some or all of these technologies results in a rich
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dataset full of information about the hemodynamics of the underlying brain
tissue. However, only with well-developed analytical tools can this
information be processed to yield accurate and quantitative measurements of
CBF. The closely related concept of frequency-domain (FD) NIR provides
analogous information to time-resolved NIR if measurements are collected
across a range of modulation frequencies Mei et al, 2013). However,
commercial FD systems typically use only a single modulation frequency.

Figure 1.8: Distribution of time-of-flight and instrument response function.
The DTOF and IRF for measurements acquired with a 20 mm source-detector distance on an
adult pig with an ECL thickness of 10.5 mm. Note the presence of an after-pulse in the IRF,
defined as an increased probability of a photon being detected after an initial detection event,
and is observed in almost all conventional PMTs.

Analytic-based solutions
Perhaps the simplest approach to incorporating multi-distance NIR
information was proposed by Schytz and colleagues, in a technique that
exploits the different amounts of ECL and brain signal contribution present
in short (10 mm) and long (30 mm) source-detector distances (Schytz et al
2009). In this approach, the change in optical density in the brain was
calculated by scaled subtraction of the short source-detector distance signal
from the long source-detector distance signal. While the approach represents
a good first step in trying to use multi-distance NIR measurements to isolate
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the brain signal, the scaling factor was based on an assumed value and
applied to the group as a whole. Therefore, the amount of intra-subject
variability likely impacted the results of the study, which did not show
sensitivity of NIR measurements to changes in CBF. A more robust approach
is to properly model the light propagation in the head for each subject
separately. This approach was used in the study highlighted in Chapter 2 of
this thesis. While collection of CW NIR information at multiple distances can
provide a limited ability to separate out the brain contribution to the signal,
TR NIR offers an exquisite amount of information even in a single or fewchannel approach. However, the main problem with TR NIR data is that the
experimental DTOFs represent the convolution between the instrument
response function (IRF) and the tissue impulse function (TIF). Although the
IRF can be measured independently, the recovery of a TIF from the DTOF
requires deconvolution of the signal; a challenging mathematical problem
that has only recently been addressed successfully (Diop and St. Lawrence
2012). Therefore, the proper analysis of DTOFs to exploit the sensitivity of
late-arriving time-bins has been challenging. An elegant approach was
proposed by Liebert and colleagues, and involves determining the statistical
moments of DTOFs―intensity, mean time-of-flight, and variance―effectively
reducing the large dataset into three "principle components" (Liebert et al
2004). The kth order moment of the DTOF, N(t), is defined as
t2



mk  t k N (t )dt ,

(1.23)

t1

where t1 and t2 are temporal integration limits. In addition to reducing the
size of the problem set, the influence of the IRF can be removed by using the
change in the normalized moments:

A  ln(m0 )

(1.24)
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The change in attenuation, ΔA, change in mean time-of-flight,  t , and the
change in variance, ΔV, are the principle moments used in moments-based
TR NIR methods. Theoretically, there is no limit to the number of moments
that can be used, however, noise increases significantly with order of
moment. Conceptually, the relationship between moment order and brain
sensitivity is not as straightforward as when considering the time bins of the
DTOF. However, in general, the sensitivity of brain tissue is highest in
higher order moments because changes in the tail of the TPSF have a more
dramatic effect on the width and skewness of the distribution. Figure 1.9
shows the sensitivity of attenuation and variance to layers located at depths
of 1, 5 and 9 mm. Note, the sharp increase in the sensitivity of variance to the
9 mm layer for source-detector distances greater than 30 mm.

Figure 1.9: Moment sensitivity factors as a function of source-detector distance
(A) The relationship between source-detector distance and mean partial pathlength, the
sensitivity factor for attenuation, and (B) the relationship between source-detector distance
and variance sensitivity factor, corresponding to depths of 1 mm (solid black line), 5 mm
(solid grey line) and 9 mm (dashed black line). Reproduced from Liebert et al 2004.

39
The sensitivity of a particular moment to a particular tissue region below the
surface of the head is represented by its sensitivity factor. Sensitivity factors
can be readily calculated using Monte Carlo simulations (Liebert et al 2004).

1.6.3. Multilayer reconstruction
The previous section described a variety of instrument-based and analytical
approaches to increasing the sensitivity of the detected signal to brain tissue.
However, proper isolation of the brain tissue signal requires the use of optical
reconstruction: a general term that describes the recovery of local changes in
tissue optical properties at a predefined region from a measured signal
containing contributions from multiple regions. Optical reconstruction forms
the basis for imaging methods including diffuse optical tomography (DOT)
and fluorescence molecular tomography (FMT), and is analogous in some
ways to CT and PET reconstruction. The optical reconstruction forward
problem is given generally by
NJ

S  

 A   ,
J

J

J

(1.27)

J 1

where μJ represents the collective optical properties defined for NJ spatial
regions, and  J is the local variations in optical properties responsible for
the variation S  in the detected signal S associated with the background
properties  J . The transformation between these two variations is given by

AJ, also called the Jacobian. Optical reconstruction is performed by
minimizing the difference between the experimental measurements of S ,
and the predictions of the model based on the update equation (Eq. 1.27).
Essentially, all optical reconstruction methods can be broken down into four
considerations: (i) selection of linear or nonlinear solver, (ii) definition of the
signal domain, (iii) calculation of the Jacobian, and (iv) availability of a priori
knowledge or "priors".
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Typically, DOT involving large variations in μa and μs must be solved
with nonlinear iterative solvers. However, in the DCE-NIR methods
described in this thesis, an assumption of linearity is made between the
measured signal and the change in absorption caused by the introduction of
tracer. This assumption is valid under the concentrations used in DCE
methods, based on the fact that ICG has a negligible effect on scattering
(Kuebler et al 1998) and its effect on the optical pathlength is negligible. The
signal domain is defined primarily according to the spatial location of source
and detector pairs used to construct the signal data. In DCE measurements
acquired on the surface of the head, spatial information is typically simplified
by using source-detector distance, ρ. The signal domain can be further
divided into dimensions that are specific to the type of instrumentation used.
For example, in broadband NIRS, signal can be defined according to
wavelength, λ, as in DOT methods that employ spectral constraints (Corlu et

al 2005). In the case of TR-NIR, the signal domain can be labeled according to
time-of-flight, t, or when used in conjunction with a moments-based
approach, moment order, k. Regardless of how the signal domain, Ω, is
defined, the Jacobian must be defined accordingly, in addition to being
defined for each region, J. In optical reconstruction, the Jacobian is
essentially a matrix comprised of partial derivatives of fluence and flux taken
with respect to μa and μs′. Therefore, to compute the Jacobian, light
propagation models are needed. The two principle models―Monte Carlo and
diffusion approximation, typically formulated as a finite element method
(FEM) are used. The FEM approach has the benefit of being fast, flexible,
and accurate under most conditions. As a result, it is the most widely used
method for FMT reconstruction. Monte Carlo is computationally demanding,
but more accurate, and calculation of TR DTOF functions is very
straightforward. Furthermore, Monte Carlo methods for calculating the
moments-based Jacobians are published (Liebert et al 2004).
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The incorporation of priors into optical reconstruction is perhaps the
most fertile ground for advances in quantitative DOT and FMT methods
(Pogue et al 2011). The importance of priors can be understood from an
algebraic perspective, in that optical reconstruction is an ill-posed and often
underdetermined

problem.

Therefore,

regularization

(which

is

itself,

fundamentally a prior in that it forces a solution with predetermined
qualities―i.e. smoothness) and prior-based constraints are essential for
converging to a unique solution. In recent years, a number of priors have
been described and each has been implemented in a variety of different ways.
For example, anatomical priors—information provided by an alternate
imaging modality such as CT or MRI—can be implemented into the
reconstruction process as a soft prior using Laplace regularization (Davis et

al 2007). Another common approach is to use spectral priors to constrain the
reconstruction of broadband data (Corlu et al 2005). Chapter 5, which is
based on a paper published in Optics Letters, describes a previously
unexploited prior based on temporal changes in absorption caused by the
injection of tracer. This "kinetic prior" was incorporated directly into the
optical reconstruction problem, in an approach referred to as kinetic
deconvolution optical reconstruction (KDOR). The standard approach to
extracting physiological measurements from DCE data is a two-step method
of first performing image reconstruction and then recovering kinetic
parameters with subsequent modeling. The use of KDOR mitigated much of
the loss-of-information that

occurs

due to

the ill-posed

nature of

unconstrained optical reconstruction (Elliott et al 2012). The KDOR approach
is highlighted in Chapters 5 and 6, and Appendix A.

1.7. Research objectives
The goal of this doctoral work is to develop a reliable bedside optical
technique capable of quantifying CBF in adult patients. It was hypothesized
that CBF can be measured accurately by correcting for inter-subject
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variability in tissue anatomy and optical properties. With this in mind, the
following four objectives were addressed:
(i)

Designing and optimizing a clinically-compatible instrument

(ii)

Developing an analytical framework

(iii)

Developing a clinically relevant ABI animal model

(iv)

Validating the technique against CT perfusion

Each chapter in this thesis represents a progression toward the central goal,
by advancing one or more of these objectives. A secondary goal of this thesis
is to provide the reader with an appreciation for the way in which this
research has unfolded, by which each study provided an important "piece to
the puzzle".

1.8. Thesis outline
The reminder of the thesis is divided into five chapters outlining published or
completed studies, and a final concluding chapter.

1.8.1. Measuring quantitative cerebral blood flow in a juvenile
porcine model using multidistance continuous-wave nearinfrared spectroscopy (Chapter 2)
Advancing CW-NIRS methods from neonatal applications to a juvenile pig
model with a non-negligible ECL can be achieved by employing multidistance measurements. This chapter summarizes the work presented in the
paper “Quantification of CBF in a juvenile porcine model by depth-resolved
near-infrared spectroscopy,” published in the Journal of Biomedical Optics in
2010 by Elliott JT, Diop M, Tichauer KM, Lee T-Y, and St. Lawrence K. The
proposed depth-resolved approach, which uses an algebraic approach to
separate signals by depth, is presented alongside with a comparison to a
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simple-subtraction approach and the single-channel method used in neonatal
studies. These optical methods are compared to CT perfusion measurements
as a clinical gold standard.

1.8.2. Measuring cerebral blood flow changes in adult pigs with
statistical moments of time-resolved near-infrared
measurements (Chapter 3)
A single-channel time-resolved method to measure changes in blood flow
using statistical moments of the time-of-flight distribution (DTOF) is
presented. Previous DCE methods using moments have examined the timeto-peak of the dye concentration curve; a more robust method is presented
that takes into account variations in the AIF. This method has the benefit of
being relatively insensitive to uncertainties in optical properties and ECL
thickness, but provides only a measure of the change in CBF. The work in
this chapter is based on the paper entitled “Variance of time-of-flight
distribution is sensitive to cerebral flow dynamics of indocyanine green as
confirmed by comparing scalp and brain measurements in adult pigs”
published in Biomedical Optics Express in 2013, by Elliott JT, Milej D,
Gerega A, Weigl W, Diop M, Morrison LB, Lee T-Y, and St. Lawrence K. The
work presents a series of animal experiments investigating the influence of
extracerebral and cerebral blood flow on the proposed blood flow index, and
represents a straightforward means of tracking CBF changes in a clinical
setting.

1.8.3. Measuring the arterial input function with a standard pulse
oximeter to facilitate the clinical implementation of DCE
optical methods (Chapter 4)
All of the DCE methods described in this thesis require the measurement of
the AIF—the time-dependent arterial concentration of dye. Currently, this
can only be measured noninvasively by a pulse dye densitometer, which is a
specialized device designed to measure arterial blood concentration of
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indocyanine green. In this chapter, an alternative method is described which
was first published in “Arterial input function of an optical tracer for dynamic
contrast enhanced imaging can be determined from pulse oximetry oxygen
saturation measurements” by Elliott JT, Wright EA, Tichauer KM, Diop M,
Morrison LB, Pogue BW, Lee T-Y and St. Lawrence K, published in Physics

in Medicine and Biology in 2012. The proposed method involves using a
standard pulse oximeter device to measure the AIF, with the goal of
overcoming practical obstacles to enable the use of DCE optical techniques in
clinical settings.

1.8.4. Kinetic deconvolution optical reconstruction: theoretical
basis and numerical simulations (Chapter 5)
To leverage the advances in instrumentation described in Chapter 3, a
completely novel analytical approach was developed to combine the optical
reconstruction of time-resolved multi-distance data with nonparametric
kinetic analysis, or deconvolution, used in previous DCE NIR methods. The
chapter is based largely on the published paper “Model-dependent constraint
to improve the optical reconstruction of regional kinetic parameters”
published in Optics Letters in 2012 by Elliott JT, Diop M, Lee T-Y, and St.
Lawrence K. This paper presents the theoretical derivation of the KDOR
concept, and demonstrates improved accuracy and precision in simulated
blood flow measurements in the human head. The KDOR methodology is
fully described in this chapter, and numerical simulations have been
expanded for completeness.
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1.8.5. Measuring cerebral hemodynamics in an adult pig model of
ischemia with time-resolved near infrared and kinetic
deconvolution optical reconstruction (Chapter 6).
The culmination of instrumentation and analytical advances is presented in
this chapter, where the DCE TR-NIR method is used in combination with the
KDOR approach to quantify CBF in adult pigs before and during cerebral
ischemia. This work, which will be submitted to a peer-reviewed journal in
the near future, establishes NIR as a potential tool to measure CBF in under
ischemic conditions. In addition to multidistance time-resolved data collected
before injection of ICG, segmented anatomical CT images are incorporated
into an optimization framework to determine the subject-specific Jacobian
used in KDOR.

1.8.6. Conclusions and future work (Chapter 7)
In the final chapter, the most significant findings from the previous five
chapters are summarized within the context of the stated objectives in
Section 1.7. In addition, areas of future work are discussed based on the
findings and limitations determined in the studies. Finally, the principle
conclusions of the thesis are presented.
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Chapter 2
MEASURING QUANTITATIVE CEREBRAL
BLOOD FLOW IN A JUVENILE PORCINE
MODEL USING MULTIDISTANCE
CONTINUOUS-WAVE NEAR-INFRARED
SPECTROSCOPY
This chapter is adapted from the work entitled “Quantitative measurement of
cerebral blood flow in a juvenile porcine model by depth-resolved nearinfrared spectroscopy” by Elliott JT, Diop M, Tichauer KM, Lee T-Y, and St.
Lawrence K, published in the Journal of Biomedical Optics in 2010. The focus
of this paper is to extend the quantitative continuous-wave (CW) nearinfrared spectroscopy (NIRS) methods of measuring blood flow to a scenario
where the extracerebral layer (ECL) is non-negligible: the juvenile pig model.
The original journal article from which this chapter was adapted can be
found at http://biomedicaloptics.spiedigitallibrary.org/article.aspx?articleid=

1103440.

2.1. Introduction
The rationale for measuring cerebral blood flow (CBF) at the intensive care
bedside was explained in Chapter 1. In particular, the ideal monitoring tool
should be noninvasive, portable, quantitative, and fully compatible with the
clinical environment. Although dynamic contrast-enhanced (DCE) near-

61
infrared (NIR) methods require the injection of indocyanine green (ICG), this
procedure is considered minimally invasive since intravenous access is
ubiquitous in the context of intensive care. Furthermore, the dye is extremely
safe as reflected in the low incidence of adverse reaction (approximately 1 in
250 000 (Garski et al 1978)). The portability of NIR is attractive, since
current methods of quantifying blood flow (e.g., CT, MRI, PET) are of limited
use in intensive care since patients are often unstable and not easily
transported to imaging suites. In fact, it is estimated that adverse effects
occur in up to 70% of transfers involving critically-ill patients (Waydhas
1999).
Continuous-wave, broadband, NIRS is a particularly robust technique
that is compatible with the intensive care environment as it is relatively
insensitive to ambient light. Dynamic contrast-enhanced NIRS capable of
measuring CBF employs either a change in arterial oxygenation or a bolus
injection of the light absorbing ICG. Both methods have been shown to
provide accurate CBF measurements in animal models and neonates
(Themelis et al 2007; Tachtsidis et al 2009; Brown et al 2002; Tichauer et al
2006; Springett et al 2001; Patel et al 1998). However, when applied to
juvenile or adult subjects, measuring CBF accurately has proven difficult.
The main reason for the reduced accuracy is the non-negligible effects on the
near-infrared signal of the ECL, as discussed in the previous chapter.
Because of the ECL, CBF is substantially underestimated (Owen-Reece et al
1996; Gora et al 2002; Rothoerl et al 2003). As such, NIRS has yet to develop
into a clinically feasible method for patients older than a few weeks of age,
and intensivists continue to rely on invasive subdural CBF techniques or
intracranial

pressure

(ICP)

probes

to

infer

changes

in

cerebral

hemodynamics. Not only do these techniques carry a risk of infection and
bleeding, evidence suggests that adhering to a set ICP threshold does not
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always ensure adequate oxygen delivery owing to differences in intracranial
compliance between patients (Wright 2007; Stiefel et al 2006).
This chapter describes a multidistance continuous-wave NIRS method
enabling depth-resolved measurements to quantify CBF in the presence of
significant ECL signal contamination. The approach is partly based on a
previous method for measuring CBF in neonates (Brown et al 2002), but
depth sensitivity is improved by collecting NIR signal from two detection
probes placed at different distances from the source. The relationship
between the depth of light penetration and source-detector distance forms the
basis for the separation of intra- and extra-cerebral signals (Hongo et al
1995). Monte Carlo simulations of a two-layer medium were performed using
subject-specific optical properties and ECL thickness parameters optimized
from CT anatomical priors and second-derivative spectroscopy measurements
of water, which was assumed to have a concentration of 80% in the brain.
Monte Carlo simulation results were then used to determine the mean partial
pathlengths (MPPs) for each layer and source-detector pair, which were used
to reconstruct the time-dependent concentration of ICG in brain. The brain
tissue concentration curve, in addition to the arterial input function, was
used to recover CBF using a nonparametric model (Cenic et al 1999).
The set of experiments highlighted in this chapter validates the
multidistance CW NIRS technique by collecting measurements of CBF with
NIRS and CT perfusion (Cenic et al 1999) over a range of hemodynamic
states in juvenile pigs. These results are compared with two other analytical
approaches: the single-probe method identical to that used in the previous
neonatal studies (Brown et al 2002), and a simple-subtraction method
whereby MPP values are assumed for the entire group (Schytz et al 2009).
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2.2. Materials and methods
2.2.1. Animal experiment
The study was approved by the Animal Use Subcommittee of the Canadian
Council on Animal Care at the University of Western Ontario (AUP #2007050-06). Eight juvenile Duroc x Landrace crossbred pigs were delivered from
a local supplier on the morning of the experiment. The pigs were
tracheotomized and mechanically ventilated while anaesthetized by 3%
isoflurane. Cannulae were inserted into each ear for injection of the NIRS
and CT contrast agents. An additional cannula was inserted into a femoral
artery for continuous monitoring of arterial blood pressure and to allow blood
samples to be collected for gas and glucose analysis. Following the surgical
procedure, isoflurane was reduced to 1.75% and the animals were allowed to
stabilize for 1 hour before measurements were collected.
Near-infrared spectroscopy and CT measurements of CBF were
collected concomitantly over a range of blood flow values. The range was
achieved by adjusting the respiratory rate in each animal to produce distinct
levels of arterial blood CO2 tension (PaCO2): hypocapnia (PaCO2 < 28 mm
Hg), normocapnia (PaCO2 ≈ 40 mm Hg) and hypercapnia (PaCO2 > 50 mm
Hg).

2.2.2. Instrumentation
An in-house developed continuous-wave spectrometer was used to collect
broadband, near-infrared intensity data (Diop et al 2009). The main
components of the system included an illumination unit, a multiplexer, and a
spectrometer consisting of a holographic grating and a cooled charge-coupled
device. The illumination unit was a 50-W quartz halogen light bulb that was
bandpass filtered to remove light outside the 600 to 1000 nm range. The
filtered light was coupled to a 2-m fiber-optic bundle (emission optode) with a
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numerical aperture of 0.55 and a 3.5-mm diameter active area. The opposite
end of the emission optode was placed on the scalp of the animal and held in
position by a specially designed probe holder. Two optical fiber bundles
(detection optodes) with the same specifications as the emission optode were
positioned at 10 and 30 mm distances from the emitter to collect light having
traveled through the multi-layered tissue. Light collected by the detection
probes was sequentially recorded at intervals of 200 ms using a multiplexer
as described in detail elsewhere (Diop et al 2009).

2.2.3 Near-infrared spectroscopic measurements of cerebral blood
flow
Cerebral blood flow was measured using a bolus-tracking method that
requires an intravenous bolus injection of ICG (0.1 mg/kg in 1 ml of sterile
water),

followed

by

continuous

measurements

of

the

time-varying

concentrations of ICG in arterial blood and brain tissue (Brown et al 2002).
The arterial concentration, Ca(t), was measured by a pulse dye densitometer
(PDD) (DDG-2001 A/K, Nihon Kohden, Tokyo, Japan) and the tissue
concentration, C(t), was measured by NIRS. Recall from Chapter 1 that the
two concentration curves are related by the following equation:

C(t)  Ca (t)  FR(t)

(2.1)

where FR(t) is the flow-scaled impulse residue function and * represents the
convolution operator. A necessary assumption is that blood flow remains
constant during the bolus-tracking experiment, which typically lasts about 70
seconds. An in-house developed deconvolution routine was used to calculate

FR(t) from the measured arterial and tissue concentration curves (Cenic et al
1999).
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2.2.4. Single-probe near-infrared spectroscopy
If it is assumed that the head is a homogeneous medium—i.e., the
contribution from the ECL is negligible—then the modified Beer-Lambert
Law can be used to determine time-dependent changes in the concentrations
of chromophores in brain from the change in light attenuation, ΔA(λ,t),
measured from a detector:

A , t  



n

   C n t   DPL

(2.2)

n

In this equation, λ represents wavelength, εn(λ) is the wavelength-dependent
extinction coefficient of each chromophore (corrected for the wavelength
dependence of the pathlength (Cope et al 1991)), ΔCn(t) is the concentration
change in the ith chromophore, and DPL is the total differential pathlength in
the medium, averaged across the fitting range 800−880 nm.

Without

attempting to remove ECL signal contamination, the absolute change in the
tissue concentration of ICG, C(t), following an injection of the dye can be
determined from ΔA(λ,t) data acquired at a source-detection distance of 30
mm. By collecting broadband NIRS spectra, the DPL can be determined by
second differential analysis using the spectral features of water absorption,
which are distinct at 740 nm and 830 nm, and assuming a water
concentration in the brain of 80% (Matcher et al 1994). This single-probe
homogenous approach is referred to as single-probe (SP) NIRS.

2.2.5. Depth-resolved near-infrared spectroscopy
If the ECL is non-negligible, brain signal can potentially be resolved with
NIRS by modeling the head as a two-layered medium and simultaneously
collecting ICG tissue concentration curves from two detection optodes placed
at different source-detector distances. The modified Beer-Lambert Law can
be generalized for this collection geometry as follows (Hiraoka et al 1993):
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A , t  

 
n

n

   C n, j t   MPPn

(2.3)

j

where ΔA(λ,t) is the wavelength-dependant change in attenuation measured
by the detector at time t, ΔCn,j is the concentration of the nth chromophore in
the jth layer, MPPn is the mean partial pathlength of light in the jth layer.
Depth-resolved measurements can be obtained by collecting signal at
multiple source-detector distances. Assuming that all other chromophore
concentrations remain constant during the time that the bolus is measured,
the concentration of ICG in the jth layer, Cj(t) is related to the change in
attenuation measured at the ith source-detector distance by:

Ai  , t  



icg

   C j t   MPPi , j

(2.4)

j

Note that this expression is a specialized version of the optical reconstruction
forward problem (Eq. 1.27). Recovering the layer-specific ICG concentration,

Cj(t), is achieved by optimizing the following expression:

arg min Ai     icg   C j  MPPi , j

2

subject to C j  0.

(2.5)

Cj

To solve Eq. 2.5, MPPs were estimated from a look-up table generated from
Monte Carlo simulations for various ECL thicknesses and various ECL
component (skull, scalp, and CSF) ratios (see subsection 2.2.7). First, the
thickness of the ECL was measured from a CT anatomical image of the
subject’s head. Second, a set of potential MPPs were selected from the library
from simulations that employed ECL thicknesses within 20% of the
measured value. Third, for each potential set of MPPs, second derivative
spectroscopy was applied to baseline attenuation data (i.e., attenuation data
acquired prior to ICG injection) to calculate the concentration of water in the
brain, CH2O,brain. Finally, the set of MPP values that resulted in a water

67
concentration closest to the assumed value of 80% was selected. Equation 2.5
was solved using these MPP values to recover Cj(t). The brain concentration
curve, C2(t), along with the arterial input function, Ca(t), were deconvolved to
recover FR(t) from Eq. 2.1. The deconvolution procedure used in this study is
explained in depth in subsection 1.4.3. This multistep procedure is referred to
as depth-resolved (DR) NIRS.

2.2.6. Simple-subtraction technique
If anatomical priors are unavailable, it has been proposed that ECL
contamination can be reduced by calculating a weighted difference in
attenuation measurements from the two optodes (Schytz et al 2009). In a
two-distance approach, if the light collected by an optode placed at 10 mm is
assumed to have interrogated only the ECL and the mean partial pathlength
of light through the ECL is assumed to be the same for light collected at both
distances, Eq. 2.4 can be simplified to

Cbrain(t ) 

A2  , t   A1  , t 
 icg    r  DPL

(2.6)

where ΔA1 and ΔA1 are change in attenuation measured at 10 mm and 30 mm
source-detector distances. Values for DPL and r were estimated from the
literature (Owen-Reece et al 1996); a pathlength factor of 5.9 was chosen (van
der Zee et al 1992) (corresponding to a DPL of 177 mm for a source-detector
distance of 30 mm) and the fraction of the DPL through the brain, r, was
assumed to be 0.35. This value represents the group average determined
from the Monte Carlo simulations presented in the following section. The
same values of DPL and r were used to analyze all data sets, irrespective of
the animal’s ECL thickness. This simple subtraction technique is referred to
as simple subtraction (SS) NIRS.
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Table 2.1: Optical properties used in the Monte Carlo simulations

Medium

µs' (mm−1)

µa (mm−1)

760 nm

830 nm

760 nm

830 nm

Scalp

0.73

0.66

0.0177

0.0191

Skull

0.93

0.86

0.0125

0.0136

CSF

0.01

0.01

0.0021

0.0026

Brain

1.18

1.11

0.0195

0.0106

Values are taken from literature (Strangman et al 2003).

2.2.7. Monte Carlo Library Generation
Monte Carlo simulations have been extensively used to model light
propagation in multi-layered media (Hiraoka et al 1993). To generate the
MPPs required for equations 2.3-2.5, a Monte Carlo code in C++ was
programed based on the code first published by Wang and colleagues (1995),
using the optical properties listed in Table 2.1. A library of MPP values was
generated for combinations of different ECL thickness (5 to 20 mm in steps of
1 mm) and relative scalp-to-bone ratios (3:7, 4:6, 5:5, 6:4, and 7:3; effectively
varying the bulk optical properties of the ECL) at two wavelengths (760 and
830 nm).
The use of only two wavelengths to characterize MPP over the fitting
range was necessary because central processing unit (CPU)-based Monte
Carlo simulations are time consuming—n.b., graphics processing unit (GPU)based solutions (Fang and Boas 2009) were not published at the time this
study was conducted. These particular wavelengths were used because their
optical properties for the various extra- and intra-cerebral tissues are well
documented, and they are also close to a distinct water feature at 740 nm and
enclose the peak absorption of ICG at 805 nm. Small discrepancies between
wavelengths was accounted for by correcting ε(λ) for the wavelength
dependency of pathlength (Cope 1991).
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Simulations were performed in parallel on the Shared Hierarchical
Academic Research Computing Network (SHARCNet) system, a high
performance computer cluster, and required 4-6 CPU hours per simulation on
average for 108 photons on a 2.2 GHz CPU core.

2.2.8. Computed tomography perfusion imaging
Computed tomography images of CBF were acquired using a LightSpeed QXi
multislice CT scanner (GE Healthcare, Milwaukee, WI). Eight 5 mm-thick
coronal slice scans (80 kVp, 190 mA) were collected at 1 s intervals for 40 s
upon injection of 1.0 ml/kg of the iodinated contrast agent iohexol (300 mg/ml;
Omnipaque™, GE Healthcare); the injection rate was 1 ml/s.

Figure 2.1: CT anatomical and perfusion images
(A) CT anatomical image showing the region of interest (yellow outline) directly below the
optical probe holder (white arrow). Red dashed lines on probe holder indicate position of the
optode. (B) Corresponding cerebral blood flow map determined by CT perfusion.

Parametric maps of CBF were generated from the cine images using CT
Perfusion 3 software (GE Healthcare). Regions of interest were defined on the
CBF images that corresponded to the brain volume interrogated by the NIRS
probes (Figure 2.1A). The thickness of the ECL was measured using
anatomical CT images acquired at the start of the experiment. Since the
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probe-holder was visible on the CT image, ECL thickness could be measured
directly below the location of the optodes (Figure 2.1B).

2.2.9. Statistical Analysis
All data are presented as mean ± SE unless otherwise stated. SPSS 16.0
(SPSS, Chicago, IL) was used for all statistical analyses and statistical
significance was defined as p < 0.05. Physiological parameters were analyzed
using one-way ANOVAs and a Tukey’s test for post-hoc analyses.
Correlations between CT and NIRS CBF were analyzed using parametric
linear regression. Non-parametric analysis was used to analyze the
relationship between the errors in the NIRS CBF measurements and ECL
thickness.

2.3. Results
Cerebral blood flow measurements were acquired in eight juvenile pigs. All
pigs were between one and two months of age with a mean weight of 16.2 ±
0.5 kg. The thickness of the ECL, as determined from anatomical CT images,
ranged from 7.5 to 14.5 mm, with a mean value of 10.4 ± 0.6 mm. In total, 25
ICG runs were completed; however, four NIRS measurements could not be
analyzed. In three cases the concentration of ICG injected was below the
threshold required for accurate PDD analysis and in one case the CT contrast
agent concentration was too low.
The results of the physiological parameters for the eight pigs at the
three different conditions are summarized in Table 2.2. As expected, average
PaCO2 and pH values were significantly different between hypo-, normo- and
hyper- capnia groups (p < 0.05). No statistically significant differences were
observed for any of the other physiological parameters.
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Table 2.2: Physiological parameters during the three conditions.

Hypocapnia
(nx=6)††
Heart Rate, beats/min

Normocapnia Hypercapnia
(nx=13)
(nx=6)

122 ± 5

132 ± 5

159 ± 15*

Mean arterial pressure,
mmHg

54.5 ± 2.0

57.8 ± 1.9

63.2 ± 1.9*

Arterial PCO2, torr

22.6 ± 1.3

38.9 ± 1.2*

57.4 ± 4.4*†

Arterial PO2, torr

238.7 ± 21.0

227.1 ± 15.8

212.9 ± 22.1

Arterial pH

7.58 ± 0.02

7.43 ± 0.01*

7.30 ± 0.03*†

Values are mean ± SE. *p < 0.05 compared with hypocapnia. †p < 0.05 compared with
normocapnia. ††nx refers to the number of ICG runs acquired at each capnic level.

To determine the error caused by ignoring the ECL, the SP-NIRS approach
was applied to ICG tissue concentration curves acquired with a sourcedetection distance of 30 mm and the resulting CBF estimates were compared
with CBF measured by CT perfusion. Figure 2.2A depicts an example of the
time-dependent change in optical density measured at both optode distances
following ICG injection.

Figure 2.2: Measured optical signals and recovered tissue dye concentration curves.
(A) The change in optical density following ICG injection at 1 cm and 3 cm detector probes
measured at 800 nm, and (B) the corresponding change in ICG concentration in the ECL and
brain following data processing by the DR-NIRS method. Data are from the same ICG run in
an animal with an ECL thickness of 14 mm.
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Figure 2.3 shows the SP-NIRS CBF measurements plotted as a
function of the corresponding CBF measurements acquired with CT
perfusion. The SP-NIRS technique consistently underestimated CBF and no
significant correlation was observed between CBF measurements from the
two techniques. The mean CBF determined by SP-NIRS was 18.17 ± 3.26 ml
min−1 100g−1, which was significantly different from the mean CBF value
determined by CT perfusion (69.91 ± 3.25 ml min−1 100g−1, p < 0.001).

Figure 2.3: Comparison of SP-NIRS CBF and CT perfusion CBF
Correlation plot comparing CBF measurements acquired by CT perfusion and single-probe
NIRS. Symbols represent the data grouped according to ECL thickness: less than or equal to
8 mm (solid diamonds), between 8 and 12 mm (shaded triangles), and greater than or equal
to 12 mm (open circles). No significant correlation between CBF measurements from the two
techniques was detected. The line of unity (dashed line) is shown for comparison.
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Figure 2.4 shows CBF values derived from the SS-NIRS technique
plotted as a function of the corresponding CBF values determined from CT
perfusion. Similar to the SP-NIRS results, no significant correlation was
observed between CBF measurements from the two techniques. The mean
CBF calculated by SS-NIRS (42.80 ± 7.58 ml min−1 100g−1) was greater than
that determined using SP-NIRS, but still underestimated the mean CBF
calculated from the CT perfusion data set.

Figure 2.4: Comparison of SS-NIRS CBF and CT perfusion CBF
Correlation plot comparing CT and SS-NIRS measurements of CBF. Symbols represent three
ECL groups described in figure 2.3. No significant correlation between the two
measurements was detected. The dashed line indicates the line of unity.
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The correlation between CBF measurements from DR-NIRS and CT
perfusion is shown in Figure 2.5. In this case, a strong, statistically
significant correlation was revealed (r2 = 0.714, slope = 0.92, p < 0.001). The
mean CBF measured using the DR-NIRS approach was 64.93 ± 3.47 ml min−1
100g−1, which was not significantly different from that measured by CT
perfusion.

Figure 2.5: Comparison of DR-NIRS CBF and CT perfusion CBF
Correlation plot comparing the CT and DR-NIRS measurements of CBF. Symbols represent
three ECL groups described in figure 4. The solid line represents the line of regression ( r2 =
0.714, slope = 0.92, intercept = 2.7, p < 0.001), and the line of unity (dashed line) is shown for
comparison.

A Bland-Altman plot was used to investigate the existence of any bias
in the CBF measurements and to determine the variability in the
measurements (Figure 2.6). The mean difference between the two techniques
was −2.83 ml min−1 100g−1. The limits of agreement, i.e., the region in which
95% of the differences lay, were −19.63 ml min−1 100g−1 and 14.00 ml min−1
100g−1. No discernible CBF-dependent errors were observed.
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Figure 2.6: Bland-Altman plot of DR-NIRS and CT perfusion CBF
Bland-Altman plot comparing CT and DR-NIRS measurements of CBF. Symbols represent
three ECL groups, as described in figure 4. The mean difference between the two
measurements (solid line) is −2.83 ml min−1 100g−1. The limits of agreement (dashed lines),
within which 95% of the differences reside, are 13.97 and −19.63 ml min−1 100g−1.

Non-parametric regression analysis was performed to further investigate the
relationship between ECL thickness and the percent difference between CT
perfusion and CBF values obtained with each of the NIRS techniques.
Significant correlations were observed for both SP-NIRS (ρ = -0.884, p <
0.001) and SS-NIRS (ρ = -0.861, p < 0.001). In contrast, there was no
correlation between ECL thickness and percent difference in CBF values for
DR-NIRS.

2.4. Discussion
An integral part of critical care management of ABI patients is the
maintenance of adequate CBF to avoid secondary brain injury. Near-infrared
spectroscopy has long been recognized for its potential as a non-invasive
bedside cerebral monitor due to its portability and sensitivity to cerebral
hemodynamics (McCormick et al 1991). However, its application to adult
patients has been challenged by the significant signal contamination from the
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scalp and skull. Previous studies have reported that CBF collected using
traditional NIRS approaches can be underestimated by more than a factor of
3, due primarily to the increase in optical pathlength through extra-cerebral
tissue (Owen-Reece et al 1996). Moreover, not only does ECL contamination
affect the accuracy of the CBF measurements, studies using ICG bolus
tracking methods have found that NIRS is also insensitive to changes in
CBF, which questions if NIRS can even be used to monitor relative CBF
(Schytz et al 2009; McCormick et al 1991). To overcome this major hurtle, a
multidistance NIRS approach was developed to resolve depth-specific
information. Monte Carlo simulations were used in conjunction with the twolayer modified Beer-Lambert law to extract the cerebral ICG concentration
curve from multi-distance NIRS data. The use of subject-individualized
Monte Carlo simulations to model depth-resolved NIRS has been proposed
previously in neural activation studies (Boas et al 2002; Custo et al 2010;
Yamada et al 2009). Selection of the appropriate simulation parameters for
each animal was based on its specific ECL geometry (i.e., thickness and
relative scalp-to-skull ratio) determined from anatomical CT images. A fixed
cerebral water concentration provided an additional constraint in the
selection process. The main finding of this paper was that CBF
measurements obtained with our Monte-Carlo driven, depth-resolved NIRS
technique correlated well with CT perfusion data (a clinically validated and
widely used technique for measuring CBF in humans (Konstas et al 2009a,
2009b)). As a corollary, we found that the more simplistic SP-NIRS and SSNIRS techniques did not provide reliable measurements of CBF.
It was expected from previous studies (Owen-Reece et al 1996; Gora et

al 2002) that the SP-NIRS technique would be inadequate for measuring CBF
in the intact adult head since the cerebral NIR signal comprises only about
30% of the total signal at a source-detector distance of 30 mm (see subsection
1.6.1). Qualitatively, this effect can be seen in the attenuation signal shown
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in Figure 1.2A. Signal collected by the 30 mm detector probe demonstrates a
relatively slow washout, typical of ECL tissue and attributable to its lower
blood flow. The effect of the significant ECL MPP was evident by the large
underestimations of CBF, calculated from the long-distance NIRS data
compared to the measurements acquired with CT perfusion. Furthermore, no
correlation between the two techniques was observed over a range of CBF
from 35 to 90 ml min−1 100g−1. These results agree with previous studies
conducted in humans (Gora et al 2002; Rothoerl et al 2003) and clearly
demonstrate that SP-NIRS is unsuitable for measuring CBF in adults.
Marginal improvements were observed for SS-NIRS, which relied upon
an assumed value of the mean partial pathlength in brain, over the SP-NIRS
approach; however, it also performed poorly relative to DR-NIRS. It might be
anticipated that even if SS-NIRS cannot accurately measure absolute CBF, a
correlation with CT perfusion could be expected, but this was not observed.
The most likely explanation for this discrepancy is that the relative
contributions of brain and ECL varied substantially from experiment to
experiment, as suggested by the dependency of SS-NIRS error on the ECL
thickness revealed by non-parametric analysis. Further analysis of the data
revealed that assuming the ECL MPPs are the same for both distances
introduced an error. The difference in the actual ratio compared to the
assumed ratio of unity was correlated with the error in SS-NIRS measured
CBF (r = −0.76, p < 0.01), suggesting that the large variability in the SSNIRS data has its source in the error of MPP values used in this approach.
Since the calculation of CBF is heavily dependent on the height of the ICG
curve, which in turn is dependent on the chosen value of brain MPP, any
discrepancy between the assumed MPP and the true value will lead to
considerable variance in the CBF estimate. These findings suggest that in
order to measure CBF precisely, a case-by-case method of calculating the
MPP values is prerequisite. These results also provide a plausible reason for
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the failure of SS-NIRS to detect changes in CBF in healthy human subjects,
as reported in a recent study (Schytz et al 2009), and may help to explain
some of the contamination issues observed in studies measuring cerebral
blood saturation by spatially resolved NIRS (Muehlschlegel and Lobato
2006).
The approach presented in the current study is based on a previously
validated technique using broadband continuous-wave NIRS to measure CBF
in neonates (Brown et al 2002). In contrast to the simpler techniques
presented above, the DR-NIRS technique attempted to correct for the
primary sources of inter-subject variability. By using independent Monte
Carlo simulations, with a priori information of the ECL thickness, MPP
values can be defined on a subject-by-subject basis. Furthermore, by using a
continuous-wave broadband NIRS system, second derivative spectroscopy can
assist with selecting the appropriate MPP values. By virtue of the fact that
the water concentration in brain is known (80%) and relatively stable
(Matcher et al 1994), the MPP selection process was constrained to only those
choices that met this criterion. Finally, our system uses a shutter
multiplexing system that allows for rapid collection of NIR signals from
multiple probes with high fidelity (Diop et al 2009). It is likely that these
characteristics contributed to the strong correlation that was observed
between CBF measurements from CT perfusion and DR-NIRS (Figure 2.5)
and also resulted in the small bias revealed by the Bland-Altman method
(Figure 2.6). When compared with the previous validation study published by
our group for the neonatal pig model which also used CT perfusion (Brown et

al 2002), the 95% confidence intervals shown in the Bland-Altman plot were
only slightly larger (±16.8 ml min−1 100g−1 compared to ±12.7 ml min−1 100g−1
in the previous study). Given the sources of uncertainty introduced by the
depth-resolved approach, as well as the decreased signal-to-contrast ratio, it
is encouraging to note that the difference in precision was only marginal.
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There are a few significant limitations in this study which should be
addressed. The first concern pertains to the reliance on a priori knowledge of
the ECL geometry from anatomical imaging. Certainly, a completely
independent technique would be more attractive and may potentially emerge
in the future. However, given that standard procedure for head trauma
neurological assessment upon admittance includes CT or MRI scanning, the
requirement

of

this

additional

information

for

subsequent

NIRS

measurements does not represent a significant burden. A second concern is
the possibility that the two-layer Beer-Lambert model used to characterize
light propagation through the pig head may not adequately represent the
human head. Similarly, this approach relied on assumed optical properties
for the ECL. While the selected brain MPP value was constrained by the
known

water

concentration—a

benefit

of

using

broadband

NIRS—

uncertainties in the assumed scattering and absorption coefficients for the
different extra-cerebral layers (scalp, skull and CSF) are likely to affect the
accuracy of the CBF measurements. More complex instrumentation, such as
frequency-domain and time-resolved NIRS have the ability to calculate the
optical properties directly from reflection measurements either by employing
an analytical model (Kienle and Patterson 1997) or fitting to Monte Carlo
simulations (Elliott et al 2011). In particular, multi-distance time-resolved
NIR methods have the benefit of also being more sensitive to deeper tissue
structures, and for this reason, the work presented in subsequent chapters
will explore this instrumentation.
A final limitation with this study pertains to the animal model that
was used. First, the mean thickness of the ECL in these animals was 10 mm
and, consequently, was more representative of a juvenile patient group than
an adult one. Second, the thick temporalis muscles originating in the
temperoparietal region have evolved in the pig to allow powerful mastication
are more metabolically demanding than the human scalp (Ström et al 1986).
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As a result, the blood flow values are significantly higher than what is
expected in the human (on the order of 3-4 times higher). Furthermore, hypoand hyper-capnia conditions are likely to elicit a global vascular response.
These factors combined result in an animal model that is likely more
favourable than the clinical scenario in terms of measuring CBF accurately.
All of these issues will be addressed in subsequent chapters, and ultimately
culminate

with

the

validation

of

the

kinetic

deconvolution

optical

reconstruction (KDOR) method of analyzing multidistance time-resolved DCE
NIR measurements (Chapter 6).

2.5. Conclusion
The salient finding of the present study is that, in contrast to the SP- and SSNIRS methods, the DR-NIRS technique demonstrated for the first time that
accurate measurements of CBF can be acquired with NIRS despite the
presence of a significant ECL. These results highlight the promise of using
NIRS for acquiring bedside measurements of CBF in neurological intensive
care patients, demonstrating the potential of NIRS to greatly improve clinical
management of these individuals.
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Chapter 3
MEASURING CEREBRAL BLOOD FLOW
CHANGES IN ADULT PIGS WITH STATISTICAL
MOMENTS OF TIME-RESOLVED NEARINFRARED MEASUREMENTS
This chapter is adapted from the work entitled “Variance of time-of-flight
distribution is sensitive to cerebral blood flow as demonstrated by ICG bolustracking measurements in adult pigs” by Elliott JT, Milej D, Gerega A, Weigl
W, Diop M, Morrison LB, Lee T-Y, Liebert A and St. Lawrence K, published
in Biomedical Optics Express in 2013. The focus of this paper is two-fold: to
investigate the specificity of time-resolved measurements to cerebral blood
flow (CBF) effects by sequential acquisition on the intact and ischemic scalp,
the skull, and directly on the dura matter; and, to determine the sensitivity of
time-resolved measurements acquired on the surface of the head to
hypocapnic decrease in CBF. Furthermore, this chapter describes a method
using more advanced instrumentation than in the previous continuous-wave
(CW) near-infrared spectroscopy (NIRS) study, as well as a more accurate
animal model of the adult neurotrauma patient, but highlights an analytical
approach that is only able to determine relative changes in CBF. The original
journal article from which this chapter was adapted can be found at

http://www.opticsinfobase.org/boe/abstract.cfm?uri=boe-4-2-206
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3.1. Introduction
In the previous chapter, a broadband CW-NIRS method of quantifying CBF
was presented. The salient finding of this study was that reconstruction of
brain-specific

optical

changes

is

possible

using

a

multi-distance

reconstruction technique stabilized with anatomical (i.e., CT or MRI imaging
data) and physiological/spectral (i.e., assumed water concentration of 80%)
priors. However, this approach was applied to smaller animals whose
anatomy more closely approximates the juvenile patient. Furthermore, it is
likely that the higher blood flow observed in the scalp of pigs compared with
humans limits the conclusions that can be drawn regarding the performance
of the method in adult subjects. To this end, the work presented in Chapter 3
describes the application of the more sensitive time-resolved (TR) NIR
instrumentation to investigate the influence of extracerebral hemodynamics
and optical properties (by systematically removing the scalp and skull) on the
measured signal. In addition, measurements acquired directly on the brain
were compared with contralateral measurements acquired on the head
surface during normo- and hypo-capnia. In this way, both the sensitivity—

i.e., the ability to reliably detect changes in CBF or hemoglobin
concentrations—as well as the specificity—i.e., the confidence that a change
in signal reflects only the brain and not the extracerebral tissue—were
investigated.
Dynamic contrast-enhanced (DCE) methods based on analysis of the
statistical moments of measured distributions of times-of-flight of photons
(DTOF) have been proposed as a way to increase the sensitivity to signal
changes occurring in the brain over conventional CW NIRS methods (Liebert

et al 2004). Following an injection of the vascular tracer indocyanine (ICG), it
is possible to record the concentration-dependent changes in three statistical
moments of DTOFs: total number of photons, N, mean time-of-flight, <t>, and
variance, V. To date, the moments-based technique has been applied to
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healthy volunteers (Liebert et al 2004, Jelzow et al 2012), stroke patients
(Steinkellner et al 2010; Liebert et al 2005), and other neurotrauma patients
(Liebert et al 2012), and qualitative analysis strongly suggests that the timedependent change in variance of the DTOF shows good sensitivity to
absorption changes occurring in the brain. However, these previous studies
employed qualitative methods, or attempted to quantify changes in CBF
using the time-to-peak (TTP) method, a relatively straightfoward but indirect
method of measuring change in CBF (Steinkellner et al 2010; Kuebler et al
1998; Terborg et al 2003), that is also dependent on cerebral blood volume
(CBV) and variations in the arterial input function (AIF).
To further investigate the potential pitfalls associated with the TTP
method limitation, an error analysis was conducted. In particular, the
dependency of TTP accuracy on the CBV and the TTP of the arterial input
function is highlighted. As an alternative to this method, a nonparametric
deconvolution-based method is introduced (Cenic et al 1999; Brown et al
2002; Elliott et al 2012) that enables the recovery of a relative blood flow
index, dBF. While this method differs from the quantitative deconvolution
method used in the previous chapter (since only a relative blood flow index is
recovered), the advantage of this approach compared to TTP measurements is
that confounding effects due to the AIF and CBV are removed.
In this study, an adult pig model is used to conduct a within-subject
comparison of moments collected on the surface of the scalp and moments
collected directly on the brain. In Part A (subsection 3.4.1), the experiments
involved manipulating the extracerebral layer to cause perturbations in both
scalp blood flow and the extracerebral optical properties (by surgically
altering the ECL composition). In Part B (subsection 3.4.2), DCE-NIR
measurements are acquired directly on the brain and contralaterally on the
scalp during normocapnia and hypocapnia—the latter causes CBF to
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decrease. Concomitant measurements were acquired by CT perfusion (CTP)
for comparison.

3.2. Theory
3.2.1. Statistical moments of distributions of times-of-flight
Time-resolved NIR techniques measure the times-of-flight of individual
photons at each detector over a few hundred milliseconds, building a
histogram

that

approximates

a

distribution

function.

It

has

been

demonstrated theoretically (Zaccanti et al 1995) and experimentally
(Steinbrink et al 2001) that later time-bins correspond to a group of photons
are statistically more likely to have interrogated deeper tissue structures.
Therefore, changes in absorption of light in brain tissue, for example
following the injection of dye, will differentially affect certain time bins in the
DTOF. A transformation can be written as follows:
N i 

A

i, j

  a , j ,

(3.1)

j

where ΔNi is the change in the number of photons occurring in the ith timebin of the DTOF, Δμa,j is the change in absorption coefficient in the jth layer,
and Ai,j is the sensitivity matrix describing the transformation between these
two functions. Since the experimentally measured DTOF is in reality a
convolution between ΔNi and the instrument response function (IRF), direct
analysis of the DTOF is challenging (Diop et al 2012). A simpler approach is
to use statistical moments, mk, of the DTOF:
t2

mk (t ) 

t

k

N (t )dt ,

(3.2)

t1

where k is the order of the moment, and t1 and t2 are temporal integration
limits. This approach reduces the dimension of the problem in Eq. 3.1, and
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the change in normalized moments is independent of the IRF (Liebert et al
2004). Furthermore, it has been demonstrated previously that higher-order
moments are more sensitive to changes occurring in deeper tissues (Liebert et

al 2004). A similar transformation to Eq. 3.1 can be written:

mk 

A

k, j

(3.3)

  a, j ,

j

where Ak,j is the sensitivity matrix describing transformation between a
change in the kth moment and the change in absorption coefficient occurring
in the jth layer. The changes in three moments are used to describe the timedependent changes that occur in the head following a bolus injection of dye:
attenuation, A, which is related to the zeroth moment, mean time of flight,

<t>, and variance of the DTOF, V. The mathematical definitions of these
moments and the sensitivity factors corresponding to the change in these
moments are given in Table 3.1. Sensitivity factors can be determined with
analytical (Kacprzak et al 2007) or Monte Carlo based methods (Steinbrink et

al 2001; Liebert et al 2003); the latter was used for this study.
Table 3.1: Definitions of statistical moments

Name

Related moment

Formula

Sensitivity
factor

Attenuation

zeroth moment (area
under the curve)

A  ln(m0 )

MPP

Mean time of
flight

first normalized
moment

t  m1 m0

MTSF

Variance

second centralized
moment

V  m2 m0  m1 m0 

2

VSF

The three moments used in DTOF analysis, along with their formulae and the abbreviations
for their sensitivity factors. MPP, mean partial pathlength; MTSF, mean time-of-flight

sensitivity factor; VSF, variance sensitivity factor.
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3.2.2. Indicator dilution theory
The previous section provides the mathematical basis for understanding how
a change in the absorption coefficient of underlying tissues will produce a
change in the measured moments. With dynamic contrast-enhanced
techniques, this change in absorption is caused by the injection of an
exogenous dye. If all other chromophores are assumed constant for the period
of time required to collect a measurement, then the change in absorption
coefficient in a tissue of interest as a function of time, T, is related to the
tissue dye concentration, C, by
a (T )  C (T )    ln(10),

(3.4)

where ε is the wavelength-dependent extinction coefficient of the dye.
Following a bolus injection into a peripheral vein, the dye is delivered first to
the heart, where it is subsequently pumped though the arterial circulatory
system to all tissues of the body. According to the convolution theorem (Meier
and Zierler 1954), the time-dependent tissue dye concentration is given by:
T



C (T )  F  Ca (u )  R(T  u )du,

(3.5)

0

where F is blood flow, Ca(T) is the time-dependent arterial concentration of
dye (i.e., the AIF), and R(T) is referred to as the impulse residue function.

R(t) represents the fraction of dye remaining in the tissue at time, T,
following an idealized bolus injection. The convolution theorem can be
derived from the Fick Principle and a previous publication provides
additional details of this derivation (Elliott et al 2011). The function Ca(T) is
common to all tissue regions in the body, while in contrast, R(T) and F are
specific to each tissue region. Therefore, if C(T) is characterized from signal
containing information from multiple regions of tissue, F and R(T) are in
reality a weighted average of the tissue-specific functions represented in the
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probed region. In the case that the region-of-interrogation contains multiple
layers of tissue, a more rigorous expression is found by combining Eqs. 3.3
and 3.4 with the convolution in Eq. 3.5, yielding the moment-specific solution:
T

mk (T ) 

 F    ln(10)  A  C (u)  R (T  u)du.
j

j

a

k, j

j

(3.6)

0

This convolution describes the fundamental relationship between the
behavior of contrast agent in the tissue and the measured change in DTOF
moments.

3.2.3. Quantification of blood flow changes
In this paper, we investigated two different approaches of measuring change
in CBF: the time-to-peak method and the relative deconvolution method. The
time-to-peak of the tissue function, TTPC, is defined as the time elapsed
between the first appearance of dye, T0, and the peak concentration of dye,

Tmax (Fig. 3.1).

Figure 3.1: Time-to-peak analysis
A depiction of the time-to-peak (TTP) method. Hypothetical tissue and arterial concentration
curves including the effects of dye recirculation are shown by the solid black lines, along with
their corresponding TTP values (TTPC and TTPCa, respectively). The solid grey lines
represent the first moments of the concentration curves without the effects of recirculation.
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The time-to-peak can be related to CBF using the first moments of the
tissue and arterial concentration curves. A property of a convolution is that
the first moments are additive (Jaynes 2003) and, therefore, Eq. 3.5 can be
written as:

t

C

 t

Ca

 MTT .

(3.7)

The mean transit time (MTT), which is the first moment of the flow-scaled

R(t), is equal to CBF/CBV by the central volume principle (Meier and Zierler
1954). Typically, tissue and arterial functions can be approximated by
gamma variate functions (Thompson et al 1964). However, over the interval

T0 < t ≤ Tmax, these functions can be approximated by a symmetrical function,
such as a Gaussian. In this case, the first moment equals the time-to-peak:
t

C

= TTPC and

t

Ca

= TTPCa. Eq. 3.7 can be rewritten as:

TTPC  TTPCa 

CBV
.
CBF

(3.8)

Note that TTPC not only depends on CBF, but also on CBV and TTPCa.
Therefore, the influence of initial values of these two parameters must be
considered when interpreting the relative change in TTPC.
An alternative approach to characterizing the DCE curves is to
perform a deconvolution to recover a relative blood flow index, dBF,
representing the scalar quantity defined by the summation in Eq. 3.6.
Generally, dBF for the kth moment is

dBFk 

 F    ln(10)  A
j

k, j .

(3.9)

j

It has been suggested that the variance of measurements acquired on the
scalp has greater sensitivity to brain tissue and the influence of the extra-
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cerebral layers is relatively small (Liebert et al 2004). If this is the case, the
variance sensitivity factors for the extracerebral layers are approximately
zero and the summation in Eq. 3.9 collapses to:
dBFV  CBF    ln(10)  VSF ,

(3.10)

where VSF is the sensitivity factor for the brain layer. If VSF remains
constant between measurements, the change in dBF equals the true change
in CBF (ΔCBF). To recover dBF, an algorithm incorporating physiologically
derived constraints was used to stabilize the deconvolution, which is an
inherently unstable process. This algorithm has been described and validated
previously, both for CT perfusion (Cenic et al 1999), and near-infrared
techniques in neonatal models (Brown et al 2002; Diop et al 2010b) as well as
in more complex multi-regional scenarios (Elliott et al 2010; Elliott et al
2012).

3.2.4. Influence of CBV and AIF on time-to-peak measurements
A series of numerical simulations were performed to determine the effect of
CBV and AIF on the relationship between ΔTTPC and ΔCBF. To investigate
the effect of CBV, cerebral blood volume was related to cerebral blood flow
according to the Grubb relationship (Grubb et al 1974):

CBV  g  CBF  .

(3.11)

where g and γ are empirically derived parameters. Values for g and γ are
described in the rhesus monkey as 0.8 and 0.38 (Grubb et al 1974), and
similar CBV values have been measured in humans (Grubb et al 1977). For
the simulations, g was set to 0.8 and γ varied between 0.2 and 0.6 to
investigate how the relationship between ΔTTPC and ΔCBF (Eq. 3.8) was
affected by changes in CBV. In these simulations, TTPCa was set to zero,
which represents the ideal case where the arterial input function is a Dirac
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delta function. The results are summarized in Fig. 3.2A. Similarly, the effect
of TTPCa on Eq. 3.8 was performed by setting γ = 0.38 and varying TTPCa
from 0 to 6 seconds. These results are summarized in Fig. 3.2B.

Figure 3.2: Effect of CBV and AIF on TTP analysis.
The relationship between changes in tissue-curve TTP (ΔTTPC) and changes in CBF (ΔCBF)
(grey lines). (A) The effect of varying the relationship between CBV and CBF, which was
performed using the Grubb relationship for γ = 0.2, 0.4 and 0.6, and setting TTPCa = 0. (B)
The effect of varying the arterial TTP (TTPCa) from 0 to 6 s with γ set to 0.38. The solid lines
show the negative unity slope for comparison.

The results of the simulations illustrated in Fig. 3.2 predict that the
relationship between ΔTTPC and ΔCBF can be strongly influenced by how
CBV and CBF are related, and by the finite width of the AIF (i.e., TTPCa).

3.3. Materials and methods
3.3.1. Instrumentation
A time-resolved near-infrared system, assembled in-house, was used for all
optical measurements. A detailed description of this system and its
characterization can be found in (Diop et al 2010b). Briefly, a picosecond
diode laser light source (LDH-P-C-810, PicoQuant, Germany) emitting at 802
nm, close to the peak absorption wavelength of ICG, was used. The laser
output was attenuated by a neutral density filter to below ANSI safety limits
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for skin exposure (52.2 mW/cm2 measured at fiber output compared to limit of
317 mW/cm2 for 800 nm), and a pulse repetition rate of 80 MHz was used.
The beam was coupled into a 1.5-m long multimode fiber (core = 400 μm and
N.A. = 0.22; Fiberoptics Technology, Pomfret, CT) and directed onto the scalp.
Photons exiting the tissue were collected by a fibre bundle 1.5 m long. The
proximal end of the bundle was placed on scalp to provide measurements at a
source-detector distance of 30 mm. The source and detector light-guides were
held in place using a probe holder, constructed from black polychloroprene
rubber. The distal end of the collection optode was secured in front of an
electromechanical shutter (SM05, Thorlabs, Newton, NJ). Light transmitted
through the shutter was passed through a bandpass filter (FEB800-10,
Thorlabs) to remove fluorescence emission, before being collected by a Peltiercooled photomultiplier tube (PMT). A photon count rate corresponding to
roughly 1% of the laser repetition rate was used.

3.3.2. Animal experiments
All animal experiments were conducted following the guidelines of the
Canadian Council on Animal Care and approved by the Animal Use
Subcommittee at the University of Western Ontario (AUP #2007-050-06).
Duroc x Landrace crossbred pigs (n = 4) were acquired from a local supplier
on the morning of the experiment. Animals were anesthetized with 1.75-3%
isofluorane,

tracheotomized

and

mechanically

ventilated

on

an

oxygen/medical air mixture. A femoral artery was catheterized to monitor
heart rate and blood pressure and to collect blood gas samples. Body
temperature was maintained between 37.5 and 38.5°C throughout the
experiment.
Following a 1-h stabilization period, the rubber probe holder was
placed on the head and fixed in place with tissue glue (Vetbond™ 1469SB,
3M Health Care, St. Paul, MN). The respiration rate, anesthetic levels and
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glucose levels were closely monitored and adjusted to ensure that
physiological parameters remained stable throughout the experiment.
All four animals were included in Part A (i.e., the manipulation of the
extracerebral layers) and two animals were included in Part B ( i.e., the
manipulation of CBF). In Part A, two sets of time-resolved measurements
during inflow and washout of ICG (0.1 mg/kg, Cardiogreen, Sigma-Aldrich,
St. Louis, MO) were acquired on the surface of the head. All measurements
were separated by a delay of 20 min to allow sufficient time for clearance of
the dye. After these scalp measurements, three incisions were made around
the probe holder to reduce scalp blood flow. The tissue medial to the probe
holder was left intact and the three incisions were cauterized to stop
bleeding. Two sets of measurements were acquired under this ischemic scalp
condition. After the exact position of the probe holder was marked, the
underlying scalp was removed using the probe holder as a guide. Two
measurements were acquired directly on the skull of the animals at
approximately the same location as the previous measurements. Following
the skull measurements, holes were carefully drilled through the skull in the
same locations. Probes were inserted into the holes until they rested directly
on the dura matter. In this way, two sets of time-resolved measurements
were acquired on the brain.
In Part B, time-resolved measurements were acquired directly on the
brain and then concomitantly on the contralateral scalp during normocapnia
and hypocapnia. Hypocapnia was achieved by adjusting the respiration rate
on the mechanical ventilator until blood CO2 concentration reached 25
mmHg. Computed tomography perfusion measurements were acquired using
a CT scanner (LightSpeed QXi, GE Healthcare, Milwakee, WI) during
normocapnia and hypocapnia. Each cine scan (80 kVp, 190 mA) was acquired
for 40 s following injection of the contrast agent (1.0 ml/kg of 300 mg/ml 300Isovue, Bracco Diagnostics Inc., Princeton, NJ) at an injection rate of 1 ml/s.
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Eight coronal slices (5 mm thick, temporal resolution of 1 s) were used to
generate CBF maps using CT Perfusion 4 software (GE Healthcare). Regionof-interests were drawn encompassing the cortical tissue of each hemisphere
which approximate the region interrogated by the NIR light.

3.3.3. Data processing
Data processing was performed in the MATLAB programming environment
(MathWorks, Natick, MA). Prior to the analysis, the DTOFs of diffusely
reflected photons were denoised using a three-step method which uses an
Anscombe

transformation,

followed

by

wavelet

denoising

and

then

subsequent inverse Anscombe transformation, as described previously (Diop

et al 2012). Denoising was done to reduce the susceptibility of higher
moments to noise-related artifacts. Statistical moments were calculated from
the denoised datasets using a previously described approach (Liebert et al
2003). For calculating the moments, the upper integration limit was defined
on the level of 5% of the maximum of the DTOF in order to reduce the
influence of any remaining noise. Following subtraction of IRF contribution,
moments were smoothed using the Savitzky-Golay algorithm (11.6 second
window span, 6th order polynomial) to remove high-frequency components not
related to dye kinetics.
Attenuation and variance of the DTOFs were analyzed using the timeto-peak method and the kinetic deconvolution method. When presenting the
percent change in TTP, values were multiplied by −1 to facilitate comparison
with the other indices. These four values were obtained for all time-resolved
measurements. For Part A, analysis of differences between groups was
performed using SPSS 17.0 (IBM, Armonk, NY). Statistical significance was
considered to be p < 0.05.
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3.4. Results
3.4.1. Part A: Extracerebral manipulations
During these experiments, the extracerebral environment was manipulated
in several ways to demonstrate the sensitivity of the measured parameters to
perfusion changes in the different layers. Blood flow indices were determined
under four conditions: (i) baseline, (ii) following partial scalp ischemia, (iii)
probes placed on the skull, and (iv) probes placed directly on the brain (17
datasets were collected from 4 animals). The shape of the tissue
concentration curves acquired on the scalp showed large differences between
the different moments of DTOFs (A, <t> and V). Furthermore, the higher
order moments showed less variability when the extracerebral layer was
manipulated compared to attenuation. Figure 3.3 shows the attenuation ICG
curves and the variance ICG curves for one animal under the four conditions.
This representative example was typical of all animals. Figure 3.3C shows
the similarity between the ICG curves derived from the scalp variance
measurements and the brain attenuation measurements.

Figure 3.3: Dynamic contrast-enhanced curves during ECL manipulation
Representative curves from one animal (pig #2) under the four conditions. In this case, the
thickness of the extracerebral layer was 10.2 mm. (A) Change in attenuation (ΔA) for
measurements made on intact scalp (solid grey), ischemic scalp (dashed grey), skull (dashed
black) and brain (solid black). (B) Change in variance ( ΔV) for the same conditions. (C) ΔA
measured on the brain (solid black) compared with ΔV measured on the scalp (dashed black).
Curves are normalized to brain curve.
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In terms of the qualitative blood flow indices (TTP and dBF) calculated
from changes in attenuation (ΔA) and variance (ΔV) of the DTOF, Figure 3.4
summarizes the percent difference between the measurements under the
three extracerebral manipulations and the measurement directly on the
brain. From the ΔA measurements, the average difference was −47.9 ± 7.8%
for dBF and −8.0 ± 6.31% for TTP. From the ΔV measurements, the average
difference was −0.2 ± 2.43% for dBF and by −3.5 ± 2.22% for TTP. The values
for ΔV TTP, ΔV dBF, and ΔA TTP were not significantly different, but ΔA

dBF was significantly lower than the other three parameters (p < 0.001).

Figure 3.4: Variations in blood flow indices during ECL manipulation.
Box-and-whisker plot of the difference in measured blood flow indices during the
extracerebral manipulations compared to measurements acquired on the brain. Each
parameter was evaluated from seventeen measurements acquired in four pigs. Boxes are
bound by 1st and 3rd quartiles, with the center line indicating the median. Error bars
represent the range of the data, and crosses signify outliers. Only ΔA dBF was significantly
different from the expected change of zero (p < 0.001). Additionally, none of ΔA TTP, ΔV TTP,
or ΔV dBF differed significantly from each another, as measured by a paired t-test.

3.4.2. Part B: Hypocapnic challenge
To augment the results of Part A, we further analyzed the sensitivity of the
attenuation and variance TTP and dBF measurements to reductions in CBF
caused by hypocapnia. Sequential bilateral measurements were made in two
animals during normocapnia and hypocapnia. On the ipsilateral side,
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measurements were made directly on the brain and on the contralaterial
side, measurements were made on the scalp. A reduction in CBF was
observed during hypocapnia as depicted by the CBF maps generated by CT
perfusion (Fig. 3.5).

Figure 3.5: CT perfusion maps during normocapnia and hypocapnia
CT perfusion images of the brain from one animal during normocapnia and hypocapnia. The
mean reduction in global CBF during hypocapnia was 43% in this case.

Qualitatively, a large reduction of amplitude was also observed in ΔV
from the DTOFs measured on the contralateral site that reflected ΔA
measured directly on the brain. There was also a decrease in ΔA measured on
the scalp; however, it was less marked. Figure 3.6 provides a representative
example of the ΔA and ΔV ICG curves during normo- and hypo- capnia.

Fig. 3.6: Dynamic contrast-enhanced curves during hypocapnia
Representative curves from one animal under normocapnia (solid lines) and hypocapnia
(dashed lines). (A) The change in attenuation ( ΔA) made on intact scalp for the two
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conditions. (B) The change in variance ( ΔV) made on intact scalp for the two conditions. (C)
ΔA measured directly on the brain for the two conditions. Note: curves have been normalized
to the maximum of the normocapnia curve.

Table 3.2 summarizes the hypocapnic changes CBF and scalp blood
flow measured by CT perfusion and the corresponding quantitative NIRS
blood flow indices from the two animals. As a reference, the values obtained
with the NIRS indices were compared to CBF values obtained by CT
perfusion—the current clinical standard-of-care.
Table 3.2: Comparison of TTP and dBF changes during hypocapnia

Animal #1
Percent
Change

Animal #2

Error

Percent
Change

Error

Ipsilateral (brain)
CTP brain

−32.0%

-

−44.4%

-

CTP scalp

-

-

-

-

ΔA TTP

−16.7%

15.3%

10.5%

54.9%

ΔV TTP

−21.1%

10.9%

4.5%

48.9%

ΔA dBF

−28.0%

3.9%

−45.5%

−1.1%

ΔV dBF

−31.6%

0.4%

−42.3%

2.1%

Contralateral (scalp)
CTP brain

−31.7%

-

−42.2%

-

CTP scalp

−19.1%

-

−29.3%

-

ΔA TTP

−16.7%

15.1%

−22.2%

20.0%

ΔV TTP

−20.0%

11.7%

−26.3%

15.9%

ΔA dBF

−20.9%

10.9%

−27.4%

14.8%

ΔV dBF

−31.6%

0.1%

−42.7%

−0.5%

Percent change in the blood flow indices (TTP and dBF) obtained by analysis of attenuation
(A) and variance (ΔV) of DTOF during hypocapnia. Measurements were obtained directly on
the brain and on the contralateral scalp. The error values are relative to the CBF change
measured by CT perfusion (CTP). The thickness of the extracerebral layer was 10.2 mm and
11.2 mm for animal 1 and 2, respectively.
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3.5. Discussion
A number of recent studies have suggested that the DTOF variance signal
collected on the scalp is sensitive to decreased CBF in neurological disorders
such as stroke (Steinkellner et al 2010; Liebert et al 2005). The principle
objective of this study was to verify these findings in an adult pig model in
which scalp and cerebral blood flow could be manipulated. The results of Part
A indicated that the ΔV signal was less sensitive to the extracerebral layer
than the corresponding ΔA signal, as demonstrated by the greater variability
in the shape of the ΔA ICG concentration curves over the different
manipulations of the extracerebral layers. In general, the dynamics of the ΔA
ICG curves reflected flow contributions from both scalp and brain. The curves
shown in Fig. 3.3 illustrate that the ΔA signal acquired under the ischemic
scalp condition resulted in the slowest kinetics, whereas the ΔA signal
acquired directly on the brain have the fastest. The ΔA signals collected on
the skull and the intact scalp demonstrated intermediate kinetics. The
former was the most similar to the brain ICG curve since the thickness of the
skull in this animal was only about 5 mm. Interestingly, the shape of the ΔA
ICG curve acquired on the intact scalp was more similar to the ΔA signal
collected on the skull rather than the signal acquired from ischemic scalp,
despite the fact that the thickness of the extracerebral layer approximately
doubled.
The influence of the extracerebral layer on the shape of the ΔA ICG
curve is also reflected in the TTP and dBF measurements shown in Figure
3.4. In both cases, the increased variability was not due to increased
measurement error, but rather, it was attributed to the different flow
contributions under the four conditions. The dBF measurements determined
from the ΔA ICG curves that included an extracerebral layer were also
consistently lower than the value determined from the brain ICG curve. This
is because ΔA dBF represents a weighted average of the blood flow in each
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layer scaled by its mean partial pathlength. Therefore, the addition of each
extracerebral layer resulted in a reduction in average blood flow within the
region of interrogation
The faster ICG dynamics for the ΔA signal collected on the intact scalp
would appear to be at odds with previous studies involving human subjects,
in which a large difference in the shape of the ΔA and ΔV ICG curves was
reported (Liebert et al 2004; Steinkellner et al 2010; Liebert et al 2006). This
apparent discrepancy can be attributed to differences in head anatomy
between pigs and humans. We found that the pig’s scalp was highly
vascularized and well perfused, likely to supply the thick temporalis muscles
that originate at the temporoparietal region of the head. This observation
was confirmed by CT perfusion, which revealed an average scalp blood flow of
approximately 25 ml min-1 100g-1. In contrast, scalp blood flow in the human
head, as determined by a radioactive xenon clearance technique, was only
about 5 ml min-1 100g-1 (Friberg et al 1986). Given this difference, the
ischemic scalp condition in Part A more closely reflects the intact human
scalp.
In contrast to the ΔA signals, the ΔV ICG curves shown in Fig. 3.3B
exhibited less sensitivity to the extracerebral tissue. In this case, there was a
noticeable improvement in the similarity of the ICG curves acquired under
the two extremes—i.e., on the brain and on the ischemic scalp—compared to
the ICG curves obtained from the ΔA signal. This insensitivity to the top
layers was also reflected in the lower variability observed in the ΔV TTP and

dBF values across the four conditions, as shown in Fig. 3.4. As well, the
underestimation of CBF by ΔA dBF was not observed when dBF was
determined from the ΔV signals.
A secondary objective of this study was to compare two analytical
methods of tracking change in CBF from the measured DTOF moments. The
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metric of choice in these studies has been time-to-peak, since it is relatively
easy to calculate, and can be applied to normalized signals of variance of the
DTOF. The ability to use the normalized signal makes TTP a robust
longitudinal tool because it will be relatively insensitive to small changes in
the signal amplitude, for example, from light coupling issues. This is a major
benefit when using time-resolved equipment that is sensitive to light
coupling and noise; however, time-to-peak also has some drawbacks that may
not always be appreciated. In particular, a limitation of the TTP method is
the implicit assumption that the AIF is consistent from measurement to
measurement. In a clinical environment, it may be difficult to achieve an AIF
of reproducible shape, since bolus injections are operator dependent, and the
AIF depends on the cardiac output of the patient. For example, in the
ipsilateral measurements acquired from animal #2 (Table 3.2), TTP
measurements did not correctly identify the large decrease in CBF. Further
investigation revealed that the arterial TTP changed in the opposite direction
by 30%, obscuring the expected change in tissue TTP caused by hypocapnia.
After adjusting the tissue TTP value to account for the unexpected change in
arterial TTP, the change in ΔV TTP was −13.6% instead of 4.5%. In certain
applications, such as inter-hemisphere comparisons in stroke patients, the
absolute change in TTP (as opposed to the percent change in TTP) is
independent of the arterial input function (Steinkellner et al 2010). However,
when percent change in TTP is used as a surrogate of percent change in CBF
across serial injections of ICG, any variability in the arterial input function,
including systemic physiological changes, will have a dramatic effect on the
accuracy of the measurement.
Another important consideration with using the time-to-peak method
as a surrogate CBF is that it also depends on CBV and the time-to-peak of
the AIF (Eq. 3.8). Therefore, it exhibits a non-linear relationship with CBF.
The numerical simulations depicted in Fig. 3.2 demonstrate how the

107
relationship between ΔCBF and ΔTTP can be altered by both the relationship
between CBV and CBF (the Grubb relationship) and the finite width of the
AIF. In these simulations, both effects cause the measured ΔTTP to be
underestimated relative to the true change in CBF. Interestingly, when CBF
decreases by about 80%, which would be similar to the expected perfusion
reduction during clinical ischemia, this error is not as severe.
An alternative method to analyzing DCE data is derived from the
convolution theory of tracer kinetics. If the AIF is measured, a deconvolution
method can be used to recover the blood flow index, dBF, which is equal to
the average blood flow in the region of interrogation weighted by the layerspecific sensitivity factor (Eq. 3.9). In addition to accounting for variability in
the AIF, the deconvolution method also decouples the effects of blood flow,
blood volume and mean transit time. When ΔA is measured in the intact
head, the acquired signal is highly sensitive to extracerebral tissue, and the
average blood flow recovered by deconvolution will represent a weighted
average of scalp and cerebral blood flow as shown in Fig. 3.4. In contrast, the
region of interrogation represented in the ΔV signal has greater sensitivity to
brain tissue and, therefore, the change in dBF better reflects the true change
in CBF. Note that this relative approach is in contrast to previous methods
that recover absolute CBF from time-resolved measurements acquired
directly from the brain, or in a scenario where the scalp contribution is
negligible. In these special cases, deconvolution of the ΔA signal permits
recovery of absolute CBF in units of ml min-1100g-1, since the differential
pathlength can be measured directly from the time-resolved data (Diop et al
2010a).
In Part B, concomitant measurements were acquired on the ipsilateral
brain and the contralateral scalp during normocapnia and hypocapnia in two
animals. In addition, CT perfusion measurements were acquired under the
two conditions to measure scalp and cerebral blood flow. Table 3.2
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summarizes the percent change in TTP and dBF caused by hypocapnia for
both animals. Despite a small sample size, three observations can be made
about these results. First, all four ΔV dBF values and the two ΔA dBF values
derived from ispilateral measurements exhibited good agreement with the
CBF values from CT perfusion. Second, contralateral ΔA dBF measurements
were almost identical to the scalp blood flow values from CT perfusion. When
considered along with the results of Part A, this suggests that ΔA is mainly
interrogating the extracerebral layer, while ΔV is sensitive to the brain.
Finally, all eight TTP measurements (when the corrected TTP measurement
for animal #2 as described above is substituted), showed a consistent
underestimation of the CBF change measured by CT perfusion. This
underestimation occurred whether the measurements were acquired on the
scalp or directly on the brain. The numerical simulations presented in
subsection 3.2.4 provide insight into this underestimation: the average
arterial TTP in the animal experiments was about 4 seconds and the Grubb
exponent, γ, was about 0.4 (determined from the CT perfusion data). For this
combination, a 40% decrease in CBF is predicted to result in a roughly 20%
change in TTP.

3.6. Conclusions
The salient finding of this study was that the variance of the DTOF
was relatively insensitive to changes in extracerebral blood flow and optical
properties caused by physically manipulating the extracerebral layers in the
pig. A corollary finding was that the variance signal measured on the scalp
was sensitive to changes in CBF. Finally, while both TTP and dBF obtained
from the variance signal showed similar robustness in the presence of
extracerebral variability, dBF had better sensitivity to hypocapnic CBF
changes when compared to CT perfusion. This improvement suggests a
benefit to measuring the AIF during acquisition of DCE time-resolved data.
Despite differences in scalp blood flow in this animal model compared to
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humans, the methods presented in this study for measuring CBF changes are
translatable to the human adult.
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Chapter 4
MEASURING THE ARTERIAL INPUT
FUNCTION WITH A STANDARD PULSE
OXIMETER TO FACILITATE THE CLINICAL
IMPLEMENTATION OF DCE OPTICAL
METHODS
The contents of this chapter have been adapted from the journal article
published in 2012, entitled “Arterial input function of an optical tracer for
dynamic contrast enhanced imaging can be determined from pulse oximetry
oxygen saturation measurements” by Elliott JT, Wright EA, Tichauer KM,
Diop M, Morrison LB, Pogue BW, Lee T-Y, and St. Lawrence K in Physics in

Medicine and Biology. All of the dynamic contrast enhanced (DCE) near
infrared (NIR) methods presented in this thesis (including the DCE
fluorescence molecular tomography (FMT) and diffuse optical tomography
(DOT) methods in Appendix A) require the proper characterization of the
arterial input function (AIF). This chapter presents a practical solution to
characterizing the AIF using a standard pulse oximeter (PO), offering an
alternative to the current pulse dye densitometer (PDD) devices that are
specialized and not typically compatible with small animal imaging. The
original journal article from which this chapter is adapted can be found at

http://iopscience.iop.org/0031-9155/57/24/8285

119

4.1. Introduction
In Chapters 2 and 3, nonparametric kinetic analysis was used to quantify
CBF and to provide a meaningful relative blood flow index, respectively. Both
these methods, (and additionally, the method highlighted in the next two
chapters) require that the AIF—the time-dependent change in arterial dye
concentration—be characterized. This is a common requirement not just in
DCE optical methods, but in medical imaging in general where tracer kinetic
modeling is commonly used to characterize physiological processes (Sourbron
and Buckley 2012). Extracting quantitative measurements from kinetic data
requires that the AIF be measured, because it describes the delivery of tracer
to the tissue. Therefore, proper characterization of the AIF is an important
goal in many modalities, including optical imaging. In this thesis, as well as
in many other optical applications, the tracer indocyanine green (ICG) is
used. Indocyanine green acts as an intravascular tracer in most tissues due
to its binding with plasma proteins (e.g., albumin). Since ICG is FDA
approved (United States Food and Drug Administration 2012), it has been
used in clinical settings to assess neurological function (Steinkellner et al
2010; Liebert et al 2005) and to characterize breast tumours (Schneider et al
2011), in addition to measuring cerebral blood flow (CBF) in Chapter 2 and
elsewhere (Brown et al 2002; Diop et al 2010; Springett et al 2001). The
principles of tracer kinetic modeling can also be applied to targeted optical
contrast agents that are conjugated with ligands to study receptor binding
potential and drug delivery mechanisms (Becker et al 2001).
To properly measure the AIF of an optical dye, a device known as a
PDD is usually needed (Iijima et al 1997). However, these units are
specialized pieces of equipment that are not commonly found and are only
optimized for determining the AIF of ICG. Furthermore, in preclinical small
animal studies, no PDD is available that functions at the high heart rates of
these animals. Because of these obstacles, more simplistic kinetic models are
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used that do not correct for AIF-dependent effects. For example, dynamic
contrast-enhanced MRI techniques will perform kinetic analysis on tissue
measurements with the assumption that the AIF is constant across
measurements or patients, but these assumptions can be problematic and
lead to errors in the recovered parameters (Parker et al 2006). The wider
application of kinetic modeling to quantify important parameters such as
blood flow, vascular leakage and receptor binding potential requires a more
accessible method of measuring the AIF.
The methodology presented in this chapter enables the conversion of
an off-the-shelf pulse oximeter (PO) into a PDD. This is accomplished by
deriving a mathematical relationship between the arterial concentration of
dye and the negative change in apparent SaO2 measured by the pulse
oximeter, which occurs because the increase in absorption due to the dye is
interpreted as an increase in deoxyhemoglobin. While this interference has
been previously observed (Sidi et al 1987), this study is the first time it has
been used to actually quantify the AIF. Validation experiments were
conducted in rabbits using a small animal oximetry device (MouseOx, STARR
Life Sciences, Oakmont, PA), but the approach is translatable to the clinic,
capitalizing on the ubiquity of pulse oximeters.

4.2. Theory
4.2.1. Pulse oximetry
Pulse oximeters record oscillations in light attenuation (ΔA1 and ΔA2) at two
wavelengths (λ1 and λ2) that results from oscillations in arterial blood vessel
diameter, ΔD, in response to the beating heart (Aoyagi 2003). Oxyhemoglobin
and deoxyhemoglobin are the dominant light-absorbing molecules in the
blood for the wavelengths selected by pulse oximeters. In this case, the
changes in attenuation can be approximated using the Beer-Lambert Law:
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A1   a,1  Ca   b,1  Cb   D

(4.1a)

A2   a, 2  Ca   b, 2  Cb  D,

where

Ca

and

Cb

are

the

concentrations

of

(4.1b)
oxyhemoglobin

and

deoxyhemoglobin, respectively, and εa,i and εb,i are their corresponding
extinction coefficients defined for i = (λ1, λ2). In pulse oximetry, equations
4.1a and 4.1b are rearranged to determine SaO2 as follows:
A1   a,1  SaO2  tHb   b,1  (1  SaO2 )  tHb  D

(4.2a)

A2   a, 2  SaO2  tHb   b, 2  (1  SaO2 )  tHb  D,

(4.2b)

where SaO2 is the oxygen saturation ratio, defined as CHbO2 / tHb, and tHb,
the total hemoglobin concentration, equals Ca + Cb. In practice, scattering
and partial volume errors arising from the expansion of non-blood media
create systematic errors in the measured signal. To overcome many of the
subject-dependent errors, the channel-dependent information is converted to
a ratio:



A1  a ,1  SaO2   b,1  (1  SaO2 )

.
A2  a , 2  SaO2   b, 2  (1  SaO2 )

(4.3)

Small errors that still remain in this expression are generally calibrated by
adjusting the intensity and gains of the electronics until the actual SaO2
measured by hemoximetery matches the SaO2 recovered by solving Eq. 4.3.
Alternatively, a calibration curve can be used to generate a linear
approximation:

  M s  SaO2  bs ,

(4.4)
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where Ms and bs are the calibration factors determined by the manufacture,
typically obtained from healthy subjects (Mendelson 1992), to convert the
measured change in light absorption SaO2.
The addition of another chromophore (such as an intravenously
injected optical dye) will not appreciably alter the calibration process
described above if it does not cause an appreciable change in the scattering
properties of the tissue and does not substantially accumulate in the nonblood media within the region of interrogation. The relationship between the
apparent SaO2 (aSaO2) reported by the pulse oximeter and the concentration
of injected dye can be given by

 a ,1  aSaO2   b,1  (1  aSaO2 )

 a, 2  aSaO2   b, 2  (1  aSaO2 )

Ci
tHb
C
 i
tHb

 a*,1  SaO2   b*,1  (1  SaO2 )   i*,1 
 a*, 2  SaO2   b*, 2  (1  SaO2 )   i*, 2

(4.5)
where Ci represents the concentration of the additional chromophore and εi,j
represents the extinction coefficient of the ith chromophore at the jth
wavelength that is normally used by the system. Extinction coefficents, εi,j*,
represent the extinction coefficient of the ith chromophore at the jth
wavelength that is actually used to acquire the measurement. If the native
probes are used to acquire the signal, then εi,j* is equal to εi,j. However, if a
customized probe is used to modify the emission wavelength of the probe, εi,j*
must be adjusted for the difference in absorption at the new wavelength. This
additional parameter allows the use of a different wavelength of light in
order to increase the sensitivity of the system to the desired optical dye, as
was done in the validation experiments. The variable aSaO2 represents the
apparent SaO2 that is reported by the instrument, whereas the variable SaO2
represents the actual SaO2. The latter can be measured before the injection
and assumed to be constant during the period that the AIF is measured.

123
Finally, the total haemoglobin concentration, tHb, is determined from a
venous blood sample. To obtain Ci, Eq. 4.5 is solved using the fminsearch
function in MATLAB (The MathWorks, Natick, MA).

4.2.2. Tracer kinetic modeling
In tracer kinetic modeling, the time-dependent concentration of contrast
agent in tissue, Ct(t), is related to the AIF by the convolution in Eq. 1.5
(Meier and Zierler 1954). The specific definition of the impulse residue
function, R(t), will change depending on the behaviour of the contrast agent
in the tissue region of interest. For the purpose of this validation paper, the
adiabatic approximation to the tissue homogeneity model (AATH), which
characterizes blood flow and tracer leakage into the surrounding tissue, was
used to simulate tissue concentration curves (St Lawrence and Lee 1998).
The impulse residue function, R(t), derived from the AATH model is given by:
R(t )  1  (t  Tc )   Ee



EF
( t Tc )
Ve

(t  Tc )

(4.6)

where Θ(t) is the Heaviside step function, Tc is the transit time through the
capillary, E is the extraction fraction of the dye from the IVS to the EVS, Ve
is the distribution of tracer in the EVS and F is blood flow. The tracer kinetic
portion of the error analysis in the next section was conducted for an
untargeted tracer using the input summarized in Table 4.1.
Table 4.1: Input parameters

Parameter
Blood flow, F
Capillary transit time, Tc
EVS distribution volume, Ve
Permeability-surface area
product, PS

Units

Input value

ml min-1 100g-1

15.0

s

6.5

ml 100g-1

75.0

ml min-1 100g-1

10.4

Input parameters for the AATH forward model (Eq. 4.6) used in the validation experiment.
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4.3. Methods
4.3.1. Validation of arterial input functions measured by pulse
oximetry
An error analysis based on simulated data was conducted to better
understand the effect of certain variables on the ability to recover the AIF
accurately. First, the measurement resolution of the recovered dye
concentration was characterized since it depends on the resolution of the
pulse oximeter SaO2 channel, the absorption properties of the dye, and tHb.
For this analysis, tHb was fixed at 12 g/dl, the true SaO2 was set to 95%, and
the apparent SaO2 was decreased from 95% to 75% in steps of 0.1%, which is
the resolution of the SaO2 data stored by the MouseOx system. The
concentration of dye at each SaO2 level was recovered from Eq. 4.5 using the
extinction coefficients of indocyanine green. This was repeated for different
“red channel” wavelengths from 600 to 900 nm to determine the relationship
between the selected wavelength and the resolution of the measured dye
concentration. Next, the effect of total haemoglobin concentration on the
measurement resolution of the recovered dye concentration was investigated.
The “red channel” wavelength was fixed at 760 nm, the true SaO 2 was set to
95%, and the apparent SaO2 was decreased from 95% to 75% in steps of 0.1%.
The concentration of dye at each SaO2 level was recovered, and this process
was repeated for tHb values from 5 to 25 g/dl.
In the second part of the experiment, the relationship between the
PDD measured dye concentration and the dye curves extracted with the PO
method were investigated in a rabbit model (see subsection 4.3.3). Regression
plots were generated for each set of ICG curves, and a meta-analysis was
performed to determine the mean and 95% confidence interval of the
regression slopes. Theoretical tissue curves were generated by the AATH
model using the measured AIF from the pulse oximeter and from the PDD to
further understand how differences between the two AIFs would affect the
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accuracy of the derived model parameters. The ‘true’ Ct(t) was generated
using the PDD-measured AIF and the values of the model parameters given
in Table 4.1. The AIF derived from pulse oximetry was then used to recover
best-fit estimates of the model parameters from the theoretical Ct(t) curve by
the fminsearch minimization function. The percent difference between the
recovered and input F and PS values were determined.

4.3.2. Instrumentation
For the validation experiments, a small animal pulse oximeter (MouseOx,
STARR Life Sciences, Oakmont, PA) was used. This unit is sensitive to fast
heart rates, making it suitable for mouse and rat experiments, in addition to
animals with slower heart rates such as rabbits. Custom-made probes with a
“red channel” wavelength of 753 nm were used to improve the sensitivity of
the pulse oximeter to ICG (see Fig. 4.1). The extinction coefficients for the left
side of Eq. 4.5 were provided by the engineering team at STARR Life
Sciences, whereas the modified extinction coefficients for the right side of Eq.
4.5 were determined in two steps: first, the light source spectrum was
characterized with an off-the-shelf broadband spectrometer (QEE65000,
Ocean Optics, Dunedin, FL). Second, this reference spectrum was used as a
probability density function to sample from the extinction spectra of the three
chromophores, which have been previously measured (Landsman et al 1976).
Finally, a pulse-dye densitometer (DDM2000, Nihon Koden, Japan) capable
of measuring the AIF in rabbits, which have a normal heart rate range of
190-310 bpm (Murphy et al 2011), was used to validate the AIF obtained from
pulse oximetry. This instrument has been previously validated by comparison
to serial blood sampling (Iijima et al 1998).
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4.3.3. Animal experiments
All animal experiments were approved by the animal use committee at
Western University (AUP #2009-087). Measurements using the PO and PDD
were acquired in four New Zealand white rabbits (Oryctolagus cuniculus),
approximately 6 months old (weight = 2.8 ± 0.3 kg). Animals were induced
and maintained with isofluorane gas anaesthesia at 4% and 2.5%
concentration, respectively. A mixture of 2:1 oxygen and medical air was
maintained for the duration of the experiment, and blood gases, glucose, and
rectal temperature were monitored frequently. The pulse oximeter and PDD
probes were placed on separate hind limbs, and adequate signal strength was
verified in both instruments before proceeding with tracer injection. Animals
were allowed to rest for 30 minutes to stabilize before the experiment was
started.
For each animal experiment, a solution of ICG (Cardiogreen, SigmaAldrich, St. Louis, MO; 0.3 mg kg-1 ml-1 dissolved in 0.5 ml of sterile water)
was prepared. A total of two bolus injections were administered by
intravenously with approximately 40 min between injections to allow the ICG
to clear the system. Boli were rapidly injected, resulting in a first-pass full
width half maximum of approximately 5 seconds. During each injection, data
were acquired by the PO and PDD simultaneously, and downloaded to a
laptop for subsequent analysis. The sampling rate of the pulse oximeter was
15 Hz; the PPD records each measurement at systole (equivalent to
approximately 5 Hz in these animals) to a maximum of approximately 6 Hz.
Heart rate, arterial oxygen saturation, and total haemoglobin were also
measured and recorded, with the latter being measured by hemoximetry
(ABL 80 FLEX CO-OX, Radiometer, Copenhagen, Denmark).
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4.4. Results and discussion
4.4.1. Error analysis
Measurement resolution is defined as the minimum change in dye
concentration that produces a detectable instrument response. The recorded
SaO2 channel used to calculate the dye concentration has a measurement
resolution of 0.1%. Additionally, the degree to which a change in dye
concentration causes a response in the SaO2 channel depends on the
absorption properties of that dye. These two factors ultimately determine the
AIF measurement resolution. For error analysis, simulations were performed
by varying the “red channel” of the dye from 600 to 900 nm (step size: 5 nm),
while fixing SaO2 at 95% and tHb at 12 g/dL. Fig 4.1 depicts the
measurement resolution as a function of the wavelength of the “red” channel,
which is the numerator in Eq. 4.5, when ICG is used as the optical dye. The
absorption spectrum of ICG is shown for comparison. Note that the resolution
function is not a perfect mirror of the ICG spectrum due to the additional
influence of the other chromophores.

Figure 4.1: Influence of “red” channel wavelength on measurement resolution
The measurement resolution of the dye concentration extracted from the pulse oximeter
SaO2 channel plotted on a log scale (black line), and the corresponding ICG absorption
spectrum in plasma (gray line) plotted on an arbitrary linear scale.
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As expected, the highest measurement resolution is achieved when a “red
channel” wavelength is used that corresponds to the absorption peak of the
dye (802 nm for ICG in plasma). If a light source is used that corresponds to
the absorption peak of ICG, then a pulse oximeter that has a measurement
resolution of 0.1% is capable of resolving 0.01 mM changes in dye
concentration. A standard pulse oximeter, which employs a light source of
around 650 nm would be able to resolve submilimolar (~0.5 mM)
concentrations.
The amount of endogenous light absorption depends on the total
haemoglobin concentration, tHb. Therefore, the relative effect of the dye on
the overall signal change will depend on this parameter, which ultimately
will affect the measurement resolution. An error analysis was performed by
varying tHb from 5 to 25 g/dL (step size: 0.25 g/dL). A “red channel”
wavelength of 760 nm was used, and SaO2 was set to 95%.

Figure

4.2:

Influence

of

hemoglobin

concentration

variations

on

measurement

resolution
The measurement resolution of the dye concentration extracted from the pulse oximeter
SaO2 channel plotted on a log scale (black line) versus the total haemoglobin ( tHb). A forest
plot of tHb reference ranges are shown to provide context (London Laboratory Services
Group 2012; Abbassi-Ghanavati et al 2009). *Values obtained from animals used in this
experiment.

129
Figure 4.2 summarizes the relationship between tHb and dye measurement
resolution, and normal haemoglobin ranges are highlighted for several
patient groups by a forest plot. The error analysis suggests two distinct
resolution

levels

within

the

range

of

normal

human

haemoglobin

concentration, which may reduce the performance of the technique in a
certain subjects such as healthy adult men, by a factor of approximately 5. It
is important to note that the abrupt changes in measurement resolution are
not artificial, but represent an amplification of the rounding error resulting
from the SaO2 channel measurement resolution of 0.1%.

4.4.2. Validation experiment
A representative example of the AIF acquired with the PDD plotted alongside
the AIF calculated from pulse oximetry is depicted in Fig. 4.3. In this case,
the slope and y-intercept of the regression between the two curves was 0.915
and 0.1 mM, respectively. There was a −3.3% difference in the peak
concentration, and a −10.2% and 5.5% percent difference in F and PS when
the pulse oximeter AIF was used to extract the kinetic parameters from Ct(t)
generated from the PDD-measured AIF.

Figure 4.3: Arterial input functions measured by the two instruments
The AIF recovered with the PO method (gray line) using the method presented in this
Chapter, and the AIF directly recovered using the PDD (black line).
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This analysis was performed for all measurements across the four
rabbits used in the study, and group means were determined as well as the
95% confidence intervals for each parameter. Figure 4.4 summarizes the
regression results for the group analysis. The mean slope was 0.92, bound by
a 95% confidence interval of 0.787 - 1.063. The mean y-intercept was 0.2 mM
with a 95% confidence interval of –0.3 - 0.6 mM.

Figure 4.4: Relationship between PO and PDD measured ICG concentration
The regression plot comparing ICG concentration values obtained with the PO and the PDD
simultaneously. The individual regression lines-of-best fit (n=8) were determine separately
for the two ICG boli given to each of the four animals. The average line of best fit is indicated
by the dashed line (slope = 0.92 ± 0.03, y-intercept = 0.18 ± 0.09 mM)

Figure 4.5 shows the Bland-Altman plot comparing the ICG
concentration values obtained with the PDD and PO techniques. Linear
regression analysis revealed a significant relationship between difference and
mean concentration (p < 0.05) suggesting a proportional bias. The bias was
defined by the line with a slope = −0.052 and a y-intercept = 0.19 mM. The
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95% confidence intervals for the slope and y-intercept were −0.13 - 0.2 and
−0.28 - 0.66, respectively.

Figure 4.5: ICG concentration Bland-Altman plot
The Bland –Altman plot comparing the ICG concentration measurements obtained with the
PDD and calculated from PO measurements of SaO2. As in Fig. 4.3, data are represented by
lines-of-best fit of each ICG bolus (n=8). The mean difference between the two techniques is
indicated by the solid line, and the 95% confidence interval is indicated by the dashed line.

As suggested by the proportional bias in the Bland-Altman analysis,
the pulse oximeter tended to underestimate the concentration of ICG at high
concentrations. This could be in part due to the dynamic range of the
detectors used by this specific oximeter, which may not be as sensitive to
SaO2 below 60%.
Table 4.2 summarizes the group mean and confidence intervals for the
percent differences in peak concentration, F, PS, and Tc extracted from the
theoretical ICG tissue concentration data using the AIF from the pulse
oximeter AIF rather than the true AIF from PDD. In addition, the p values
from a paired t-test comparisons of values obtained using the two AIFs are
shown. While there was no significant difference in the parameters obtained
with the two AIFs, blood flow measurements were most affected by the
underestimation in high ICG concentrations previously mentioned.
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Table 4.2: Percent difference in recovered parameters

Parameter

Mean

95% Confidence
Interval

p value

Peak concentration

−7.4%

−27.6 - 12.8%

0.23

Blood flow, F

−8.5%

−23.3 - 6.3%

0.06

Permeability-surface
area product, PS

1.7%

−7.4 - 10.9%

0.45

Capillary transit
time, Tc

1.5%

−6.5 – 9.5%

0.40

Percent difference in parameters recovered using the pulse oximeter AIF from the forward
data generated using the DDG AIF. Results of the paired t-test between input and recovered
values are shown in the fourth column.

The results of this study suggest that the commonly used pulse
oximeter can be readily converted to a PDD fairly easily, which provides an
accessible means of acquiring an AIF for use in tracer kinetic studies.
Advancements in dynamic contrast-enhanced optical techniques have
resulted in the ability to assess cerebral hemodynamics in neonates (Arora et

al 2012), stroke patients (Steinkellner et al 2010) and traumatic brain injury
patients (Keller et al 2001), and to localize and assess tumors in breast
cancer patients (Schneider et al 2011). In addition, dynamic contrastenhanced techniques have been described for a wide of range of applications
including diagnosis of peripheral artery disease (Kang et al 2010) and
monitoring muscle oxygenation (Boushel and Piantadosi 2000), and have
been theoretically described for pre-clinical imaging methods such as
fluorescence molecular tomography (Elliott et al 2012). In all cases, the
ability to measure the AIF would enable the use of more sophisticated and
more accurate kinetic models that would account for the between-subject
variability in AIFs (Schneider et al 2011). For example, recent work by
Schneider and colleagues demonstrated the ability of NIRx to detect breast
cancer in a group of patients undergoing biopsy (Schneider et al 2011). In
that study, relative metrics such as time-to-peak and relative peak
concentration were used to discriminate between benign and malignant
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tissues. The acquisition of the AIF would allow blood flow and vascular
leakage of the regions of interest to be characterized, possibly providing
additional sensitivity and specificity, and would also reduce intra-subject
variability since measuring the AIF implicitly accounts for differences in
blood circulation. Despite the benefit of characterizing the AIF, only a limited
number of groups regularly employ a PDD because they are expensive and
few units have been approved for patient use. The methodology described in
this note enables clinicians and researchers to instead capitalize on pulse
oximeters, which exist in virtually every advanced trauma center or intensive
care unit around the world, and can be combined with current dynamic
contrast-enhanced optical techniques at little additional cost.
In small animal imaging, an additional challenge to measuring the AIF
is that no PDD device has been developed that is compatible with the high
heart rates of rodents. There are, however, several pulse oximeter devices,
including the MouseOx device used in this study, which are suitable for heart
rates up to 900 bpm and can therefore be used to measure the AIF. Doing so
would enable more sophisticated tracer kinetic models that could determine
key parameters in the study of cancer development and treatment. For
example, plasma input two-tissue compartment models (Mintun et al 1984)
could be used to quantify molecularly targeted optical probe binding.
While the method described in this paper will be useful for a variety of
applications, there are several limitations that will ultimately determine
whether the use of a pulse dye densitometer is more appropriate. First, the
accuracy of the recovered dye concentration will be affected by any errors in
the extinction coefficients in Eq. 4.5, as well as the accuracy of the measured

tHb concentration. The former can be minimized if the peak wavelength of
the two channels can be obtained either from the manufacturer of the device,
or by spectrometric measurement by the user. Careful consideration of Eq.
4.5 reveals that an error in tHb concentration will result in an equal error in
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recovered dye concentration. This could be important, for example, in the
critical care setting, where trauma patients presenting lower initial
haemoglobin concentration may receive a packed red blood cell (PRBC)
transfusion to improve the oxygen carrying capacity of the blood. In this case,
a PRBC-corrected value of tHb may be helpful, where tHb is incremented by
1 g for every one unit of infused PRBC (Christy et al 2011). More
significantly, the limited measurement resolution of this approach in certain
circumstances may hinder its applications. As demonstrated in the error
analysis, measurement resolution issues are addressed by using higher dye
concentrations, constructing custom probes that use a “red channel”
wavelength at the peak absorption of the dye-of-interest, and being aware of
the potential tHb-related pitfall. In some cases, however, the measurement
resolution may still be limited. For example, when performing a tracer
kinetic binding study, only a limited concentration of dye can be injected to
avoid receptor saturation. However, given that demand often drives
technological advances, the adoption of this technique as a means of
measuring the AIF may result in the development of pulse oximeters capable
of 0.01% or better SaO2 measurement resolution.

4.5. Conclusions
The results of this study demonstrate that with a basic understanding of
pulse oximetry, it is possible to convert an off-the-shelf pulse oximeter into a
dye densitometer that can be used to approximate the arterial input function
in

dynamic

contrast-enhanced

studies.

This

finding

has

immediate

applications in both clinical and preclinical contexts.
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Chapter 5
KINETIC DECONVOLUTION OPTICAL
RECONSTRUCTION: THEORETICAL BASIS
AND NUMERICAL SIMULATIONS
This chapter highlights the kinetic deconvolution optical reconstruction
(KDOR) methodology, which can be applied to a variety of dynamic contrast
enhanced (DCE) biomedical optics problems. The theoretical basis for KDOR
was published in “Model-independent dynamic constraint to improve the
optical reconstruction of regional kinetic parameters” by Elliott JT, Diop M,
Lee T-Y, and St. Lawrence K, in Optics Letters in 2012. This chapter is an
expanded version of the Letter, providing additional details on the theory and
numerical results. The original Letter from which this chapter is adapted can
be found at http://www.opticsinfobase.org/ol/abstract.cfm?uri=ol-37-13-2571

5.1. Introduction
Chapters 2 and 3 highlighted the use of DCE near-infrared (NIR) methods to
measure tissue hemodynamic parameters: blood flow (BF), blood volume (BV)
and mean transit time (MTT). Analogous to DCE methods in computed
tomography (CT) and magnetic resonance imaging (MRI), the methodology
requires the injection of a bolus of contrast agent, the recording of the timedependent signal change, and then the reconstruction of time-dependent
contrast concentration for each pixel or region-of-interest. As in CT and MRI,
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the conventional approach is a two-step (TS) process that first involves
reconstructing a time-series of DCE images or datapoints, followed by
performing kinetic analysis on the data from individual regions or image
pixels to recover the parameters of interest (Cenic et al 2000). For example,
in Chapter 2, continuous-wave (CW) NIR measurements were collected at
two source-detector distances, and separation of brain and extracerebral
layer (ECL) information was achieved using subject-specific anatomical and
spectral priors to estimate mean partial pathlength (MPP) values. In Chapter
3, the variance of the time-resolved signal was used to increase sensitivity to
cerebral blood flow (CBF), and was deconvolved with the arterial input
function (AIF) to estimate change in CBF. These steps represent first steps
towards the goal of a robust bedside tool to measure CBF in the neurocritical
care unit. However, the first study used an animal model that was an
imperfect representation of the clinical reality, and was likely a “best-case
scenario.” The second study achieved partial separation of brain and ECL
signal enabling the quantification of changes in CBF, but would require
calibration with another imaging modality in order to provide absolute CBF.
The principle challenge to addressing the limitations in the previous
studies is that complete separation of DCE signal arising from different
tissue regions is non-trivial. First, the volume of interrogation is optically
heterogeneous, with each region exhibiting different scattering and
absorption properties. The adult head is comprised of scalp, skull,
cerebrospinal fluid (CSF) and brain (which can be further divided into grey
and white matter), each of which interacts with light differently. Therefore,
the sensitivity function (or Jacobian) in the reconstruction forward problem is
likely to contain model errors since the exact optical properties of each region
are not known. Furthermore, even if the exact optical environment is
sufficiently characterized, the scattering nature of light means that
information measured across multiple source-detector pairs is highly similar.
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This degree of interrelatedness reflected in the Jacobian results in an illposed system (Bonfert-Taylor et al 2012), which is a common theme in almost
all biomedical optical reconstruction problems.
Subsequent kinetic analysis further complicates matters since
nonparametric

kinetic

analysis

(i.e.,

deconvolution)

is

an

unstable

mathematical problem, often requiring modeling constraints to achieve
acceptable precision (Lee 2005; Wirestam et al 2000). An implicit assumption
is that the image region-of-interest or region-specific tissue concentration
curve contains information from only one homogeneous tissue region.
Because of the problems with spatial reconstruction, this assumption is
invalid in many optical applications where the medium is heterogeneous and,
as a result, quantitative kinetic analysis has been elusive.
Combining spatial reconstruction and kinetic deconvolution into a
single mathematical system improves both problems and enables the
reconstruction of kinetic parameters from multiple regions. In this chapter,
the theoretical basis for this “kinetic deconvolution optical reconstruction”
(KDOR) approach will be provided and, as a proof-of-principle, numerical
simulations of time-resolved NIR measurements on the adult head are
described. The accuracy and precision of KDOR recovered parameters will
also be compared with values calculated using the traditional TS approach.

5.2. Theory
The KDOR approach combines the traditionally distinct steps of image
reconstruction and tracer kinetic modeling in order to improve accuracy and
precision of the recovered kinetic parameters (BF, BV, and MTT). Recall that
optical reconstruction is governed by the forward problem, which in matrix
form is given by
S  AC.

(5.1)
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In this case, S is the optical signal data vector (usually defined for a finite set
of spatial coordinates or source-detector distances), C is the concentration of
tracer in tissue (defined on the spatial set of nodes, voxels, or regions
representing the imaging domain, Ω), and A is the transformation between
these two vectors (conventionally referred to as the “Jacobian”). The Jacobian
is defined for the domains of S and C, and includes scaling factors such as ε,
the extinction coefficient of the tracer. The exact domains of S and C will vary
for different applications. For example, in reflectance measurements on the
head, C is typically defined for two regions (ECL and brain) and S is collected
at various source-detector distances. Other ways of encoding S include:
source-detector

pair,

i;

moment

k;

order,

and

time-of-flight,

t.

Notwithstanding differences in the encoding of S, optical reconstruction
involves solving



arg min AC  S

2

,

(5.2)

C

either in the least-squares sense, or using an iterative solver such as the
Levenberg-Marquardt algorithm (Dehghani et al 2008). The recovered C
vector is equivalent to a concentration map when spatially oriented according
to the coordinates of Ω.
When S is characterized temporally with a resolution on the order of
seconds to minutes, tracer kinetic theory can be used to describe the behavior
of C as a function of time. The time-dependent change in dye concentration at
any location in the medium is given by the convolution between a global AIF,

Ca(t) (since the same circulatory system feeds all tissue regions) and a flowscaled impulse residue function FR(t) (Eq. 1.5). The KDOR algorithm is
formulated by substituting this definition for C into Eq. 5.1, yielding:

S  BR F ,

(5.3)
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where B is the Kronecker product, ACA , RF is the vector constructed by
stacking all node-specific FR(t) functions, and S is the vector constructed by
stacking all time-specific data vectors. Quantification of blood flow, F, along
with other kinetic parameters is achieved by the recovery of RF through



arg min BRF  S

2



subject to GR F  0 and HR F  0

(5.4)

Equality and inequality constraints G and H are block matrices with
identical-sized partitions equal to the number of regions, constructed based
on the physiological assumptions outlined in subsection 1.4.3 for a single
kinetic region. For example, in the case where RF represents the
hemodynamic functions of three regions, the constraints in Eq. 5.4 would be
represented by:

g 1 0
G   0 g 2
 0 0

0
h1 0

0 , H   0 h 2
 0 0
g 3 

0
0 ,
h 3 

(5.5)

where gj and hj are the inequality and equality constraint vectors for the jth
region. Recall from Eqs. 1.10 and 1.11 in the first chapter, that constraints
are defined for time-intervals given by the lag time, Lj, which is equal to the
time between the injection and first appearance of dye, and the minimum
transit time, Mj, which is the shortest time that an idealized bolus (i.e., a
Dirac-delta function) can travel across the capillary bed within the region of
interrogation, specific to the jth region. In this case, the compartment hj in the
equality constraint presented in Eq. 5.5 is represented as:
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where NT is the number of columns in CA. Similarly, the compartment gj in
the inequality constraint in Eq. 5.5 is represented as:

1 0 0   
0 1 0   

0 0 1   

     
     
NT

     
     

     
     
gj 

0 0 0   

0 0 0   
0 0 0   
0 0 0  0 0

0 0 0  0 0
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0 0 0  0 0

 
M j  L j 1


   0 0 0 
   0 0 0 
   0 0 0 

      
      

      
      

      
      .

   1 0 0 
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0 1 1  0 0 
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(5.7)

It is therefore necessary to determine L and M for all tissue regions before
the minimization of Eq. 5.4. This is done iteratively by solving Eq. 5.4 for
different Lj and Mj values, and then comparing the reconstructed signal, S, to
the experimentally measured signal. To speed up the process, only the first
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30 seconds of the signal was used in the optimization. Figure 5.1 shows a
representative example of this fitting procedure, which is analogous to the
procedure used in the single-region deconvolution except that an iterative
search was used instead of an exhaustive search (Lee 2005).

Figure 5.1: Iterative search of lag and minimum transit time.
The implementation of equality and inequality constraints in the deconvolution method
require that the lag time, L and minimum transit time, M, be defined. This was done
iteratively: the initial guesses for L and M shown in (A) were adjusted so that (B) shows the
optimized value for L and (C) shows the convergence of both L and M.

Once the values of L and M are optimized, Eq. 5.4 is minimized for all
time points to recover RF. Finally, hemodynamic parameters are recovered
from the region-specific FR(t) functions: BF is recovered by determining the
maximum of FR(t), since R(t) is a normalized function with a maximum of
unity (Meier and Zierler 1954); BV is given by the area under FR(t), and MTT
can be calculated by the central volume principle (Zierler 1965) where MTT =

BV / BF.

5.3. Methods
5.3.1. Forward model of the adult head
A segmented finite element mesh of an adult human head was obtained
online

from

the

mesh-based

Monte

Carlo

(MMC)

repository

(http://mcx.sf.net/mmc/). The MMC program and related files were developed
by Qianqian Fang and are available free to use (Fang 2010). The adult head
model was segmented from an MRI into four tissue regions: scalp, skull, CSF,
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and brain. For the purpose of the forward model, these were assigned the
optical properties summarized in Table 5.1.
Table 5.1: Optical properties used in the Monte Carlo simulations

Medium

µs' (mm−1)

µa (mm−1)

g

Scalp

0.70

0.018

0.9

Skull

0.80

0.013

0.9

CSF

0.01

0.002

0.9

Brain

1.10

0.015

0.9

Continuous-wave signals were simulated for source-detector distances
of 10, 20, 30 and 40 mm. First, MMC was used to simulate photon
propagation in the adult head mesh, and photons “detected” at the four
source-detector distances were recorded. Then, the mean partial pathlengths
were determined from the photon history files using a previously described
method (Boas et al 2002). In this way, the Jacobian, A, was constructed to
relate the change in absorption occurring in the brain and in the ECL
(representing the scalp, skull, and CSF) to the change in signal for the four
distances. Time-dependent absorption changes in the two regions were
generated by first convolving a simulated Ca(t) with layer-specific FR(t)
functions defined by a gamma variate model (Thompson et al 1964) to obtain
region-specific C(t) curves. These curves were then converted to change in
absorption coefficient using the ICG specific absorption at 800 nm.
example is shown in Fig. 5.2.

An
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Figure 5.2: Change in tissue absorption coefficient
The dye-induced change in tissue absorption coefficient in the scalp (gray line) and brain
(black line) used in the forward model. Absorption curves are plotted along with the Ca(t)
function (dashed line, secondary y-axis) used in the simulations.

Gaussian noise of 10% was added to both the arterial input function and the
signal data vector. Noise was generated independently for each simulation
using a unique pseudorandom number seed.

5.3.2. Data reconstruction
The KDOR reconstruction method was performed by numerical optimization
of Eq. 5.4 using the MATLAB function lsqlin. The TS method, on the other
hand, involves first performing spatial reconstruction to recover the brain
and ECL specific C(t) curves, and then deconvolving these curves with the

Ca(t) function using the single-region method described in subsection 1.4.3.
Spatial reconstruction was regularized with the truncated singular-value
decomposition (TSVD) method which has been proposed elsewhere for this
application (Liebert et al 2004) and is an example of a common regularization
method to stabilize optical reconstruction.
A reconstruction Jacobian, Arec, was used in both KDOR and TS
reconstructions, which differed from the Jacobian used to generate the
forward data to avoid committing an “inverse crime”. The reconstruction
Jacobian was essentially a noisy version of the forward Jacobian to simulate
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uncertainty in the sensitivity factors that occurs during experimental
conditions. Two aspects of uncertainty were added to the reconstruction
Jacobian: the total sensitivity factor for each channel was randomly varied
between ± 10% of the original value, and the ratios between region-specific
sensitivity factors and the total sensitivity factor for that channel were varied
between ± 10%. These randomizations represent uncertainties that would be
introduced if the bulk scattering coefficient was inaccurate, or if there were
inaccuracies in the ECL thickness, respectively. For each iteration, Arec was
uniquely randomized with a new pseudorandom number seed.

5.3.3. Numerical experiments
Numerical experiments were conducted to compare the accuracy and
precision of the KDOR and TS methods. Hemodynamic input parameters
used to generate the forward data were held constant for all iterations. For
the ECL, BF = 5 ml min-1 100g-1, BV = 1 ml 100g-1, and MTT = 12 s and for
the brain, BF = 50 ml min-1 100g-1, BV = 4 ml 100g-1 and MTT = 5 s.
Reconstruction was repeated 100 times on the forward data to compare the
precision of the KDOR and TS methods.

5.4. Results and discussion
Brain-specific absorption curves obtained from the TS and KDOR approaches
are shown in Fig. 5.3. Note that the TS absorption curve is recovered in the
first step of the procedure, and then subsequently analyzed to recover the
hemodynamic function. The KDOR absorption curve is generated by
convolving the recovered FR(t) function with the original arterial input
function. Two important differences are observed when comparing these
curves. First, the TS curve shows a bias in the peak absorption compared to
the input curve, of about -10%, whereas, the KDOR curve shows no
discernible bias. In addition, the variability in the TS curve was two times
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greater than the KDOR curve around the absorption peak, and this
variability increased to five times at all other time points.

Figure

5.3:

Brain

tissue

change

in

absorption

coefficient

recovered

with

KDOR

and TS
(A) The brain change in absorption coefficient recovered with the KDOR method (open
circles), and (B) the change in absorption coefficient recovered with the TS method (open
circles). Both are compared with the true input curves (black solid line). Data points are the
mean of 100 iterations, and error bars are the standard deviation.

Next, the average FR(t) curves recovered with the two approaches, which are
shown in Fig. 5.4, were compared. Interestingly, the ECL curves are
recovered well by both methods, suggesting that there is sufficient
information present in the measured signal pertaining to this region to allow
direct reconstruction with minimal regularization.
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Figure 5.4: Impulse residue functions recovered with KDOR and TS
(A) and (B) show the true (solid black line) and recovered (open circles) FR(t) curves for the
ECL and brain tissue, respectively, calculated with the KDOR algorithm. (C) and (D) show
the true and recovered curves for the ECL and brain tissue, respectively, obtained using the
TS method. Data points are the mean of 100 iterations, and error bars are standard
deviation.

However, the reconstructed brain FR(t) curves show marked differences
between the two methods, similar to the differences seen in the absorption
curves. In particular, the TS approach seemed to do a poor job of capturing
the shape of the top of the curve. Since the plateau is used to calculate BF,
this resulted in an underestimation of BF by 11%. The precision of the
recovered curves was higher for the scalp region, and higher when using
KDOR compared to TS. Taken together, these results suggest that errors in
the TS during spatial reconstruction propagate into the kinetic analysis,
resulting in increased variability and an underestimation bias.
The three hemodynamic parameters of interest (BF, BV and MTT)
were calculated for the two tissue regions from the recovered FR(t) curves.
Box-and-whisker plots shown in Fig. 5.5 summarize the results of the kinetic
analysis.
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Figure 5.5: Hemodynamic parameters recovered with the two methods
Box-and-whisker plots of the blood flow (BF), blood volume (BV) and mean transit time
(MTT) recovered with the KDOR and TS methods for scalp (top row) and brain (bottom row)
regions. Boxes are bound by the 1st and 3rd quartiles, and the median is given by the centre
line. Error bars are min and max, with outliers shown as crosses. Dashed lines show the true
value of the parameter.

In general, the KDOR method does a better job of recovering the
hemodynamic parameters than the TS method. In particular, the mean error
in recovered CBF was −1.4% using the KDOR approach, compared with
−11.0% using the TS approach. Additionally, the precision of the CBF
estimate derived from the KDOR method was about two times greater.
The improvements that were observed by using the KDOR are most
likely a result of the reduced loss-of-information when solving the inverse
problem in Eq. 5.3. In particular, when compared to the spatial
reconstruction problem in Eq. 5.1, the linear operator in Eq. 5.3 (i.e., the
Kronecker product of A and CA) is of higher rank since its rank is equal to the
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sum of the ranks of A and CA (Laub 2005). In signal processing, the
numerical rank (also called the effective rank or pseudorank) is often more
instructive than the algebraic rank, and is defined as the number of columns
in the matrix that, with respect to some error tolerance, are practically
linearly independent (Hansen 1998). Since measurement and modeling errors
do not depend on the analytical method, the resulting effective rank is also
higher in the KDOR inversion than in the TS inversions. Furthermore, the
ability

to

constrain

the

KDOR

inversion

temporally,

using

rigid

physiologically derived equality and inequality constrains is likely to add
further stability to the inverse problem. The exact degree to which these
constraints improve reconstruction will depend on how different the FR(t)
functions are for the different regions. For example, if two regions of very
similar FR(t) functions are interrogated, there is likely to be crosstalk
between the two regions as the amount of interrelated information in B is
increased. However, in this case, since the regions are so similar to begin
with, any crosstalk will have a negligible effect on overall accuracy. An
additional benefit to using the KDOR approach is that it can be applied to
data that is encoded across any number of different dimensions (e.g., spectral,
spatial, as well as temporal in the case of time-resolved data). Because it is
compatible with the use of other constraints (e.g., spectral and anatomical
priors) it has the potential to improve optical—and potentially photoacoustic
or optoacoustic—reconstruction across a wide range of applications.

5.5. Conclusions
Taken together, these numerical simulations suggest that KDOR enables the
accurate and precise characterization of hemodynamics for a wide range of
conditions. Based on these encouraging results, the next chapter will validate
multi-distance, time-resolved NIR measurements of cerebral hemodynamics
recovered using the KDOR method in an animal model of cerebral ischemia.
This represents a final step in the development of instrumentation and
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analytical methods presented in this thesis to monitor adult patients in the
neurocritical care unit.
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Chapter 6
MEASURING CEREBRAL HEMODYNAMICS IN
AN ADULT PIG MODEL OF ISCHEMIA WITH
TIME-RESOLVED NEAR INFRARED AND
KINETIC DECONVOLUTION OPTICAL
RECONSTRUCTION
This chapter presents the validation of cerebral hemodynamic parameters
measured by time-resolved (TR) near-infrared (NIR) in combination with the
kinetic deconvolution optical reconstruction (KDOR) analytical method in an
adult pig model of ischemia. As such, this work extends the theoretical
derivations presented in the previous chapter, establishing the outlined
methodology as a robust technique capable of accurately quantifying cerebral
blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT).
This chapter is based on a manuscript entitled "Measurement of cerebral
hemodynamics in an adult pig model of ischemia using a quantitative
dynamic contrast-enhanced optical method" by Elliott JT, Diop M, Morrison
LB, d'Esterre CD, Lee T-Y, and St. Lawrence K, which will be submitted to a
peer-reviewed journal in the near future.

6.1. Introduction
In the previous chapter, the kinetic deconvolution optical reconstruction
(KDOR) analytical method was introduced and, based on numerical
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simulations, it was suggested that KDOR could be used to recover cerebral
hemodynamics from multi-distance dynamic contrast-enhanced (DCE) NIR
measurements, even in the presence of large extracerebral layer (ECL) signal
contamination. By employing the KDOR approach, while at the same time
leveraging improvements in optical instrumentation presented in Chapter 3
(i.e., time-resolved NIR), it is hypothesized that resulting CBF measurements
acquired in an adult pig during baseline, hypocapnia and ischemia will show
strong agreement with CT perfusion measurements, similar to the
continuous-wave, two-step approach in Chapter 2 demonstrated on a juvenile
pig model with less ECL contamination. Furthermore, by validating this
approach in a clinically relevant model, using anatomical and dynamic priors
that are also available clinically, this study represents a final staging ground
before deploying DCE-NIR in clinical trials.
With this goal in mind, this chapter will address three main objectives.
First, the KDOR method will be used in combination with time-resolved NIR
measurements acquired at four source-detector distances to evaluate the CBF
and CBV in an adult pig under three physiological states: baseline,
hypocapnia, and ischemia. Concomitant measurements will be acquired using
CT perfusion, in similar fashion to the juvenile pig study presented in
Chapter 2, and regression and Bland-Altman analysis will be used to
determine the difference between the two techniques. Second, to induce
ischemia in the adult pig, intracortical injections of endothelin-1 will be
administered. The reproducibility of this method will be determined, and the
resulting lesion will be described in terms of three abnormal tissue states:
infarct core (defined as CBF < 10 ml min-1 100g-1), penumbra (defined as CBF
between 10 ml min-1 100g-1 and 20 ml min-1 100g-1), benign oligemia (defined
as CBF between 20 and 40 ml min-1 100g-1) and normal tissue state (defined
as CBF > 40 ml min-1 100g-1). In particular, for the purpose of this
experiment, it is important to understand how each tissue state is
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contributing to the region interrogated by the NIR light. Finally, an error
analysis will be conducted to investigate the effect of probe positioning errors
(i.e., corregistration with CT or MRI anatomical information) and model
dependent errors caused by inaccuracy in the ECL reduced scattering
coefficient input value, which has a stronger influence on the sensitivity
factors (e.g., mean partial pathlength) than absorption coefficient. In
particular, the dependency of the method on correctly estimating the optical
properties of the ECL provides insight into whether or not TR NIR
instrumentation

(which

is

more

complex

and

expensive

than

CW

instrumentation, but provides greater sensitivity) is needed in clinical
applications.

6.2. Materials and methods
6.2.1. Animal protocol
Animal experiments were conducted according to the guidelines of the
Canadian Council on Animal Care and approved by the Animal Use
Committee at Western University (AUP #2007-050-06). Eight Duroc x
Landrace crossbred pigs (Sus scrofa domesticus, weight = 15.4 ± 0.74 kg, 6
females) were obtained from a local supplier on the day of the experiment.
Following anesthetic induction with 1.75-3% isoflurane, the animals were
tracheotomized and mechanically ventilated on a mixture of oxygen and
medical air. A polychloroprene probe holder was constructed in-house and
fixed on the head of the animal with tissue glue (Vetbond® (n-butyl
cyanoacrylate), 3M, St. Paul, MN). The adult pig has thick temporalis
muscles that originate at the temperoparietal region of the head are highly
vascularized, resulting in a scalp blood flow of about 25 ml min-1 100g-1
(Elliott et al 2013b)—much higher than is typical in the adult scalp,
estimated to be 5-8 ml min-1 100g-1 (Friberg et al 1986). To improve the
relevance of the animal model, three surgical incisions were made (caudial,
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rostral, and lateral to the probe holder) to reduce the blood flow to about 10
ml min-1 100g-1, measured with CT perfusion. Following the preparation and
surgical procedures, the animals were moved to the CT imaging suite and
allowed to stabilize for 1-hr before the experiment was continued.

6.2.2. Study design
The study consisted of collecting CT and DCE-NIR measurements at three
different levels of CBF. Following stabilization, physiological parameters
were recorded and a DCE-NIR measurement was acquired over a period of
about 5 minutes. The optical probes were removed from the probe holder and
a CT perfusion scan was performed. Following the CT scan, the probes were
replaced in the probe holder, and a second DCE-NIR measurement was
acquired. A period of at least 15 minutes was given between DCE-NIR
measurements to allow for clearance of the dye. This process was repeated for
the hypocapnia and ischemia conditions, resulting in a total of six optical
datasets and three CT perfusion datasets for each animal. A total of five
animals were subjected to all three conditions and a total of three animals
were subjected to only baseline and hypocapnia conditions; for two animals,
the experiments were conducted before a protocol modification was submitted
to allow the ischemia procedure, and for one animal, endothelin-1 was
unavailable.

6.2.3. Modification of cerebral blood flow
Hypocapnia was achieved by adjusting the ventilation rate on the mechanical
ventilator to achieve a PCO2 of 25 mmHg. Blood gas levels were confirmed
using a hemoximeter (ABL 80 FLEX CO-OX, Radiometer, Copenhagen,
Denmark). Once the appropriate PCO2 level was achieved, the physiological
parameters were allowed to stabilize before proceeding with the experiment.
Ischemia was achieved by intracortical injection of endothelin-1 (SigmaAldrich, St. Louis, MO), a potent vasoconstrictor. A burr hole was drilled
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through the scalp and skull just lateral to the probe holder, half way between
the source optode and the 40 mm detector optode. A 30-Ga needle was
carefully inserted into the cortical tissue, angled towards midline, and a lowdose CT scan was performed to confirm the location of the needle tip. The
needle was connected to a catheter, which in turn was connected to a syringe
containing approximately 1 μg/kg of endothelin-1 in 0.1 ml of sterile water.
Using a syringe pump, the contents of the syringe were delivered to the
cortical tissue over 10 minutes. Data collection proceeded 10 minutes after
the endothelin-1 injection was finished.
The reproducibility of endothelin-induced blood flow change was
reported as the standard deviation of mean CBF across the DCE NIR region
of interrogation (determined from light propagation modeling). The
reproducibility of infarct-size was determined tracing the infarct perimeter
free-hand, and computing the corresponding area using image analysis
software (ImageJ 1.46, National Institutes of Health, Bathsheba, MD). The
area was determined on the eight blood flow maps, and the volume was
calculated by multiplying the sum of the areas from each stack by the slice
thickness (5 mm).

6.2.4. Physiological measurements
In addition to CT and DCE-NIR measurements, physiological parameters
were monitored throughout the experiment, including: arterial oxygen
saturation, heart rate, respiration rate, end-tidal CO2, mean arterial
pressure, and rectal temperature. In addition, a hemoximeter was used to
measure arterial blood pH, PCO2, PO2, and glucose. The main purpose of
collecting these measurements was to ensure physiological stability at each of
the three conditions, which was achieved by adjusting the respiration rate on
the mechanical ventilator, and by maintaining temperature and glucose
homeostasis via a heated blanket and dextrose administration, respectively.
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6.2.5. Instrumentation
Optical measurements were collected using a time-resolved NIR system that
has been described previously (Diop et al 2010), and is depicted in Fig. 6.1.
The system comprised of a picosecond diode laser light source that was used
to emit 802 nm light pulses with a repetition rate of 80 MHz. A 1.5-m long
multimode fiber was used to guide the light from the source to the surface of
the animal head at a single position. Photons exciting the scalp were collected
by four optodes configured linearly at distances of 6, 20, 30, and 40 mm from
the source, which was guided through bandpass filters (FEB800-10, Thorlabs,
NJ; to exclude fluorescence) to four photomultiplier tubes (PMC-100, Becker
& Hickl Gmbh, Berlin, Germany). To perform DCE-NIR measurements, timeof-flight histograms were collected every 0.4 seconds for a total of 320 seconds
during the passage of indocyanine green (ICG), the optical dye used as a
contrast agent. Baseline data of 12.8 s were collected before the bolus
injection. Distributions of time-of-flight (DTOF) were measured at all four
channels simultaneously. In addition, the arterial input function (AIF) was
acquired using a pulse dye densitometer (DDM2000, Nihon-Koden, Japan).
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Figure 6.1: Layout of the time-resolved NIR system
The source fiber guides the pulsed light towards the sample, where it is collected by four
fibers, and detected using four photomultiplier tubes (PMTs). The PMTs send constant
fraction descriminator (CFD) signal to the four single-photon counting (SPC) boards located
in the PC where the data is stored and displayed. The PMT data is synchronized to the laser
driver via a sync cable.

Computed tomography anatomical images and CT perfusion maps
were acquired using the LightSpeed QXi scanner (GE Healthcare, Waukesha,
WI). Dynamic CT data was acquired during the bolus injection of an iodinebased contrast agent (1.0 mL/kg of iopamidol [300-Isovue®], Bracco S.p.A.,
Milan, Italy) at a rate of 1 ml/s. CT data was used as anatomical information
in the light propagation modeling, as previously described (Elliott et al
2013a)

Region-of-interest

analysis

was

performed

on

CT

perfusion

parameteric maps to determine the mean value of CBF, CBV, and MTT
within the volume of tissue interrogated by the DCE-NIR light. The region-ofinterrogation was estimated from Monte Carlo generated sensitivity maps
(Fang and Boas 2009). In addition to DCE-NIR validation, CT perfusion maps
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were also used to confirm the magnitude and volume of the ischemic lesion
following endothelin-1 injection.

6.2.6. Data analysis
The DTOFs measured at the four source-detector distances were converted to
the three statistical moments of attenuation, mean time-of-flight and
variance (Liebert et al 2004), which were smoothed using a Savitzky-Golay
filter (using a window size of 12 seconds and a 7th order polynomial) prior to
being analyzed (Savitzky and Golay 1964). The KDOR method, which was
developed in-house and has been described in detail previously (Elliott et al
2013a; Elliott et al 2012b) was used to analyze the DCE-NIR moments.
Briefly, CT anatomical images were segmented manually into scalp, skull,
and brain, and Monte Carlo eXtreme (Fang and Boas 2009) was used to
model light propagation at the source-detector positions used in the
experiment. The transformation between the detected signal and the change
in dye concentration in the tissue regions, known as the Jacobian, A, was
calculated from the Monte Carlo results (Liebert et al 2004) using optical
properties determined by fitting the baseline (pre-ICG) time-resolved data
(Diop et al 2010) and anatomical information from the CT image. The
Jacobian function, the DCE-NIR data and the AIF are input into the KDOR
algorithm, which was used to recover BF, BV, and MTT for the ECL and
brain regions. Specifically, these three parameters were calculated from
region-specific impulse residue functions, based on the previously described
method (Meier and Zierler 1954). A schematic of this process is provided in
Fig. 6.2.
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Figure 6.2: KDOR workflow
Flow chart outlining the steps involved in recovering the hemodynamic parameters. The
parallelograms indicate the measured data from the three devices. Rectangles represent the
analytical processes used: fit, diffusion approximation (DA) fitting routine; seg, manual or
automatic segmentation; and MC, Monte Carlo modeling of the Jacobian. Intermediary
parameters are represented by ovals: μ, region-specific bulk optical properties, B, binary
segmented CT volume; and A, Jacobian. Finally, the recovered hemodynamic parameters
(BF, blood flow; BV, blood volume; and MTT, mean transit time) are indicated by triangles.

The ECL fitting step (fit) involved optimizing the difference norm of
time-resolved data collected at the 6 mm source-detector distance and the
time-resolved function generated with the reflectance model of the diffusion
approximation (Kienle and Patterson 1997). This procedure is described in
detail elsewhere (Diop et al 2010). Segmentation (seg) was performed
manually, slice-by-slice, on CT anatomical data that was acquired with a slice
thickness of 5 mm.

6.2.7. Error analysis
An error analysis was conducted to investigate the influence of errors in the
anatomical information used in the KDOR procedure that might occur during
the clinical implementation of this technique. If it is assumed that the CT
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images can be accurately segmented from clinical-resolution scans, then a
potential source of error when inputting the anatomical information into the
KDOR algorithm is co-registration of the optical probe positions using either
feducial markers or a landmarking system (such as SLM10-20; Custo et al
2010). Errors in probe positioning could result in differences between the
modeled and actual ECL geometry. This error was investigated by generating
DCE-NIR forward data on a two-layer slab (ECL and brain) according to a
previously described method (Elliott et al 2012). Following the addition of 5%
Gaussian noise to the NIR and AIF signals, CBF was recovered with KDOR
using a Jacobain modeled with four-layer slabs of varying thicknesses. The
thickness of the ECL was varied between 14 and 17 mm, representing the
variation in thickness measured from T2-weighted MRI images of 5 healthy
subjects for positional changes of approximately 15 mm (data not published).

6.2.8. Statistical analysis
All data are presented as mean ± SEM unless otherwise indicated. An
analysis of variance (ANOVA) was used to uncover any physiological
condition effects on the physiological parameters, which were further
investigated with Tukey's post hoc test when appropriate.
Linear regression analysis was performed on each hemodynamic
parameter (CBF, CBV, and MTT) to examine correlations between the values
obtained using the two techniques (DCE-NIR and CT perfusion). Since
datasets

included

multiple

measurements

from

the

same

animal,

independence could not be assumed and therefore a variation of the
generalized estimating equation was utilized (Zeger et al 1988). First, a
linear fit was applied to the data from each animal separately. A t-test was
used to compare the slope and intercept values obtained from each animal to
a null hypothesis (i.e., a slope of zero). Upon rejection of the null hypothesis,
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the distribution of slopes was compared with a slope of unity to determine if
the mean regression line was significantly different from the line of identity.
For the CBF regression plot (Fig. 6.6), the 95% confidence bounds on
the regression line-of-best fit (i.e., the region containing the 95% of the
distribution of lines-of-best fit assuming a Gaussian random effect) were
calculated.

Finally, the degree of similarity between CBF measurements

acquired with the two techniques was evaluated using a Bland-Altman plot
(Bland and Altman, 1986). Differences with p < 0.05 were considered
significant.

6.3. Results
6.3.1. Physiological parameters
Table 1 summarizes the physiological parameters of the eight pigs averaged
for each condition. Respiration rate, which was artificially increased by
adjusting the mechanical ventilator setting, was significantly higher during
hypocapnia and ischemia conditions. This resulted in the intended decrease
in pCO2 measured from arterial samples, which was significantly different
during hypocapnia and ischemia compared with baseline. A significant
decrease was also observed in end-tidal CO2 measurements. No significant
differences were observed in SaO2, HR, MAP, pO2, glucose and temperature.
The mean ECL thickness in these animals was 12.0 ± 0.6 mm (ranging from
10.5 to 14 mm), measured from CT images.
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Table 6.1: Physiological parameters at each condition
SaO2
(%)

HR
(min-1)

Baseline

100 ±
0

108 ± 2

Hypocapnia

99 ±
1

Ischemia

99 ±
0

RR

MAP
(mmHg)

pCO2
(torr)

pO2
(torr)

glucose
(mM)

temp
(°C)

29 ±
1*

49± 2

37.3 ± 0.7

168.6 ±
29.4

5.3 ±
1.0

37.3

109 ± 4

46 ±
1*

46 ± 2

24.2 ±
1.2*

149.4 ± 10

5.4 ±
1.2

37.4

124 ±
17

41 ±
2b

47 ± 4

26.0 ±
2.4*

138.4 ±
15.2

5.2 ±
0.8

37.3

(min-1)

SaO2, arterial oxygen saturation; HR, heart rate; RR, respiration rate; MAP, mean arterial
pressure; pCO2, partial pressure of carbon dioxide; pO 2, partial pressure of oxygen. * p < 0.01
compared to baseline

6.3.2. Reproducibility of hypocapnia and ischemia
Analysis of variance with physiological condition (i.e., baseline, hypocapnia,
or ischemia) as a within-subject factor and modality (i.e., CT perfusion or
DCE-NIR) as between-subject factors revealed a significant condition effect
on CBF measurements acquired with the two modalities (F2,18 = 10.27, p <
0.01) but no significant condition by modality interaction. Post-hoc analysis
was performed with Tukey’s method to further elucidate this condition effect.
Compared with baseline, hypocapnia induced by artificially increasing the
ventilator respiration rate from an average of 29 min-1 to an average of 46
min-1 resulted in a significant reduction in CBF measured with CT perfusion
(43.0 ± 4.2 ml min-1 100g-1 during hypocapnia vs. 61.7 ± 3.1 ml min-1 100g-1 at
baseline; p < 0.05) and with DCE-NIR (42.6 ± 3.7 ml min-1 100g-1 during
hypocapnia vs. 62.2 ± 4.7 ml min-1 100g-1 at baseline; p < 0.05). A further
reduction in blood flow was observed following intracortical injection of
endothelin-1, which resulted in an average CBF value of 39.9 ± 3.1 and 32.7 ±
3.6 ml min-1 100g-1, measured by CT perfusion and DCE-NIR, respectively.
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Figure 6.3: Sensitivity of optical measurements to endothelin-1 lesion.
(A) CT perfusion blood flow map with visible large lesion caused by endothelin-1 injection.
(B) Map showing spatial sensitivity of optical signal measured at 40 mm source-detector
distance (arrow represents source; arbitrary units). (C) Segmentation map showing regions
identified as infarct (red), penumbra (orange), benign oligemia (green) based on thresholding
of panel A.

A closer examination of the CT perfusion data acquired during
ischemia identified the presence of four tissue states with clinical importance:
infarct (< 10 ml min-1 100g-1), penumbra (10-20 ml min-1 100g-1), benign
oligemia (20-40 ml min-1 100g-1) in addition to normal tissue (> 40 ml min-1
100g-1).

The

reproducibility

of

endothelin-1

induced

ischemia

was

investigated in terms of the change in CBF compared to baseline within the

optical region of interrogation as well as the total volume of the ischemic
lesion (i.e., infarct and penumbra regions). A mean percent decrease in CT
perfusion-measured CBF of 36.5 ± 7.3% (S.D.) was observed during ischemia
in the region interrogated by the NIR light, and the mean volume of the
ischemic lesion was estimated to be 27.6 ± 10.4 ml (S.D.).

168

Figure 6.4: Average contribution of tissue states to the optical ROI
The average contribution of these tissue states to the optical region-of-interrogation across
five animals. I, infarct (< 10 ml min-1 100g-1); P, penumbra (10-20 ml min-1 100g-1; BO,
benign oligemia (20-35 ml min-1 100g-1); N, normal.

Figure 6.3 shows a representative example of a CT perfusion map
acquired during ischemia, a corresponding Monte Carlo sensitivity map, and
a threshold map of the abnormal tissue states. To further investigate the
robustness of the ischemic model to produce clinically relevant lesions, the
percentage of the region-of-interest (ROI) representing the four tissue states
was measured across all animals subjected to ischemia. On average, the three
abnormal tissue states represented 48.7% of the total optical ROI. In Figure
6.4, a bar graph shows the mean percent contribution of the four tissue states
within the region of interrogation.

6.3.3. DCE-NIR signal and recovered ICG concentration curves
Time-resolved data were collected before and during bolus injection
enhancement at four source-detector distances. Changes in the statistical
moments of time-of-flight distribution―attenuation, mean time-of-flight, and
variance―were calculated for subsequent analysis by the KDOR method.
Figure 6.5 shows a representative example of the change in attenuation and
change in variance signals measured at two of the source-detector distances
(40 and 6 mm) during DCE measurements acquired under the three
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physiological conditions. The tissue concentration curves recovered from the
same data for the scalp and brain regions, along with the arterial input
functions measured with the dye densitometer, are also shown. In these three
datasets, the CBF (determined using the KDOR method) was equal to 45 ml
min-1 100g-1 at baseline, 32.5 ml min-1 100g-1 during hypocapnia, and 22.6 ml
min-1 100g-1 during ischemia.

Figure 6.5: Dynamic contrast-enhanced signals during the three conditions
The attenuation (top row) and variance (middle row) signal measured at 40 mm (black line)
and 6 mm (gray line) source-detector distances during baseline, hypocapnia and ischemia
(left-to-right). The recovered tissue concentration curves for the brain (solid black line) and
ECL (solid gray line), and the corresponding arterial input function (dashed line) for the
same data are presented in the bottom row.

6.3.4. Comparison of hemodynamic parameters calculated using
DCE-NIR and CT perfusion
As stated in the methods section, a simple linear regression approach could
not be performed because both independent and within-subject data are
represented. Therefore, regression analysis was performed on data from each
animal, individually, and the average of the eight analyses was determined.
This approach was used to determine the relationship between CT perfusion
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and DCE-NIR measured CBF, and between CT perfusion and DCE-NIR
values of BV. Figure 6.6 shows the regression plot of the CBF data; the lineof-best fit averaged across the individual regression analyses had a slope of
1.06 ± 0.08, and a y-intercept of −4.37 ± 4.33 ml min-1 100g-1. The average
slope was significantly different from the null (p < 0.001) but not significantly
different from the line of identity (p = 0.81). The average y-intercept was not
significantly different from zero (p = 0.76). The average r value, calculated
from the individual regression analyses was 0.86 ± 0.06.

Figure 6.6: Cerebral blood flow regression plot
Regression plot comparing CBF values calculated from DCE-NIR data and concomitant CT
perfusion values of CBF. Data are grouped by animal (n=8) and represented with a unique
symbol. Regression analysis was performed on each group individually, and the average lineof-best fit is indicated by the dashed line (slope = 1.06 ± 0.08, y-intercept = -4.37 ± 4.33 ml
min-1 100g-1).

The regression analysis of BV measured with the two techniques yielded an
average line-of-best fit with a slope of 2.49 ± 0.34 and a y-intercept of 0.14 ±
1.60 ml 100g-1. The average slope was significantly different from the null (p
< 0.01) and significantly different from the line of identity (p < 0.05). The yintercept was not significantly different from zero (p = 0.90). The average r
value for the CBV regression analyses was 0.56 ± 0.13. The mean difference

171
between BV calculated with the two techniques was 6.53 ml 100g -1, and the
data was bound by a 95% confidence interval of 3.12 – 9.95 ml 100g-1. Finally,
the average difference between the two techniques was significantly different
from the null (p < 0.001), suggesting the presence of a systemic bias that
would allow one technique to be calibrated to the other.
Figure 6.7 shows the Bland-Altman plot comparing the CBF
measurements from the two techniques. The mean difference between the
two techniques was −1.7 ml min-1 100g-1, which was bound by a 95%
confidence interval of −16.3 to 12.9 ml min-1 100g-1. In this case, the average
difference between the two techniques was not significantly different from
the null (p = 0.31).

Figure 6.7: Cerebral blood flow Bland-Altman plot
Bland-Altman plot comparing the CBF measurements obtained with the DCE-NIR method
and the CT perfusion method. Data are grouped by animal using the same symbols as in
Figure 6.6. The mean difference between the two methods is indicated by the solid line, and
the 95% confidence interval is demarcated by the dashed line. No statistically significant
CBF magnitude effect was detected.
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6.3.5. Error analysis
Two error analyses were conducted to investigate potential sources of model
uncertainty that could occur within the context of the KDOR framework
presented in Figure 6.2. Uncertainties in probe holder position, which was
determined from segmented CT images corregistered to the optical imaging
domain, were investigated by generating forward optical data (replicating the
experimental data) for an ECL thickness of 15 mm, and then reconstructing
the same optical data with light propagation models assuming ECL thickness
values from 13 to 17 mm. No significant differences were observed across
ECL thickness values (p = 0.83). The results of this error analysis are shown
in Figure 6.8A.

Figure 6.8: Probe position and scattering coefficient error analysis
(A) The relationship between error in assumed ECL thickness and error in the recovered
CBF, simulated for a range of ECL thicknesses between 13 and 17 mm. (B) The relationship
between error in the ECL reduced scattering coefficient, μs', and the error in recovered CBF.
The regression line-of-best fit (slope = -0.39, y-intercept = 4%) is also shown (dashed line).

The value of directly measuring the ECL reduced scattering coefficient
was evaluated by generating forward optical data with an ECL reduced
scattering coefficient of 0.8 mm-1, and then reconstructing the same data with
light propagation models using ECL scattering coefficient values from 0.4 to
1.2 mm-1. A significant correlation between the error in reduced scattering
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coefficient and error in recovered CBF was observed (slope = -0.39, y-

intercept = 4%, r = 0.96, p < 0.001). These numerical results are shown in
Figure 6.8B.

6.4. Discussion
Dynamic contrast-enhanced optical measurements of CBF have been
proposed for over 25 years as an attractive modality for bedside clinical
monitoring, especially within the context of critical care. In particular,
because DII is a leading contributor to poor outcome in patients that have
sustained severe traumatic brain injury (Bouma et al 1991), stroke (Dirnagl

et al 1999), and subarachnoid hemorrhage (Hijdra et al 1988), the ability to
measure CBF at the patient's bedside would be of great value. Currently,
only surrogate markers of CBF (i.e., intracranial pressure and cerebral
perfusion pressure) are available to assess neurological recovery, and
considerable controversy surrounds the use of these indirect markers of CBF
to guide patient management. Despite the significant clinical potential of
bedside CBF measurements, it is only recently that optical techniques have
shown promise in achieving the stated goal.
An early study by Owen-Reece and colleagues identified the problem of
extracerebral signal contamination as a confounding factor in optical
measurements of CBF, resulting in a large underestimation of CBF. To
overcome this problem, they suggested the use of a correction factor to
calibrate NIRS CBF measurements to measurements obtained with an
alternate technique. This was, in part, based in the assumption that the
extracerebral layer effect was primarily due to a partial volume error, and
that this effect would show low intrasubject variability (Owen-Reece et al
1996). The notion of a direct correlation between NIRS-CBF measurements
and CBF measured by an alternate method was challenged by a later study.
Schytz and colleagues showed an absence of any correlation between CBF
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measured concomitantly with NIRS and SPECT in healthy subjects before
and after administration of acetazolamide (Schytz et al 2009). In particular,
this study highlighted the lack of a universal correction factor for NIRS
measurements of CBF, underlining the importance of subject-specific
modeling using anatomical priors (Elliott et al 2010).
The advent of more sophisticated optical methods—including timeresolved and frequency-domain NIR techniques—resulted in an increase in
sensitivity to deeper tissue structures, such as the brain. In particular, timeresolved methods allowed the discrimination of photons based on the time-offlight (i.e., the time required for a photon to travel from the source fibre to the
detector), providing additional improvements in brain tissue sensitivity on
the basis that late-arriving photons are statistically more likely to
interrogate deeper tissue (Steinbrink et al 2001; Liebert et al 2004). Several
papers have been published demonstrating qualitative curve analysis
(Liebert et al 2006, Liebert et al 2012) and within subject quantification
(Steinkellner et al 2010) of ICG bolus measurements acquired in neurocritical
care patients with time-resolved methods. While this work has established
the sensitivity of DCE-NIR methods to CBF changes, measurements are
typically relative blood flow indices calculated using methods such as time-topeak (TTP). In Chapter 3, it was demonstrated that TTP analysis is
unreliable when perturbations in cerebral blood volume and the arterial
input function occur (Elliott et al 2013b). An alternative method of analyzing
DCE-NIR data was presented, in which nonparametric kinetic analysis
(Elliott et al 2013b) was used to calculate a relative blood flow index that
showed good agreement with CBF changes determined from CT perfusion.
It is likely that absolute CBF measurements will be more clinically
useful than relative blood flow indices, since well-defined CBF thresholds for
cell dysfunction and irreversible cell damage are known (Jones et al 1981;
Astrup et al 1981; Schaefer et al 2006). Therefore, to provide absolute
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measurements of CBF, time-resolved instrumentation was combined with
subject-specific light propagation modeling, and subsequently incorporated
into

an

analytical

framework

called

kinetic

deconvolution

optical

reconstruction (KDOR). The theoretical basis for the KDOR method was
described in a recent Letter, and provides a more robust means of separating
the ECL and brain contributions to the optical signal through the use of
anatomical priors and physiological constraints (Elliott et al 2012b). The
main objective of this study was to confirm these theoretical predictions by
validating

DCE-NIR

CBF

measurements

against

CT

perfusion

measurements acquired concomitantly in adult pigs.
The representative example of optical signals measured in a single
animal at three different physiological conditions provided in Figure 6.5
illustrates the features of DCE-NIR data. As expected from previous studies
(Liebert et al 2004; Steinkellner et al 2010; Liebert et al 2006), including the
study presented in Chapter 3, differences between attenuation and variance
signals were observed. The subtle differences at baseline suggest increased
sensitivity of variance to faster cerebral tracer kinetics. As CBF decreased
due to hypocapnia and ischemia, greater differences between these three
conditions were observed in the variance signal than in the attenuation
signal—a trend observed in the Chapter 3 study. Improvements in sensitivity
provided by

the variance signal

facilitated the recovery of

tissue

concentration curves, which appear to reflect the corresponding change in
CBF, both in the peak concentration and the temporal dynamics. An
interesting feature of the tissue concentration curves recovered for the
ischemia condition is the apparent transient increase in concentration
following the recirculation of dye. This is likely an artifact of the
reconstruction process, as opposed to any real kinetic effect such as
extravasation, and is an atypical feature. It is important to note that
constraints implemented by the KDOR inversion have the greatest effect on
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the first rise, and peak concentration, of the corresponding tissue
concentration curves. Therefore, any small discrepancies in the shape of the
reconstructed tissue curve is not indicative of a significant error in recovered
CBF.
For all eight animals, values of CBF and CBV recovered with the DCENIR method were compared to CT perfusion values—the most common
method used to assess these parameters clinically (Koenig et al 1998; Mayer

et al 2000). In general, an excellent agreement was observed between CBF
measurements acquired with the two modalities with a precision comparable
to previous studies published by our group for the neonatal pig model (Brown

et al 2002), as well as the juvenile pig study presented in Chapter 2. It is
likely

that the improvements in instrumentation (time-resolved vs.

continuous-wave) and the use of the KDOR method to mitigate optical
reconstruction problems (Bonfert-Taylor et al 2012) contributed to the strong
correlation with CT perfusion measurements, despite the use of animals with
thicker ECLs and reduced scalp flow. While CBV values measured with the
DCE-NIR

method

showed

a

strong

correlation

with

CT

perfusion

measurements, the optical technique reported values that were on average
2.5 times larger (baseline mean values of 4.7 ml 100g-1 and 11.39 ml 100g-1
determined with CT perfusion and DCE-NIR, respectively). One explanation
for this discrepancy is that the two methods utilize different kinetic modeling
approaches to calculate hemodynamic parameters from DCE. The CT
Perfusion 4 program utilizes a variation of the adiabatic approximation to the
tissue homogeneity (AATH) model (Bisdas et al 2008) which is essentially a
plug flow model. Plug flow models have been demonstrated to underestimate
mean transit time (MTT) in many situations (Schabel 2012; St. Lawrence et

al 2013), and since CBV is directly related to MTT by the central volume
principle, it is also underestimated. On the other hand, the DCE-NIR method
employs a nonparametric deconvolution method to recover an arbitrary
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hemodynamic function. Since the NIR region-of-interrogation is larger, it is
likely to contain a distribution of MTTs that contribute to an overall larger
CBV than would be observed for a single CT voxel. In addition to the transit
time distribution effect, because the DCE-NIR method does not truncate the
recovered hemodynamic function, it is likely that any residual scalp
contribution

that

remains

in

the

brain

signal

would

contribute

disproportionately to CBV, without significantly affecting CBF values.
Nevertheless, it is important to recognize that the discrepancy between CBV
values attributed to these differences resulted in a consistent bias across all
eight animals, suggesting that a simple calibration curve could be used to
relate the two modalities if desirable.
Given the strong correlation between the DCE-NIR method and the
clinical standard, a closer investigation of the analytical framework is
pertinent. In particular, it is worthwhile investigating the relative
importance of the priors incorporated into the workflow before the KDOR
routine is executed. First, while the acquisition of anatomical imaging (i.e.,
CT or MRI) is ubiquitous in almost all neurotrauma centers, the
segmentation and incorporation of this data into a subject-specific model may
not be trivial within the context of acute care. In particular, it may be
difficult to provide an accurate method of coregistering the anatomical data
with the location of the optical probes, which was rather straightforward in
these experiments given the visibility of the polychloroprene probe holder on
the CT images. While the use of feducal markers has been explored
elsewhere, it is likely that a landmark system such as the 10-20 international
system (Custo et al 2010) used for electroencephalogram placement would be
more clinically compatible. To this end, the effect of small errors in optical
probe corregistration was investigated by varying the ECL thickness within a
range typical of small but non-negligible positional changes on an average
human head. No significant difference was found in the recovered blood flow
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values across the range of ECL thicknesses, suggesting that the DCE-NIR
method is insensitive to small perturbations in ECL thickness. As a result, it
is reasonable to assume that a less accurate positioning system, such as the
SLM 10-20, would provide acceptable accuracy. The importance of measuring
the optical properties of the ECL using time-resolved data collected at the 6
mm source-detector distance was also investigated. Across a range of values
for the reduced scattering coefficient, a significant correlation between error
in CBF and error in μs′ was determined. More specifically, an error of about
40% in μs' resulted in a 20% error in CBF. Given that reported values of μs'
for the scalp of the human head include 1.0 mm-1 (Boas et al 2002), 1.2 mm-1
(Choi et al 2004), and 1.7 mm-1 (Okada and Delpy 2003), using an assumed
value for μs' would introduce a large amount of uncertainty. In part, the
results of this second error analysis provide a strong justification for the use
of time-resolved instrumentation to directly measure the optical properties in
the ECL, despite its relative sensitivity to stray light compared to
continuous-wave systems.
In this study of cerebral ischemia, intracortical injection of endothelin1 was used to produce a large lesion containing infarct and penumbra tissue
states, which persisted long enough to acquire the three measurements
needed for this study. A limitation with this model is that only a portion of
the lesion (14%) was reduced to ischemic levels, as defined by CBF less than
10 ml min-1 100g-1, with penumbra (10 - 20 ml min-1 100g-1) and benign
oligemia (20 - 35 ml min-1 100g-1) regions also contributing to 18 and 19%,
respectively. Since the NIR region-of-interrogation encapsulated all of these
components, the recovered CBF values by DCE-NIR and corresponding CT
perfusion values averaged over a representative region-of-interest did not
reach ischemic levels. However, given that the difference between the two
techniques, as determined with the Bland-Altman method (Fig. 6.7) did not
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depend on the blood flow level, it is reasonable to assume that DCE-NIR
would quantify even lower levels of CBF with comparable precision.

6.5. Conclusions
The present study validated the DCE-NIR method of measuring CBF, which
combines multi-distance time-resolved measurements, arterial input function
characterization, and subject-specific light propagation modeling using the
KDOR analytical framework. This work provides a convincing argument for
using this robust optical method to measure CBF in the neurocritical care
unit, where quantitative CBF measurements may provide a means of guiding
patient management and intervention.
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Chapter 7
CONCLUSIONS AND FUTURE WORK
The final chapter of this thesis provides a summary of the dynamic contrast
enhanced (DCE) near-infrared (NIR)

method developed

to

measure

hemodynamic parameters in neurocritical care unit (NCU) patients. As the
objectives of this thesis were advanced, improvements were made to the
instrumentation and the analytical approach, beginning with the depthresolved continuous-wave (CW) near-infrared spectroscopy (NIRS) method in
Chapter 2. Next, a blood flow index calculated from the variance of timeresolved (TR) NIR distribution of time-of-flight (DTOF) measurements was
described as a reliable technique to measure changes in cerebral blood flow
(CBF) (Chapter 3). Finally, a multi-distance TR moments-based method
using the kinetic deconvolution optical reconstruction (KDOR) approach was
validated in an adult pig model of ischemia (Chapter 6). Each of these
developments will be summarized within the context of the objectives
presented in Chapter 1. Following this, the future work for this technology
will be discussed and the principle conclusions of the thesis will be stated.

7.1. Summary of stated objectives
The four objectives of this thesis focused mainly on: (i) the design and
optimization of clinically compatible instruments, (ii) the development of an
analytical framework, (iii) the development of clinically relevant animal

186
model for NCU applications, and finally, (iv) the validation of the technique
against CT perfusion. These will now be addressed in turn.

7.1.1. Design and optimization of NIR instrumentation
The design and optimization of the DCE-NIR system was accomplished in
three main steps. First, a two-channel continuous-wave broadband system
was developed, based on the previous work of our group in using CW NIRS to
measure CBF in neonatal pigs (Brown et al 2002; Tichauer et al 2006) and
more recently, in the neonatal intensive care unit (Arora et al 2013). In the
subsequent study, a time-resolved system was introduced to improve brain
sensitivity through the use of statistical moments of DTOF data. Chapter 3
highlighted the results obtained using the variance signal measured at 30
mm to calculate a relative blood flow index, dBF, which is capable of tracking
changes in CBF. It was evident from the error analysis and the strong
agreement with CBF changes measured by CT perfusion that a necessary
precursor in proper kinetic analysis of DCE-NIR is the acquisition of the AIF.
Therefore, in Chapter 4, an alternate method of capturing the AIF was
described to eliminate the need of a specialized dye densitometer. The goal in
developing this pulse oximeter (PO)-based method was to facilitate clinical
implementation of DCE-NIR by leveraging the ubiquity of POs in the critical
care setting. Finally, in Chapter 6, a multichannel TR-NIR system was
presented that enabled the three statistical moments (A, <t>, and V) acquired
at four source-detector distances (6, 20, 30, and 40 mm) to be measured
simultaneously. This sophisticated instrumentation enabled accurate and
precise characterization of CBF, even in the presence of substantial ECL
contamination. In particular, an error analysis demonstrated the importance
of direct determination of extracerebral layer (ECL) optical properties, which
can be done effectively using TR-NIR.
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7.1.2. Development of the analytical framework
In parallel to the developments in instrumentation, improvements in
analytical methodology were made. In the first pig study, the inter-subject
variability in sensitivity factors (i.e., mean partial pathlengths (MPPs)) was
identified as the likely cause of reported failure of DCE NIRS to measure or
even track changes in CBF in adult subjects (Schytz et al 2009). Therefore,
subject-specific Monte Carlo simulations were implemented and a lookup
table of MPPs was generated using two-layer models with varying ECL
thicknesses. For each animal, MPPs were selected from the library using an
objective cost function that optimized two error norms: ECL thickness of the
two-layer model compared to the value measured from the animal’s CT
image, and the resulting brain water concentration compared with the
assumed value of 80%. Compared to the simple subtraction method, in which
a group averaged MPP set was used, the subject-specific approach
significantly reduced the inter-subject variability and, as a result, NIRS CBF
measurements showed good agreement with CT perfusion values. Timeresolved NIR was implemented as a way to further improve depth sensitivity
by measuring the DTOFs. The use of the change in statistical variance of the
DTOF during ICG uptake and washout to calculate a deconvolution-based
blood flow index (dBF) was investigated, avoiding the need for the subjectspecific modeling used in the previous study. A secondary goal of this study
was to highlight the pitfalls of using the TTP as a surrogate of CBF changes:
a commonly used approach in DCE optics. A more robust analytical approach
based on the deconvolution method was developed, and it is arguably the
most significant advancement of this doctoral work. The ill-posed nature of
optical reconstruction impacts almost every field of biomedical optics and any
additional unique information that can be included in the reconstruction
problem will likely improve the results. The KDOR method, described in
Chapter 5, is a novel reconstruction approach that uses dynamic priors. The

188
ability of this method to recover CBF accurately was demonstrated in
Chapter 6.

7.1.3. Development of the animal model
Adult pigs were used in all three DCE NIR studies since they have similar
ECL thickness to humans. Furthermore, the average CBF of an adult pig is
similar to the human adult. The main limitations of the pig model are small
size of the brain relative to the head and the higher scalp blood flow than in
the humans due to the thicker temporalis muscles that have evolved to
enable strong mastication. The former issue is not a problem because the
farthest source-detector distance (40 mm) was well within the length of the
brain. To overcome the second limitation, three incisions were made rostral,
caudal and lateral to the optodes in the second and third pig studies to reduce
scalp blood flow to less than 10 ml min-1 100g-1, as observed in humans. In all
three animal studies, CBF was varied over a range of values by adjusting the
PaCO2 (i.e., hypercapnia and hypocapnia). However, two limitations of this
approach were identified within the context of DCE NIR validation. First,
hypocapnia does not decrease CBF below the clinically important thresholds
of either infarct or penumbra. Second, a vascular response to PaCO2 may
occur in the ECL, as well as in the brain. The latter could confound the
ability to assess whether depth-resolved NIRS is truly sensitive to only flow
changes occurring in the brain. For these two reasons, we introduced the
ischemic model in Chapter 6, which involves inducing a large ischemic lesion
by intracortical injection of endothelin-1. Computed tomography maps were
used to demonstrate the reproducibility of the model in causing a large
volume (27.6 ± 10.4 ml) lesion with infarct, penumbra and benign oligemia
tissue states.
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7.1.4. Validation of the method against CT perfusion
Finally, validation of the DCE-NIR method was accomplished at each stage of
development through comparisons to CT perfusion, the current clinical
standard for CBF measurements. In the first study, the DCE-NIR
measurements of CBF showed strong agreement with CT perfusion values
(r = 0.84, p < 0.001), and the mean difference between the two techniques was
−2.83 ml min−1∙100 g−1 with a 95% confidence interval of −19.63 ml min−1 100
g−1 to 14.00 ml min−1 100 g−1. In the second study, the specificity and
sensitivity of the dBF index measured from the variance signal was
investigated in four animals. First, extracerebral blood flow and composition
was modulated to determine the effect of the ECL on the measured index: the
average change in dBF during these manipulations was 0.2 ± 2.4%. Second,
the ability of dBF to track changes in CBF was examined by inducing
hypocapnia and performing concomitant measurements of CBF with CT
perfusion. In this case, measurements of dBF acquired on the surface of the
head showed a similar decrease compared with CT perfusion values of CBF.
In the third pig study, DCE-NIR measurements of CBF analyzed using
KDOR showed strong agreement with CT perfusion values (r = 0.86,

p < 0.001) across a range of blood flow levels from about 25 to 75 ml min -1
100g-1. The mean difference between the two techniques was -1.7 ml min-1
100g-1, which was bound by a 95% confidence interval of −16.3 to 12.9 ml min1

100g-1. Furthermore, the validation was performed in animals with an ECL

thickness similar to adults. This final validation study confirmed that
accurate

measurements

of

CBF

can

be

obtained

from

DCE-NIR

measurements acquired on the surface of the head, during normal, oligemic
and ischemic blood flows.
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7.2. Future work
7.2.1. Improvements to DCE-NIR and KDOR analysis
The analytical method described in this thesis can be advanced in two
different directions, depending on the demands of the situation. In certain
cases, a large amount of information might be sought from a large number of
inputs—e.g., for imaging applications. To properly characterize the spatial
distribution of a parameter, such as CBF, it is necessary to increase the
number of channels of data so that the system is not underdetermined. For
example, a recent study demonstrated the use of a CW-NIRS instrument for
acquiring DCE data on the surface of the head, simultaneously, in 900
channels (Habermehl et al 2013). Another large-scale problem arises when
attempting to analyze the DTOFs directly, instead of reducing the problem to
the three statistical moments A, <t>, and V.
Since KDOR differs from traditional optical reconstruction methods, in
that it uses the NNLS algorithm with equality and inequality constraints, its
current implementation is computationally demanding, due to a need to
perform a full pseudo-inverse calculation for each iteration (Chen and
Plemmons 2009). This limitation can be somewhat mitigated by applying a
dimension-reduction method. For example, principle component analysis
(PCA) has been incorporated into FMT reconstruction schemes without
significant performance cost (Cao et al 2012). It stands to reason that an
analogous method could be applied to KDOR large-scale problems with
similar results. One immediate application could be to distinguish flow in an
infarct region from normal brain and ECL. There are other applications in
which DCE measurements could improve the clinical utility of NIRS such as
characterizing the uptake of a tracer into a tumor. In such cases, the goal
would be to reconstruct dynamic parameters on an image space defined by a
set of arbitrary node coordinates.
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Moving in the other direction, there are certain clinical settings where
it would be desirable to obtain hemodynamic measurements, but where there
is no a priori spatial information. Considering that the accuracy of the CBF
measurements obtained with the KDOR method were fairly insensitive to
uncertainties in the ECL thickness in the error analysis from Chapter 6, it
may be possible to use a standard landmarking system to place one or two
optodes on the head and estimate CBF using a population average head
geometry (Custo et al 2010; Okamoto et al 2004). Removing the dependence
of the KDOR workflow on anatomical priors from another imaging modality
would enable its use in remote or hostile environments. The development of
"field-unit" optical systems has been investigated by government defense and
humanitarian organizations as a means of directly assessing brain injury in
patients for whom access to NCU is not available. In particular, the
portability of biomedical optics compared to traditional imaging methods is
desirable in remote villages or on the battlefield. Near-infrared spectroscopy
has shown promise in assessing severity of brain injury and presence of
hematoma (Kessel et al 2007; Gopinath et al 1995). Unlike these studies,
which used simple CW instrumentation and did not account for ECL
contributions, time-resolved NIR in combination with the methods described
in this thesis would significantly improve accuracy and precision, and
therefore the predictive value of the recovered parameters. While TR NIR is
considerably less compact than CW NIR, scaled-down versions have been
developed (Wilmink et al 2011; Re et al 2010) and are therefore quite feasible.

7.2.2. Clinical validation
Clinical trials, including validation studies and randomized controlled trials,
are ambitious, yet necessary next steps before DCE-NIR can be accepted as a
clinically useful tool for the management of NCU patients. Three principle
objectives should be addressed.
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First, CBF measurements determined using the DCE-NIR method
should be compared to a clinical standard such as CT perfusion to determine
their accuracy and precision in NCU patients compared with the animal
model. The comparisons could be made during routine CT imaging, adding
the CT perfusion scan to the protocol with only a slight increase in dose to the
patient (2.0-3.4 mSv compared to 1.5-2.5 mSv for a routine head CT (Hoeffner

et al 2004)).
Second, it is necessary to determine the predictive value of DCE-NIR
measurements of CBF for identifying DII in susceptible patients. For
example, along the same lines as a previous study (Pham et al 2007), CT
perfusion and DCE-NIR measurements could be obtained in SAH patients
during the first two weeks of admission to the NCU. The two modalities could
be compared in their abilities to predict the development of DII, as defined by
the presence of delayed infarction on CT.
Finally, should the first two objectives be met, a randomized controlled
trial should be conducted comparing clinically relevant endpoints (i.e.,
Glasgow outcome scale, survival, etc.) of two groups of patients: those in
whom CBF values are calculated with DCE-NIR at regular intervals during
the acute recovery stage to inform patient management, and a control group
for whom management is determined using current clinical practices. This
final objective will be necessary before DCE-NIR can be recommended as
standard-of-care.

7.2.3. Future applications
In Appendix A, the results of a recent numerical simulation are presented to
highlight the use of the KDOR method in a completely different application.
In particular, we investigated the ability of KDOR to recover the rate
constants and molecular binding potential of a targeted tracer using the dualtracer method (Tichauer et al 2012). These numerical experiments suggest
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that the KDOR method improves the quantification of other dynamic
parameters, compared with the traditional two-step method employed in
FMT and DOT. Since commercially available solutions already exist for small
animal preclinical imaging, KDOR can likely be incorporated into existing
systems to improve the accuracy of these devices in evaluating molecular
expression and drug binding.
In addition to small animal experiments, KDOR could be used in
conjunction with targeted tracers to detect primary or metastatic cancer in

vivo. In one potential application, the dual tracer method could be applied to
breast cancer imaging targeting the HER2 receptor, which is expressed in the
majority of primary tumors and lymph node metastasis (Carlsson et al 2004).
In another application, a passive leaky tracer could be used to assess tissue
permeability, a hallmark of cancer progression, in a variety of different
cancers (St. Lawrence et al 2013). In both cases, accurate quantification of
dynamic parameters is necessary to properly direct and monitor treatment.

7.3. Principle conclusions
The salient finding of this thesis is that DCE-NIR techniques have the
potential to assess cerebral hemodynamics at the bedside of NCU patients,
given that:
(i)

CBF measurements obtained using a depth-resolved CW
NIRS method showed strong agreement with CT perfusion
measurements of CBF acquired in juvenile pigs.

(ii)

Relative changes in CBF derived from statistical moments
of TR-NIR data were in good agreement with percent
change in CBF measured by CT perfusion.
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(iii)

Numerical

simulations

demonstrated

that

KDOR

significantly improves the accuracy of flow measurements
obtained from a heterogeneous medium (e.g., the adult
head).
(iv)

Experimental multichannel TR-NIR data analyzed with the
KDOR method provided accurate quantification of CBF in
an adult pig model of ischemia.
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APPENDIX A
Applying KDOR to small animal fluorescence
imaging of molecular binding
A.1.

Background

The kinetic deconvolution optical reconstruction (KDOR) approach can be
extended to more complex tracer kinetic models to characterize the behaviour
of targeted tracers which bind to receptors of interest. Targeted tracer
methods have been extensively used in more established imaging modalities
such as positron emission tomography (PET), and have recently been applied
to planar fluorescence imaging to quantify molecular expression of epidermal
growth factor receptor (EGFR) in tumors (Tichauer et al 2012). Similar to
computed tomography (CT) perfusion, PET molecular imaging methodology
involves two-steps: spatial reconstruction of tracer concentration and
subsequent kinetic analysis. Spatial reconstruction in PET is a well-posed
problem: the radioisotope undergoes positive beta decay, and subsequent
postitron-electron annihilation, producing two 511 keV gamma photons that
are emitted at almost 180° and can be used to localize the source of the decay
(i.e., a radiolabeled tracer) with sub-centimeter resolution. However, using a
two-step (TS) reconstruction process in optical tomography will result in lossof-information that will decrease the accuracy of recovered kinetic
parameters. An alternative approach is to use the kinetic deconvolution
optical reconstruction (KDOR) algorithm to characterize the R(t) function for
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each region directly, and then to obtain information from these recovered
functions by fitting them with a kinetic model. This approach allows the
kinetic information to be extracted from the imaging data in a single
inversion, mitigating the loss-of-information from the spatial reconstruction
step.
In molecular imaging with targeted and untargeted probes, the uptake
of a tracer by the tissue can be described by the following convolution:
C t   K1C a t   R(t ),

(A.1)

where K1 is the rate constant governing the extraction of the tracer into the
interstitial space, and K1 = F x E, where E is the extraction fraction, and F is
the blood flow. Note that this notation differs slightly from applications
involving vascular tracers such as ICG, since this model specifically
characterizes the uptake of tracer into the tissue and does not attempt to
model the vascular dynamics of the dye. To extract meaningful information
from the impulse residue functions of targeted and untargeted tracers,
mathematical models are derived through compartmental analysis (Goldberg

et al 1980; Hine et al 1980; Tichauer et al 2012), assuming the targeted
tracer can be in one of three “spaces”: the arterial space, Ca(t), unbound in the
extracellular extravascular space (EES),Cf(t), or bound to its receptor in the
EES, Cb(t). The untargeted tracer is assumed to only occupy the arterial
space and the unbound EES.

The transport of each tracer from one

compartment to the other is described by first order rate constants (e.g. K1
and k2 describe transport between blood and the ESS, and k3 and k4 describe
transport between the free and bound states), and is summarized in Figure
A.1.
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Figure A.1: The dual-tracer compartment model
The targeted tracer, CT(t), characterizes the delivery, uptake and binding of a ligand to a
receptor-of-interest. The untargeted tracer, CU(t), is designed to behave identical to the
targeted tracer in terms of delivery and uptake, but does not have the ability to occupy the
bound space. By the simultaneous injection of targeted and untargeted tracers, parameters
K1, k2, and k3/k4 can be characterized. (Adapted from Tichauer et al 2012).

If an untargeted tracer is selected that has the same arterial input function,

Ca(t), as the targeted tracer, and the binding kinetics (k3 and k4) are much
faster than the vascular leakage kinetics (k2), then the following set of
equations describes the residue function in Eq. A.1 for the targeted, RT(t),
and untargeted, RU(t), tracers:

RT t   e



k2
t
1 BP

RU t   e  k2t ,

(A.2a)
(A.2b)

where BP is the binding potential and is equal to k3/k4 by definition (Tichauer

et al 2012). Often, the measurement of Ca(t) is difficult, and is avoided by
combining the targeted and untargeted model-specific versions of Eq A.1
(Lammertsma and Hume 1996). However, pulse dye densitometers can
quantify the Ca(t) of indocyanine green and its derivatives (Iijima et al 1997),
and Ca(t) can be estimated for near-infrared and red dyes using widely
available standard pulse oximeters (Elliott JT et al 2012b). Since both of
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these approaches enable the Ca(t) to be measured independent of the FMT
data at high temporal resolution, Ca(t) can be used as a time-reference for the
FMT projection data. In this case, the KDOR method recovers the K1R(t)
from each region, which is analogous to vector RF from Eq. 5.3. (see Chapter
5) in the dual-tracer approach, and can be formulized as:

S U  CA  AR U

(A.3a)

ST  CA  AR T

(A.3b)

where SU and ST represent the signal vector measured at the wavelengths
corresponding to the untargeted and targeted tracers, respectively, and RU
and RT represent the stacked RT(t) and RU(t) functions from each region. An
implicit assumption in this technique is that CA, the Toeplitz matrix of the
AIF, is the same for both tracers; this requires consideration when designing
probe pairs, but has been demonstrated to be a valid assumption in
applications using IRDye 700DX and IRDye 800CW-EGF (both by LI-COR
Biosciences, Lincoln, NE) (Samkoe et al 2012). The kinetic parameters (i.e.,

K1, k2, BP) are recovered by optimizing the following expression:
2
k

 2 t
arg min  K1 RT ,rec (t )  K1e 1 BP  K1 RU ,rec (t )  K1e k2t
K1 ,k2 , BP 
2




2

2

(A.4)

Optimization was performed in MATLAB using the fminsearchbnd function
(D’Errico 2005).

A.2.

Numerical experiment

The numerical simulations presented in this subsection demonstrate the
ability of KDOR to quantify the molecular expression of a targeted tracer in
small animal imaging of cancer using FMT. Numerical simulations were
performed with NIRFAST using the heterogenous optical digimouse (Dogdas
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et al 2007) and the previously described fan-beam FMT configuration
(Tichauer et al 2011). This configuration is shown in Fig. A.2. Fluorescence at
the targeted (800 nm) and untargeted (700 nm) dye wavelengths was
simulated in the digimouse head and signal was recorded in the five detectors
simultaneously with an integration time of 12 seconds. This was repeated for
32 source detector positions, with a rotation time (deadtime) between
positions of 32 seconds. A complete set of optical data (32 source-positions x 5
detectors) was acquired every 23.5 minutes for 2.5 hours.

Figure A.2: Fan beam FMT and digimouse mesh used in simulations
(A) The FMT system, based on published work by the Optics in Medicine group at Dartmouth
College, consists of one source position and five detector positions, which rotate around a
gantry to collect tomography data. A cross section of the mouse head with a tumor region is
shown in the centre of the system. (B) The digimous mesh used in the simulations, showing
the tumor inclusion located in the head slice.

Targeted and untargeted tracer uptake in each tissue region was
simulated using Eq. A.1. The true (input) values for the kinetic parameters
are given in Table 1 and are from kinetic planar imaging data (Tichauer et al
2012). An arterial input function was simulated using a biexponential model
of the form aetb  ce td , for which parameters a-d were defined as 0.15 uM,
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3.6 min-1, 0.05 uM, and 44 min-1. This model was previously shown to fit
experimental arterial input functions in mice with good agreement (Samkoe

et al 2012). Gaussian white-noise of 20% was added to the FMT signal and to
Ca(t). The targeted and untargeted uptake curves are shown in Figure A.3.

Figure A.3: Simulated uptake curves
The uptake curves used in the forward model for the background (grey solid line) and the
tumor (black solid line) regions, for the targeted (A) and untargeted (B) tracers. The arterial
input function is also shown (black dashed line).

Reconstruction of kinetic parameters was performed using the KDOR
and TS methods. In the KDOR approach, the region-specific K1R(t) functions
for the targeted and untargeted tracers were reconstructed from Eq. A.3, and
kinetic parameters were extracted by minimizing Eq. A.4. In the TS
approach, a time-series of targeted and untargeted concentration maps were
reconstructed using a Levenberg-Marquardt approach (Dehghani et al 2008)
with hard anatomical priors and these regions-of-interest were then used to
define the tracer uptake curves. Kinetic parameters were extracted by fitting
the tracer uptake curves with the convolution in Eq. A.1. In both cases,
reconstruction was performed on a homogeneous mesh (μa = 0.01 mm-1, μs′ =
1.0 mm-1) rather than the heterogeneous mesh used in the forward data, to
avoid the inverse crime. To compare the precision and accuracy of the two
approaches, the reconstruction procedure was repeated 100 times.
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A.3.

Results and discussion

For the tumor region, the KDOR-recovered K1R(t) functions and the tissue
uptake curves recovered from the reconstructed fluorophore maps are shown
in Fig. A.4. Both untargeted and targeted R(t) functions recovered with the
KDOR approach show a strong agreement with input values—the percent
difference in area under the fitted and input curves was less than 0.01% in
all cases and were not significantly different. Whereas the values recovered
using the TS method show marked deviations from the true values.

Figure A.4: Functions recovered with KDOR and TS methods
The mean KDOR-recovered K1R(t) (open circles ± SD) for the 100 repetitions, along with the
true (black line) and mean model-fitted (red line) K1R(t) functions for the targeted (A) and
untargeted (B) tracers. The mean C(t) uptake curves recovered with the two-step approach
(open squares ± SD), along with the true (black line) and mean model-fitted (red line) uptake
curves for the targeted (C) and untargeted (D) tracers.

Kinetic parameters were recovered by fitting the corresponding dualtracer model functions to these curves. Figure A.5 presents box-and-whisker
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plots for the three kinetic parameters recovered for the two regions
(background and tumor) with KDOR and TS methods. In general, KDOR is
more accurate and precise in recovering the kinetic parameters. In fact, the
TS method is only capable of accurately recovering the background K1
parameter, and in even in this case, exhibits high variability.

Figure A.5: Kinetic parameters recovered with the two approaches
Box-and-whisker plots of K1, k2 and binding potential recovered with the KDOR and TS
method for the background (top row) and tumor (bottom row) regions. Boxes are bound by the
1st and 3rd quartiles, and the median is given by the centre line. Error bars are min and max,
with outliers shown as crosses. Dashed lines show the true value of the parameter.

The most important parameter in preclinical cancer imaging
applications is BP, which can be used to assess molecular expression of a
particular receptor, and evaluate the affinity of a particular ligand ( e.g., a
prospective drug) for its receptor. Both methods exhibited different levels of
BP underestimation, likely owing to spatial blurring causing contamination
from the low-BP background. However, this underestimation was five times
less pronounced when KDOR was used. Also contributing to this
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improvement, the temporal resolution of the functions recovered with KDOR
show significant improvement over the uptake curves characterized from the
reconstruction fluorophore maps. This is a direct result of using the
independently-measured AIF to time-stamp each data projection. Of
particular interest, the mean error and 95% confidence interval in the tumor

BP recovered by KDOR was −5.86% (−25.0 - 13.3%), whereas the with the TS
approach, the error was −32.6% (−49.0 - −16.5%). The improved accuracy in
the KDOR-recovered values of K1 and k2 are also notable, since these
parameters could indicate enhanced vascular permeability, which is a
hallmark of tumor angiogenesis. Surprisingly, the errors in all KDOR-derived
parameters were comparable to reported results using more robust planar
imaging techniques (Tichauer et al 2012). This finding can be explained by
the negative monotonicity temporal constraint on the R(t) reconstructions
(see Chapter 5), which is valid irrespective of the kinetic model used since all
compartment models decay exponentially. Further studies are ongoing to
investigate the accuracy of this KDOR approach in animal studies.

A.4.
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